syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.079415690000001	100.0
SMITH-MAGENIS SYNDROME; SMS	5.150549014	63.74902853896851
PANDAS	2.7727338099999996	34.318494262299794
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.2147148499999996	27.41181955449057
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	2.02066968	25.01009673881503
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.992287530139443
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.0	24.754265366930262
NARCOLEPSY 1; NRCLP1	1.8373013	22.740521969602977
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.42459584	17.632411731992466
CRI-DU-CHAT SYNDROME	1.41072984	17.460790410203533
MONOSOMY 22Q13.3	1.389194554	17.194245318005166
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE II; CDG2	1.3736082	17.00133094649571
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE I; CDG1	1.3736082	17.00133094649571
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-NEGATIVE	1.3736082	17.00133094649571
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	1.3736082	17.00133094649571
DIGEORGE SYNDROME; DGS	1.300287854	16.093835295656138
LEUKOCYTE ADHESION DEFICIENCY, TYPE I	1.2636986000000001	15.64096524410913
BRAIN-LUNG-THYROID SYNDROME	1.2440830339999998	15.398180781065859
16P12.1P12.3 TRIPLICATION SYNDROME	1.2116359200000002	14.996578545892344
CITRULLINEMIA TYPE II	1.188060604	14.704783731705723
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	1.13809296	14.086327572037574
TRICHOTHIODYSTROPHY	1.134985884	14.047870880127963
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.11146498	13.75674953048492
SCHIZOPHRENIA	1.0894928	13.484796943279939
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.202275274933895
IMMUNODEFICIENCY 61; IMD61	1.05620014	13.072729273074449
IMMUNODEFICIENCY 13; IMD13	1.03703706	12.835545289290593
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	1.0175439	12.594275861550575
DISTAL 16P11.2 MICRODELETION SYNDROME	1.012721444	12.534587683778403
ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE	1.0119048	12.524479972635246
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO GAMMA CHAIN DEFICIENCY	1.0111107000000001	12.51465129157131
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	1.00671141	12.460200695528268
PROLIDASE DEFICIENCY	1.00359712	12.421654714983479
CHAR SYNDROME	1.0017908839999998	12.399298692353824
BROWN SYNDROME	1.0	12.377132683465131
TARDIVE DYSKINESIA	1.0	12.377132683465131
STRABISMUS, SUSCEPTIBILITY TO	1.0	12.377132683465131
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	1.0	12.377132683465131
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	1.0	12.377132683465131
SECRETORY COMPONENT DEFICIENCY	1.0	12.377132683465131
KERATODERMA, PALMOPLANTAR, NORRBOTTEN RECESSIVE TYPE	1.0	12.377132683465131
LEISHMANIASIS, TEGUMENTARY	1.0	12.377132683465131
CORONAVIRUS 229E SUSCEPTIBILITY	1.0	12.377132683465131
PLUMMER-VINSON SYNDROME	1.0	12.377132683465131
POLYEMBRYOMA	1.0	12.377132683465131
CARTILAGE-HAIR HYPOPLASIA; CHH	1.0	12.377132683465131
AASE-SMITH SYNDROME I	1.0	12.377132683465131
KIFAFA SEIZURE DISORDER	1.0	12.377132683465131
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.9801144539999999	12.13100664213998
DUPLICATION/INVERSION 15Q11	0.94523558	11.69930619079212
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO CD3DELTA/CD3EPSILON/CD3ZETA	0.9085285000000001	11.244977791209552
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.8488347199999999	10.506139955771973
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137844
7Q11.23 MICRODUPLICATION SYNDROME	0.83686542	10.357994341543773
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328383
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.7621951	9.433789883386973
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.7462712499999999	9.236698279105378
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.7262161200000001	8.988473274111238
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609601
POSTENCEPHALITIC PARKINSONISM	0.70087304	8.674798610343563
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.700545554	8.670745272669587
ACUTE ADRENAL INSUFFICIENCY	0.666667	8.25142591468765
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642505	8.221516573558056
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.186937835352298
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.65936251	8.161017272772604
48,XXXY SYNDROME	0.6482769640000001	8.02380999906195
COMBINED IMMUNODEFICIENCY DUE TO ZAP70 DEFICIENCY	0.6448411000000001	7.9812838544516085
SEVERE COMBINED IMMUNODEFICIENCY DUE TO DCLRE1C DEFICIENCY	0.6317457999999999	7.819201588821826
INHERITED CREUTZFELDT-JAKOB DISEASE	0.6182391599999999	7.652028113434027
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.594678234	7.360411406186724
XQ12-Q13.3 DUPLICATION SYNDROME	0.5919494699999999	7.326637132096861
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.58233251	7.207606742165284
IMMUNODEFICIENCY 21; IMD21	0.5804094	7.183804154530386
MUCOPOLYSACCHARIDOSIS TYPE 2	0.567459044	7.023515880020279
BARE LYMPHOCYTE SYNDROME, TYPE II	0.5671252000000001	7.019383848536701
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.56415163	6.9825795781031275
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.916744619189162
MANGANESE POISONING	0.5354894899999999	6.627824468331073
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.535012584	6.621921739491533
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.52677921	6.520016177060943
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.52677921	6.520016177060943
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.52677921	6.520016177060943
MANNOSE-BINDING LECTIN DEFICIENCY	0.525	6.497994658819193
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.5140845	6.36289206701283
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.513052284	6.350116192622835
OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES; EORVA	0.5121951	6.339506712520691
MOMO SYNDROME	0.5082875800000001	6.291142819017398
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.503557604	6.232599278475792
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.50190476	6.212141808982722
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.500545554	6.195318735976561
PARAPARETIC VARIANT OF GUILLAIN-BARRÉ SYNDROME	0.5	6.188566341732566
SEMANTIC DEMENTIA	0.5	6.188566341732566
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.188566341732566
ZUNICH NEUROECTODERMAL SYNDROME	0.5	6.188566341732566
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.188566341732566
VIRAL HEMORRHAGIC FEVER	0.5	6.188566341732566
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.5	6.188566341732566
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	6.188566341732566
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.188566341732566
BARTH SYNDROME; BTHS	0.5	6.188566341732566
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.016818154333632
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.48350111000000007	5.98435739107267
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.4780297100000001	5.91663714730836
IDIOPATHIC BRONCHIECTASIS	0.47549050000000004	5.885209008227178
16P13.2 MICRODELETION SYNDROME	0.46182036400000004	5.7160119211541645
SEVERE COMBINED IMMUNODEFICIENCY DUE TO COMPLETE RAG1/2 DEFICIENCY	0.4591872	5.68342090094884
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.458333	5.672848354210624
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-POSITIVE	0.458333	5.672848354210624
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.45177921	5.591731225801057
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.45177921	5.591731225801057
AUTISM	0.45177921	5.591731225801057
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445000000004	5.5681557585509
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445000000004	5.5681557585509
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445000000004	5.5681557585509
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44473696	5.504568363160925
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574125
WILLIAMS SYNDROME	0.42132148	5.214751860353901
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.06479745195534
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.4047616	5.0097880283716405
CHILDHOOD DISINTEGRATIVE DISORDER	0.40057911	4.958020794694374
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.4	4.950853073386053
PALLISTER-HALL SYNDROME	0.39641460399999995	4.906476151371287
X-LINKED ADRENOLEUKODYSTROPHY	0.39616841999999997	4.903429099338741
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.39560001	4.896393813350133
11Q22.2Q22.3 MICRODELETION SYNDROME	0.395377834	4.89364391151905
IMMUNODEFICIENCY DUE TO INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE-4 DEFICIENCY	0.392857	4.862443214628062
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.3904761	4.832974499421999
LEUKOCYTE ADHESION DEFICIENCY	0.38353785000000007	4.747098858580948
CHROMOSOME 17Q12 DELETION SYNDROME	0.38266460999999996	4.7362906512364376
CHILDHOOD APRAXIA OF SPEECH	0.37655271000000007	4.660642853988368
IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACEGLYCOPROTEIN	0.37480939999999996	4.639065674809955
49,XXXXY SYNDROME	0.371010144	4.592041779199504
COMBINED IMMUNODEFICIENCY DUE TO DOCK8 DEFICIENCY	0.3702381	4.582486088174032
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.366616654	4.537662970526028
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.363765514	4.502374032446893
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36324359000000006	4.495914109848209
ATYPICAL TERATOID RHABDOID TUMOR	0.36277170999999997	4.490073588477534
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.4380325726253105
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.358103654	4.432296439991689
ESOPHAGEAL ATRESIA	0.35359712	4.376518470731142
ANGELMAN SYNDROME	0.35319678400000004	4.371563458941175
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.34956927	4.326665236852047
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829092
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO JAK3 DEFICIENCY	0.3494019	4.324593676154816
ADNP SYNDROME	0.34824543	4.310279893520369
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.34554629	4.27687227960912
NON-DISTAL MONOSOMY 20Q	0.34535919000000004	4.274556518084045
PAPILLON-LEFÈVRE SYNDROME	0.34450622	4.263999195219029
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896494
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.342057784	4.233694577980056
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.3409091	4.219477163700683
ACNE INVERSA, FAMILIAL, 3; ACNINV3	0.3409091	4.219477163700683
PLACENTAL INSUFFICIENCY	0.34037525	4.212869631417615
SPINOCEREBELLAR ATAXIA TYPE 42	0.33902277	4.196129807005882
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361182
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361182
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361182
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.3368295	4.168983413205218
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.335783314	4.156034630271635
PRADER-WILLI SYNDROME	0.3357178	4.1552237548010105
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.33553349000000005	4.152942525476122
POTOCKI-LUPSKI SYNDROME	0.33485390400000004	4.1445311993842955
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.333878554	4.132459163021478
ELSAHY-WATERS SYNDROME; ESWS	0.333878554	4.132459163021478
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.333878554	4.132459163021478
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.33370320000000003	4.130288783296901
MAST SYNDROME	0.333333	4.125706768777483
ACITRETIN/ETRETINATE EMBRYOPATHY	0.333333	4.125706768777483
PITUITARY CARCINOMA	0.333333	4.125706768777483
ANAPLASTIC THYROID CARCINOMA	0.333333	4.125706768777483
VARICELLA, SEVERE RECURRENT	0.333333	4.125706768777483
ISOLATED CLEFT LIP	0.333333	4.125706768777483
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.069538102946649
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.3196921	3.956871539555603
ADULT IDIOPATHIC NEUTROPENIA	0.3163302	3.9152608571870617
CHROMOSOME 1P36 DELETION SYNDROME	0.314267084	3.8897253967136813
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.856037638781276
GITELMAN SYNDROME	0.31040850000000003	3.8419671905753865
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.30352690399999993	3.7567927638093823
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.297372674	3.6806210425348223
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.294281164	3.642357013072562
LEPTIN DEFICIENCY OR DYSFUNCTION	0.2940294	3.639240896639642
MYOCLONUS-DYSTONIA SYNDROME	0.29335655	3.630912942913573
2Q23.1 MICRODELETION SYNDROME	0.29246644	3.6198959333406937
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882243
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882243
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.289511774	3.5833256402233706
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.28927411000000003	3.5803840413612877
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2878137	3.562308353019028
CHRISTIANSON SYNDROME	0.28332509000000006	3.506752231484701
HYPERTRYPTOPHANEMIA; HYPTRP	0.27851856399999997	3.4472612214361744
ALLAN-HERNDON-DUDLEY SYNDROME	0.27840452	3.4458496837164216
21Q22.11Q22.12 MICRODELETION SYNDROME	0.2777728	3.438030801457623
WILLIAMS-BEUREN SYNDROME; WBS	0.27687041	3.426861800695391
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.2764808	3.4220395460305864
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.2758749	3.414540241337675
1P21.3 MICRODELETION SYNDROME	0.27544496399999996	3.4092188664202756
AUTOSOMAL DOMINANT SEVERE CONGENITAL NEUTROPENIA	0.275405	3.408724226689715
SYDENHAM CHOREA	0.27415040999999996	3.393195999796365
MARFAN SYNDROME; MFS	0.27066968	3.350114542751049
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.27066968	3.350114542751049
IMMUNE DEFECT DUE TO ABSENCE OF THYMUS	0.26805249999999997	3.3177213586345364
PRADER-WILLI-LIKE SYNDROME	0.267990744	3.316956996428537
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.26731353	3.308575028895437
LYSINURIC PROTEIN INTOLERANCE	0.2636986	3.2638325606439986
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.263143404	3.2569608260866696
WILSON DISEASE	0.25918378	3.207952034462036
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.25847458	3.1991741719629228
CHOANAL ATRESIA	0.25756512	3.1879176648726184
PREECLAMPSIA	0.25724638	3.1839725776010908
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.250545554	3.101035565110278
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.25	3.094283170866283
GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS	0.25	3.094283170866283
HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO	0.25	3.094283170866283
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.25	3.094283170866283
MÉNÉTRIER DISEASE	0.25	3.094283170866283
SPINOCEREBELLAR ATAXIA TYPE 37	0.25	3.094283170866283
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.24995319000000002	3.0937037972853703
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.24600009999999997	3.04477587784569
CONGENITAL MYASTHENIC SYNDROME	0.24600009999999997	3.04477587784569
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.243046384	3.0082173430044166
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.0037189483934075
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.239857604	2.9687493898460366
ADENYLOSUCCINASE DEFICIENCY	0.23963494400000002	2.965993497482737
SPASTIC PARAPLEGIA 16, X-LINKED	0.23927943	2.961593253533907
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362	2.9511245509389057
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.23790247400000003	2.9445504864226137
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.23225810000000002	2.874689320509513
T-B+ SEVERE COMBINED IMMUNODEFICIENCY DUE TO IL-7RALPHA DEFICIENCY	0.2294584	2.8400370621356155
PHELAN-MCDERMID SYNDROME	0.228044044	2.8225313902619606
PITT-HOPKINS-LIKE SYNDROME	0.22800763000000002	2.822080689352425
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.22798128399999998	2.821754601414746
NARCOLEPSY 7; NRCLP7	0.2261903	2.7995873548127834
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.7910378504116795
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.22545869400000002	2.790532170278764
TUBEROUS SCLEROSIS COMPLEX	0.22452100000000003	2.7789262072242753
POPOV-CHANG SYNDROME; POPCHAS	0.223889314	2.7711077457879876
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.753540831861815
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.22222199999999998	2.7504711791849883
POLYARTERITIS NODOSA	0.2208333	2.7332830550274605
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.220487524	2.7290033395967024
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417217
PARAGANGLIOMAS 4	0.216667	2.6817162071283396
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.216667	2.6817162071283396
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004	2.6576184248789403
SCHIZOPHRENIA 10	0.2144928	2.65480584524795
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.212115764	2.6253849552825765
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.21037934000000003	2.6038930050398235
PAROXYSMAL HEMICRANIA	0.20990245	2.5979904742344058
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.5914070773600706
CLEFT VELUM	0.20925926	2.5900296262637275
NARCOLEPSY TYPE 1	0.2089371	2.5860422091984225
VELOCARDIOFACIAL SYNDROME	0.2089071	2.5856708952179184
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.20877193000000002	2.583997878193095
RHABDOID TUMOR	0.20671141	2.558494548756161
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184	2.555653130406018
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.546085730613026
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.546085730613026
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.20470840400000004	2.5337030777283847
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.20444444	2.5304359602767263
APNEA, OBSTRUCTIVE SLEEP	0.2036865	2.52105483633062
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.20339339	2.51742697496977
MUCOLIPIDOSIS TYPE II	0.20148103000000003	2.493757441511219
TRANSALDOLASE DEFICIENCY	0.20054555400000001	2.482178930937022
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	2.4754265366930266
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.2	2.4754265366930266
DESMOPLASTIC SMALL ROUND CELL TUMOR	0.2	2.4754265366930266
BENIGN SCHWANNOMA	0.2	2.4754265366930266
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.2	2.4754265366930266
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	2.4754265366930266
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.2	2.4754265366930266
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.4754265366930266
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	2.4754265366930266
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.2	2.4754265366930266
EPISODIC ATAXIA, TYPE 4	0.2	2.4754265366930266
MALARIA	0.2	2.4754265366930266
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	2.4754265366930266
RADIATION PROCTITIS	0.2	2.4754265366930266
PULMONARY ARTERIOVENOUS MALFORMATION	0.2	2.4754265366930266
FAMILIAL ADENOMATOUS POLYPOSIS	0.2	2.4754265366930266
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.2	2.4754265366930266
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.4754265366930266
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	2.4754265366930266
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.4754265366930266
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.199729394	2.4720772103260846
8Q24.3 MICRODELETION SYNDROME	0.19910860400000002	2.4643936101275163
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.198029534	2.4510378175627694
PEDIATRIC-ONSET GRAVES DISEASE	0.19800696399999998	2.4507584656781036
PROGRESSIVE NON-FLUENT APHASIA	0.19787205000000002	2.449088617199247
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.19763954	2.4462108100790143
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.1970761	2.4392370384398427
HEREDITARY COPROPORPHYRIA	0.19663756	2.4338091706728355
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.19449443000000002	2.4072833663049216
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.3784708866737363
MONOSOMY X	0.19200631999999998	2.3764876987038646
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.19200631999999998	2.3764876987038646
MOSAIC MONOSOMY X	0.19200631999999998	2.3764876987038646
TURNER SYNDROME	0.19200631999999998	2.3764876987038646
DRACUNCULIASIS	0.1909091	2.362907261180913
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.189646084	2.3472747445675735
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.189525514	2.3457824336799287
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.189306384	2.3430702325950006
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.18826225400000002	2.3301468970462142
TRIGEMINAL NEURALGIA	0.18777814	2.324154953834291
GITELMAN SYNDROME	0.1870752	2.315454572185776
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.3113591027521445
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18629060000000003	2.3057434738823295
DDOST-CDG	0.18539768	2.29469168456661
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.18527559999999998	2.293180684208612
CUSHING DISEASE	0.18523062999999998	2.2926240845518366
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263564
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263564
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.2750642750998247
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.18370770400000003	2.2737746273827386
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.18333370000000002	2.2691455302505914
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18292109999999998	2.2640387253053933
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.2632453511003834
SOTOS SYNDROME	0.18199121399999998	2.252529402902897
WITTEVEEN-KOLK SYNDROME	0.180768554	2.2373963778561317
XIA-GIBBS SYNDROME	0.180448534	2.233435447854769
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.17894343000000001	2.214806575944355
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.17838315	2.207871916044463
PITT-HOPKINS SYNDROME	0.177694434	2.1993475867312378
BARDET-BIEDL SYNDROME 16; BBS16	0.176471814	2.1842150567697796
PLAGUE	0.17603755000000001	2.1788401136221274
2Q32Q33 MICRODELETION SYNDROME	0.175971204	2.1780189403771097
INSULINOMA	0.17526790999999997	2.1693141772236246
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.17479859999999997	2.1635054650839476
KOOLEN-DE VRIES SYNDROME; KDVS	0.174206054	2.1561714446208917
IMMUNODEFICIENCY 46; IMD46	0.173611	2.1488063823090644
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090644
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286091	2.1395224188545248
CHROMOSOME 16P13.2 DELETION SYNDROME	0.172051994	2.129510358192747
AURICULOCONDYLAR SYNDROME	0.17197395399999998	2.128544446758129
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.17195189400000002	2.128271407211132
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.17054221400000003	2.1108236108099048
TRISOMY 8P	0.16983503	2.1020707006102812
KOOLEN-DE VRIES SYNDROME	0.168457884	2.085025581843778
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.168457884	2.085025581843778
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.168367964	2.0839126300728807
MCLEOD SYNDROME; MCLDS	0.16835655	2.0837713574804315
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.167857	2.0775883608484067
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.167212554	2.0696119671990787
CEREBROOCULONASAL SYNDROME	0.166667	2.0628595729550834
ONDINE SYNDROME	0.166667	2.0628595729550834
MELIOIDOSIS	0.166667	2.0628595729550834
PARAGANGLIOMAS 3	0.166667	2.0628595729550834
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.0628595729550834
DERMATOLEUKODYSTROPHY	0.166667	2.0628595729550834
HEREDITARY PULMONARY ALVEOLAR PROTEINOSIS	0.166667	2.0628595729550834
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.166667	2.0628595729550834
PARAGANGLIOMAS 1	0.166667	2.0628595729550834
AL AMYLOIDOSIS	0.166667	2.0628595729550834
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.0628595729550834
ADDISON DISEASE	0.166667	2.0628595729550834
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	2.0628595729550834
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.0628595729550834
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.166667	2.0628595729550834
MICROSPORIDIOSIS	0.166667	2.0628595729550834
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.16621242	2.0572331759798335
SEVERE COMBINED IMMUNODEFICIENCY DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.16620086	2.0570900963260126
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.165421544	2.0474443987916655
PERRY SYNDROME	0.16532722	2.0462769381284303
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515095
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.1641336	2.031503345014792
SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED	0.1637426	2.0266638861355575
PGM3-CDG	0.161764	2.0021744914080535
MELAS	0.16137008	1.9972988913013827
49,XYYYY SYNDROME	0.16107896	1.9936956604345726
MYOTONIC DYSTROPHY 1	0.16025640000000002	1.9835147261744617
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.9815591392104739
SPINOCEREBELLAR ATAXIA TYPE 7	0.159996204	1.9802942457587545
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.159638054	1.9758613756881716
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.15963097399999998	1.9757737455887725
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.1589598	1.9674665359370809
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.944976048137956
VICI SYNDROME; VICIS	0.156178974	1.933047883565451
CHRONIC HICCUP	0.15454781999999997	1.9128588740802859
LENNOX-GASTAUT SYNDROME	0.15430775	1.9098874958369667
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.1536037	1.9011733755711733
DRAVET SYNDROME	0.15188942000000002	1.8799555045545626
L-2-HYDROXYGLUTARIC ACIDURIA	0.15162893	1.8767313852618466
DIENCEPHALIC SYNDROME	0.15162893	1.8767313852618466
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.15094827400000002	1.8683068156380502
BECKWITH-WIEDEMANN SYNDROME	0.15076845	1.8660811101303785
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.14925531	1.84735277558172
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454777
COFFIN-SIRIS SYNDROME 1; CSS1	0.14709080399999996	1.8205623976255632
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.1468253	1.8172762193895728
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14645412	1.8126820752801243
17Q24.2 MICRODELETION SYNDROME	0.14643326999999998	1.8124240120636737
3Q27.3 MICRODELETION SYNDROME	0.14511246	1.7960761714440265
49,XXXYY SYNDROME	0.14506307000000002	1.7954648648607903
EMANUEL SYNDROME	0.14456407400000001	1.789288725160272
NIJMEGEN BREAKAGE SYNDROME	0.144376	1.7869609083079618
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001187
8Q22.1 MICRODELETION SYNDROME	0.143402554	1.7749124380057733
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.143402554	1.7749124380057733
PRIMARY BILIARY CHOLANGITIS	0.14336909999999997	1.7744983734089805
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617782
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617782
IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION AND WITH RESPONSE TO HISTAMINE-1 ANTAGONIST	0.14285699999999998	1.7681600437617782
INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28	0.14285699999999998	1.7681600437617782
%174770 ACTINIC PRURIGOPOLYMORPHIC LIGHT ERUPTION, HEREDITARY; HPLE;;JUVENILE SPRING ERUPTION OF EARS, INCLUDED	0.14285699999999998	1.7681600437617782
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617782
LI-FRAUMENI SYNDROME	0.14285699999999998	1.7681600437617782
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617782
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.14285699999999998	1.7681600437617782
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617782
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.14285699999999998	1.7681600437617782
NEUROBLASTOMA	0.14285699999999998	1.7681600437617782
PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE	0.14285699999999998	1.7681600437617782
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617782
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617782
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617782
PERINEURAL CYST	0.14285699999999998	1.7681600437617782
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.140651204	1.7408586139971216
HUNTINGTON DISEASE-LIKE 1	0.14042569	1.7380673972971425
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.140179534	1.7350206918243116
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.13968239999999998	1.7288675983448496
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525000000003	1.7194962523335646
IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTSAND BETA-2-MICROGLOBULIN FROM LYMPHOCYTES	0.1386986	1.716690975210857
LUSCAN-LUMISH SYNDROME; LLS	0.13822633400000003	1.710845676266968
CYSTIC FIBROSIS	0.13710029999999998	1.6969086040428742
ADRENOCORTICAL CARCINOMA	0.13663752	1.6911807145796205
48,XYYY SYNDROME	0.136601954	1.6907405094786003
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13483588	1.6688815772517822
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13402696	1.6588694670814739
GRAFT VERSUS HOST DISEASE	0.13171141	1.6302095974962763
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.623272090855867
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.13053441	1.6156417123278377
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.1302778	1.6124656163099338
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.608112702516486
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668078
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.12915187	1.5985298313076397
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.12859712	1.5916636169514875
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.12856165	1.591224600055205
17P11.2 MICRODUPLICATION SYNDROME	0.127700594	1.5805671956953113
TETRASOMY 9P	0.12765052400000002	1.5799474726618503
USHER SYNDROME	0.12682065	1.5696760120532924
HSD10 DISEASE	0.12668632400000002	1.5680134413284534
LISSENCEPHALY, X-LINKED, 2	0.12645501000000003	1.5651504372589105
SMITH-MAGENIS SYNDROME	0.12632621400000002	1.5635563120778109
TONNE-KALSCHEUER SYNDROME; TOKAS	0.125881294	1.558049478204283
BRUNNER SYNDROME; BRNRS	0.12551648999999998	1.553534250692824
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.1251955	1.5495613148727587
KAPOSI SARCOMA	0.125	1.5471415854331414
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.5471415854331414
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.5471415854331414
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.5471415854331414
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.125	1.5471415854331414
IMMUNODEFICIENCY 25	0.125	1.5471415854331414
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.5471415854331414
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.12496515999999999	1.5467103661304493
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.12295130000000001	1.5217845537045265
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.12295130000000001	1.5217845537045265
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.12237621	1.5146665884695925
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12167381399999999	1.5059729399812571
X-LINKED AGAMMAGLOBULINEMIA	0.1216603	1.505805675410173
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.12149258000000002	1.5037297827165024
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.12125159999999999	1.5007471412824407
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511912
MOHR-TRANEBJAERG SYNDROME	0.11965903000000001	1.4810356910847347
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.119613294	1.4804696105443236
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.119524664	1.4793726252745882
FG SYNDROME TYPE 1	0.11950997399999999	1.4791908051954679
MYCETOMA	0.1192983	1.4765708880118282
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.11906773999999999	1.4737172163003285
COG8-CDG	0.11851840999999999	1.4669180860033204
TRISOMY XQ28	0.11851840999999999	1.4669180860033204
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.117888004	1.4591154672968683
RABIES	0.11694683	1.4474664318206405
INTESTINAL LYMPHANGIECTASIA	0.11666670000000001	1.4439992256420215
ROLANDIC EPILEPSY	0.11662072999999998	1.4434302488525623
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.11515305399999999	1.425264628264225
LIGNEOUS CONJUNCTIVITIS	0.11498661400000001	1.4232045783003895
WIEDEMANN-STEINER SYNDROME	0.11480911	1.4210075877405435
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11463909400000001	1.4189032771502317
GM2-GANGLIOSIDOSIS, AB VARIANT	0.114181954	1.4132451947153122
HENNEKAM-BEEMER SYNDROME	0.11411882000000001	1.4124637768204744
HADDAD SYNDROME	0.11374533	1.407841041534527
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.11369860000000001	1.4072626581242287
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.113502844	1.4048397601386442
STEINERT MYOTONIC DYSTROPHY	0.11235632999999999	1.3906492042371936
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.3902967034983689
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189494999999998	1.3849386427596966
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189494999999998	1.3849386427596966
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.11165655399999999	1.3819879838364892
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.11165655399999999	1.3819879838364892
W SYNDROME	0.11165655399999999	1.3819879838364892
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.11126539399999999	1.377146544616025
BEHÇET DISEASE	0.11125686000000001	1.3770409181657046
TRACHEOBRONCHOMEGALY	0.11111099999999999	1.3752355895924941
CANDIDIASIS, FAMILIAL, 9; CANDF9	0.11111099999999999	1.3752355895924941
IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN	0.11111099999999999	1.3752355895924941
TURCOT SYNDROME WITH POLYPOSIS	0.11111099999999999	1.3752355895924941
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11111099999999999	1.3752355895924941
MOUNIER-KÜHN SYNDROME	0.11111099999999999	1.3752355895924941
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.11111099999999999	1.3752355895924941
MUCKLE-WELLS SYNDROME	0.11111099999999999	1.3752355895924941
CANDIDIASIS, FAMILIAL, 8; CANDF8	0.11111099999999999	1.3752355895924941
PRIMARY IMMUNODEFICIENCY SYNDROME DUE TO LAMTOR2 DEFICIENCY	0.11111099999999999	1.3752355895924941
311450 PALLISTER W SYNDROME;;W SYNDROME	0.11111099999999999	1.3752355895924941
MICROCEPHALY, AUTOSOMAL DOMINANT	0.11111099999999999	1.3752355895924941
FOVEAL HYPOPLASIA 2; FVH2	0.11111099999999999	1.3752355895924941
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 13; ARCI13	0.11111099999999999	1.3752355895924941
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11111099999999999	1.3752355895924941
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924941
ULNAR-MAMMARY SYNDROME	0.11111099999999999	1.3752355895924941
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.1104094	1.3665517933017752
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.110274644	1.364883900409882
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.110026724	1.3618153616749975
22Q11.2 DELETION SYNDROME	0.109039514	1.349596532518554
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.10868672	1.3452299543706234
MOWAT-WILSON SYNDROME; MOWS	0.10818997000000001	1.3390816137101123
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.107255364	1.3275138712413495
HURLER SYNDROME	0.107154724	1.3262682366080856
DISTAL MONOSOMY 12Q	0.10715121400000002	1.326224792872367
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.10698568400000001	1.3241760060992727
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.106466654	1.3177519029225735
HUNTINGTON DISEASE-LIKE 1	0.1063492	1.31629815918037
TRICHOHEPATOENTERIC SYNDROME 1	0.10633490000000001	1.3161211661829966
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.10601279999999999	1.3121344917456523
YOUNG SYNDROME	0.1059783	1.3117074806680726
YOUNG SYNDROME	0.1059783	1.3117074806680726
DEMENTIA, LEWY BODY; DLB	0.1055556	1.306475666682772
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.10550188	1.3058107671150165
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10487747400000001	1.2980824112046647
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.294770612304019
KUFOR-RAKEB SYNDROME	0.10459870000000002	1.2946319884179645
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.10393371	1.2864013189547867
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.103693394	1.283426895936827
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106442
NIEMANN-PICK DISEASE, TYPE C2	0.103502854	1.2810685570753197
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.10349451400000001	1.2809653317887397
HUNTINGTON DISEASE-LIKE 2	0.10330206	1.278583303095276
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.10298430000000001	1.2746503454137783
MYASTHENIA GRAVIS	0.1029573	1.2743161628313247
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.269466059617982
SPINOCEREBELLAR ATAXIA TYPE 29	0.10245031400000001	1.2680411298406655
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.10218380400000002	1.2647425002091952
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.10179088400000001	1.259879277235208
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.10179088400000001	1.259879277235208
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.10173595400000002	1.2591994013369054
ACROMEGALY	0.10163245	1.2579183185956357
SOMATOMAMMOTROPINOMA	0.10163245	1.2579183185956357
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.10138595400000001	1.2548674048976927
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.10129223400000001	1.253707420022598
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.10101929	1.2503291559194423
9P13 MICRODELETION SYNDROME	0.10091092	1.2489878460505353
47,XYY SYNDROME	0.10082484	1.2479224224691425
NORRIE DISEASE	0.10058753	1.2449852051120294
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.10054555400000001	1.2444656625905084
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.10010446	1.239006183626628
RING CHROMOSOME 22 SYNDROME	0.10007082400000002	1.238589866391687
COG4-CDG	0.10003916400000001	1.2381980063709286
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS	0.1	1.2377132683465133
ACQUIRED ICHTHYOSIS	0.1	1.2377132683465133
IMMUNODEFICIENCY 28; IMD28	0.1	1.2377132683465133
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.1	1.2377132683465133
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.1	1.2377132683465133
IMMUNODEFICIENCY 30; IMD30	0.1	1.2377132683465133
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.1	1.2377132683465133
CHÉDIAK-HIGASHI SYNDROME	0.09959722400000001	1.2327280563527978
RAMOS-ARROYO SYNDROME	0.09920640000000001	1.2278907758489155
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.09837165400000002	1.2175590138499237
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059284
RAYNAUD-CLAES SYNDROME; MRXSRC	0.096464114	1.1939491381709064
1P36 DELETION SYNDROME	0.09564493400000001	1.1838100386192656
CHIARI MALFORMATION TYPE I	0.09545455000000001	1.1814536305904568
ISOLATED AGAMMAGLOBULINEMIA	0.09450622	1.169716024352746
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.09425988400000002	1.1666670909960322
IMMUNODEFICIENCY 36; IMD36	0.09421882000000001	1.1661588364195183
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302322
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.09361615400000002	1.1586995593737053
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09231673	1.142616416113626
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.09206949400000002	1.1395563433374971
DUANE RETRACTION SYNDROME 1	0.09180788000000001	1.136318312147645
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166453999999999	1.1345441739487967
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.1319147758815218
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.091369414	1.1308913602884565
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.0910973	1.127523369205428
CONGENITAL ANALBUMINEMIA	0.0910816	1.1273290482222977
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.09097247400000001	1.125978381241082
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0909091	1.1251939928344001
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.0909091	1.1251939928344001
PYOMYOSITIS	0.0909091	1.1251939928344001
PEMPHIGUS VULGARIS	0.0909091	1.1251939928344001
KERION CELSI	0.0909091	1.1251939928344001
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09074071000000002	1.1231098074618315
PSEUDOMYXOMA PERITONEI	0.09047619999999999	1.1198359320957278
RHEUMATOID ARTHRITIS	0.0901315	1.1155695344597376
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.08982525000000001	1.1117790375754264
SCHIZOPHRENIA 1; SCZD1	0.08949280000000001	1.1076642598148085
8Q12 MICRODUPLICATION SYNDROME	0.08934333400000001	1.1058142993011417
DUBOWITZ SYNDROME	0.08918935	1.1039084189020107
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.096126544269936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.0900867510630585
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.087859244	1.0874455204569378
RIDDLE SYNDROME	0.08772955400000002	1.0858403301192194
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100152
3Q29 MICRODELETION SYNDROME	0.08656963399999999	1.0714838463770142
GABRIELE-DE VRIES SYNDROME	0.08629349	1.0680659754492716
FAMILIAL COLORECTAL CANCER TYPE X	0.08603923999999999	1.0649190894645004
LYNCH SYNDROME	0.08603923999999999	1.0649190894645004
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.08597524400000002	1.0641270024812897
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08584681999999999	1.062537481593548
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08569503	1.060658756623525
NASU-HAKOLA DISEASE	0.08565881	1.06021045687773
SLC35A2-CDG	0.085630754	1.0598632040431626
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.08523363	1.0549479476033743
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.08496466	1.0516188702255025
LAFORA DISEASE	0.08479032	1.0494610409134673
15Q13.3 MICRODELETION SYNDROME	0.084752114	1.048988160182163
DUANE-RADIAL RAY SYNDROME; DRRS	0.08457863000000002	1.0468409256957047
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534554
JACOBSEN SYNDROME	0.084319034	1.0436278715596077
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853621
RETT SYNDROME, CONGENITAL VARIANT	0.08399551000000001	1.0396235720853224
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.08394523400000001	1.0390012993625286
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08387885400000002	1.0381797052950001
TOWNES-BROCKS SYNDROME 1; TBS1	0.08387885400000002	1.0381797052950001
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.083672734	1.0356285307062842
CONGENITAL ENTEROVIRUS INFECTION	0.08363451000000001	1.0351554271865915
HEPATOCELLULAR CARCINOMA	0.0833334	1.0314285487642731
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.08333330000000001	1.031427311051005
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.08333330000000001	1.031427311051005
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.031427311051005
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.08323697	1.0302350218596066
SIALURIA	0.08239893400000001	1.0198625390940863
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08239476400000001	1.0198109264507962
SUSAC SYNDROME	0.0823679	1.0194784271583874
PHENYLKETONURIA	0.08224077999999999	1.0179050460516652
MEND SYNDROME	0.082207994	1.0174992493795054
NIJMEGEN BREAKAGE SYNDROME	0.08204898	1.0155311120029769
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.015379120813624
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.081913094	1.0138492329511517
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.08173713	1.0116713031756384
GLASS SYNDROME	0.08163030400000001	1.0103491035995946
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.080999154	1.0025372763064255
SPINOCEREBELLAR ATAXIA 12	0.08064715	0.9981804760933151
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.080202354	0.9926751769842405
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.08011995000000001	0.9916552517425922
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.080067204	0.9910024075020701
CRANIOPHARYNGIOMA	0.07957916400000001	0.9849618716672318
PRADER-WILLI SYNDROME; PWS	0.07914104400000001	0.9795392022959521
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.078964954	0.9773597130017208
KID SYNDROME	0.07861956	0.9730847256356481
NEUTROPHIL CHEMOTACTIC RESPONSE	0.078235	0.9683249754908946
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07816843000000001	0.9675010297681564
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.07815333	0.9673141350646359
FELTY SYNDROME	0.0770881	0.9541296420162284
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.07692310000000001	0.9520874151234567
ETHYLMALONIC ENCEPHALOPATHY	0.07692310000000001	0.9520874151234567
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	0.9520874151234567
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.0766806	0.9490859604477163
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07667009	0.9489558767832131
KLEEFSTRA SYNDROME	0.076331864	0.9447696087042154
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.07603724999999999	0.9411231321358089
FRAXE INTELLECTUAL DISABILITY	0.07602131	0.9409258406408346
PRIMROSE SYNDROME; PRIMS	0.07586609	0.9390046621057071
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0753968	0.9331961975086838
SCHAAF-YANG SYNDROME; SHFYNG	0.075308034	0.9320975289489032
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.07502572	0.9286032911125036
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07495905	0.927778107676497
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.07472353000000001	0.9248630453868874
SMITH-FINEMAN-MYERS SYNDROME	0.07451932	0.9223355111215967
CASPASE 8 DEFICIENCY	0.0744048	0.9209180818866864
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.074238714	0.9188624134278204
NIPAH VIRUS DISEASE	0.0739348	0.9151008295254578
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.073923664	0.9149629977758947
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.07330605400000001	0.90731875685926
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07197415400000001	0.8908336538381528
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.07197415400000001	0.8908336538381528
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07197415400000001	0.8908336538381528
FAMILIAL THYROID DYSHORMONOGENESIS	0.07197415400000001	0.8908336538381528
ATHYREOSIS	0.07197415400000001	0.8908336538381528
THYROID ECTOPIA	0.07197415400000001	0.8908336538381528
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.07197415400000001	0.8908336538381528
THYROID HEMIAGENESIS	0.07197415400000001	0.8908336538381528
IMMUNODEFICIENCY 60; IMD60	0.07175926	0.8881738822872721
ALZHEIMER DISEASE 4	0.07142860000000001	0.8840812595941575
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.8840812595941575
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.8840812595941575
H SYNDROME	0.0714285	0.8840800218808892
XP22.13P22.2 DUPLICATION SYNDROME	0.07115972	0.8807532961582274
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524645
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.070695334	0.8750055290198837
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471941
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.069895644	0.8651076597842435
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875289
FLOATING-HARBOR SYNDROME	0.06907224000000001	0.8549162792241476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06849176	0.8477316012440497
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.068316064	0.8455569885400955
WRINKLY SKIN SYNDROME	0.067962364	0.8411791967099539
DE BARSY SYNDROME	0.067962364	0.8411791967099539
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.06795380000000001	0.841073198945653
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06791203	0.8405562061134644
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.0677778	0.8388948235933631
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067604894	0.8367547430895957
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064401
SMITH-LEMLI-OPITZ SYNDROME	0.067351624	0.8336199866948545
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.06707581400000001	0.8302062497294281
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.06704545	0.8298304304726273
EPISODIC ATAXIA TYPE 6	0.06704545	0.8298304304726273
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.06704545	0.8298304304726273
EPISODIC ATAXIA, TYPE 6	0.06704545	0.8298304304726273
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.06704545	0.8298304304726273
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.06704545	0.8298304304726273
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.06704545	0.8298304304726273
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002703
CILIARY DYSKINESIA, PRIMARY, 33	0.06682206	0.8270655028024679
MEIGE DISEASE	0.0666667	0.8251425914687648
BULLOUS IMPETIGO	0.0666667	0.8251425914687648
GLIOBLASTOMA	0.0666667	0.8251425914687648
CRANIOECTODERMAL DYSPLASIA 1	0.0666667	0.8251425914687648
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	0.8251425914687648
BACTERIAL SUSCEPTIBILITY DUE TO TLR SIGNALING PATHWAY DEFICIENCY	0.0666667	0.8251425914687648
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.0666667	0.8251425914687648
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	0.8251425914687648
HAIM-MUNK SYNDROME	0.0666667	0.8251425914687648
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	0.8251425914687648
DESMOID TUMOR	0.0666667	0.8251425914687648
FLOATING-HARBOR SYNDROME	0.06660574400000001	0.8243881309689116
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.06651470000000001	0.8232612673008782
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.065840254	0.8149135596710458
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.065243944	0.8075329516805687
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06522877	0.8073451410692298
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765597
22Q11.2 MICRODUPLICATION SYNDROME	0.06458355399999999	0.799359217027735
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.79823594272818
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.0643116	0.7959932062859362
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394994
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.7957008584119527
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.7904451565605729
AUTOIMMUNE HYPOPARATHYROIDISM	0.06370096	0.788435233984105
MICROHYDRANENCEPHALY; MHAC	0.06349210000000001	0.7858501460518366
AMISH INFANTILE EPILEPSY SYNDROME	0.06346611	0.7855284643733933
KLEEFSTRA SYNDROME	0.06338615	0.7845387888440234
IMMUNODEFICIENCY 58; IMD58	0.06312092	0.7812560019423879
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.063045554	0.7803231869605659
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.7773084392443236
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06270057000000001	0.7760532742188934
CILIARY DYSKINESIA DUE TO TRANSPOSITION OF CILIARY MICROTUBULES	0.0625	0.7735707927165707
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.0625	0.7735707927165707
CILIARY DYSKINESIA, PRIMARY, 34; CILD34	0.0625	0.7735707927165707
DYSTONIA 12; DYT12	0.06247675	0.7732830243816802
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816802
LEGIONELLOSIS	0.0621118	0.7687659898088496
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701812
CENTRAL DIABETES INSIPIDUS	0.06203684999999999	0.7678383237142237
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.061947140000000005	0.7667279711411903
13Q12.3 MICRODELETION SYNDROME	0.06185108	0.7655390237756166
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0618502	0.765528131898855
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.06134204	0.7592385681544255
PERRY SYNDROME	0.060733920000000004	0.7517117862269567
ALG11-CDG	0.060614384	0.7502322732945059
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06052326	0.7491044194558579
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.06047538	0.7485118023429735
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.060378009999999996	0.7473066409335846
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215691
TURNPENNY-FRY SYNDROME; TPFS	0.059175663999999996	0.7324250449601509
CHARGE SYNDROME	0.058998013999999994	0.7302262473389334
1Q21.1 MICRODELETION SYNDROME	0.058926594	0.7293422725226804
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.0588235	0.7280662644058111
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0588235	0.7280662644058111
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0588235	0.7280662644058111
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.0588235	0.7280662644058111
FANCONI-LIKE SYNDROME	0.0588235	0.7280662644058111
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.05881001	0.7278992968859113
16P13.11 MICRODELETION SYNDROME	0.057663813999999994	0.7137126769126542
N-ACETYLASPARTATE DEFICIENCY; NACED	0.057651204	0.7135566012695157
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.057621950000000005	0.7131945206299937
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.057621950000000005	0.7131945206299937
WOLFRAM SYNDROME	0.057531979999999996	0.7120809500024622
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.057407410000000006	0.7105391305840831
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.057346484	0.7097850413982102
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.057325443999999996	0.7095246265265501
MEDULLOBLASTOMA	0.057256964	0.7086770404803864
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267632
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.057005480000000004	0.7055643896446179
ALEXANDER DISEASE	0.05690614	0.7043348452838425
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363914
BABESIOSIS	0.05660889	0.7006557425936825
MIETENS SYNDROME	0.056400784	0.6980799870194573
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.056390930000000006	0.6979580227539944
PFAPA SYNDROME	0.056390930000000006	0.6979580227539944
RHEUMATIC FEVER	0.056390930000000006	0.6979580227539944
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05607038	0.6939905328723097
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539003
DYSPHASIA, FAMILIAL DEVELOPMENTAL	0.055555600000000004	0.6876190325095155
BENIGN OCCIPITAL EPILEPSY	0.055555600000000004	0.6876190325095155
SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2	0.055555600000000004	0.6876190325095155
FAMILIAL DEVELOPMENTAL DYSPHASIA	0.055555600000000004	0.6876190325095155
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504071
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091226
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.05515545400000001	0.6826663723747577
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.05515545400000001	0.6826663723747577
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.05515545400000001	0.6826663723747577
FILIPPI SYNDROME	0.05515545400000001	0.6826663723747577
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.05515545400000001	0.6826663723747577
HYPERTRICHOSIS CUBITI	0.05515545400000001	0.6826663723747577
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.055155454	0.6826663723747576
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.05509279000000001	0.6818907717322811
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.05482505	0.67857691822761
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0546318	0.6761850373365303
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.054620810000000006	0.6760490126483392
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307625
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307625
HYDROXYKYNURENINURIA	0.054333154	0.6724886561691443
KAWASAKI DISEASE	0.05433041	0.6724546933170608
48,XXYY SYNDROME	0.054230334	0.6712160393866303
1Q21.1 MICRODUPLICATION SYNDROME	0.053790414	0.6657710911765204
LICHTENSTEIN SYNDROME	0.05378683000000001	0.665726731532983
DISTAL MONOSOMY 7Q36	0.053626230000000004	0.6637389640240183
SIMPSON-GOLABI-BEHMEL SYNDROME	0.053557604	0.6628895709164828
BIOTINIDASE DEFICIENCY	0.053177154	0.6581806907870585
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.053016624	0.6561937896773818
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.053012050000000005	0.6561371766724878
OCULOCEREBRORENAL SYNDROME OF LOWE	0.052903030000000004	0.6547878216673364
SCHINZEL-GIEDION SYNDROME	0.052810850000000006	0.6536468975765746
MUCOPOLYSACCHARIDOSIS, TYPE II	0.05274751	0.6528629299924038
KEUTEL SYNDROME; KTLS	0.05273756	0.6527397775222034
IMMUNODEFICIENCY 15A; IMD15A	0.0526316	0.6514282965430634
PARKINSON DISEASE, LATE-ONSET; PD	0.05249942	0.649792287144963
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.052450314	0.6491844956674088
RETT SYNDROME; RTT	0.05216591	0.6456643896237005
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.05216445	0.6456463190099826
ECTODERMAL DYSPLASIA SYNDROME	0.05216445	0.6456463190099826
GIANT CELL ARTERITIS	0.05206344	0.6443961048376259
HUNTINGTON DISEASE; HD	0.05203684	0.6440668731082457
ENCEPHALITIS LETHARGICA	0.05161783	0.638880730742547
GANGLIOCYTOMA	0.0514889	0.6372849470256678
CILIARY DYSKINESIA, PRIMARY, 20; CILD20	0.05112156	0.6327383311057238
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.05092595999999999	0.6303173639528379
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.050741884	0.6280390308769964
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.050741884	0.6280390308769964
AMYOTROPHIC LATERAL SCLEROSIS	0.050723950000000004	0.6278170593794512
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.050545554	0.6256090284172516
DEXTROCARDIA	0.050545554	0.6256090284172516
HISTIDINEMIA	0.05043863	0.6242856158822048
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.050368090000000004	0.6234125329427134
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.05028286999999999	0.6223577536954282
15Q24 MICRODELETION SYNDROME	0.050267414	0.6221664527326728
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726195
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.050100484	0.6201003379738219
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.05	0.6188566341732566
NUT MIDLINE CARCINOMA	0.05	0.6188566341732566
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.05	0.6188566341732566
PLATELET DISORDER, UNDEFINED	0.05	0.6188566341732566
SCHWARTZ-JAMPEL SYNDROME	0.04993078	0.6179998890489071
OROMANDIBULAR DYSTONIA	0.04989894	0.6176058011442656
DESANTO-SHINAWI SYNDROME	0.049881454	0.6173893746021625
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.049824363999999996	0.6166827640972634
MENINGIOMA	0.049802	0.6164059619019305
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.04952376	0.6129621485040831
USHER SYNDROME TYPE 1	0.049408904	0.611540560552591
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.049288894	0.6100551808592484
AICARDI SYNDROME	0.04907410999999999	0.607396770792963
NEUROFIBROMATOSIS TYPE 1	0.048942780000000005	0.6057712819576436
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085959
USHER SYNDROME TYPE 3	0.04886335	0.6047881663085959
MICROPHTHALMIA, SYNDROMIC 1	0.04848781	0.6001400579006474
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.048405673999999996	0.5991234497305583
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.048378109999999995	0.5987822864452713
ALSTRÖM SYNDROME	0.048208614	0.5966844119639546
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.04773568000000001	0.5908308450954329
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.047658453999999996	0.5898750086468195
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.047619	0.5893866812539261
LUJO HEMORRHAGIC FEVER	0.047619	0.5893866812539261
EBOLA HEMORRHAGIC FEVER	0.047619	0.5893866812539261
LYMPHOKINE DEFICIENCY	0.047619	0.5893866812539261
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.047619	0.5893866812539261
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.047619	0.5893866812539261
LASSA FEVER	0.047619	0.5893866812539261
MARBURG HEMORRHAGIC FEVER	0.047619	0.5893866812539261
MONOCYTE CHEMOTACTIC DISORDER	0.047619	0.5893866812539261
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.047619	0.5893866812539261
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.047619	0.5893866812539261
ADULT-ONSET STILL DISEASE	0.047619	0.5893866812539261
HALLERMANN-STREIFF SYNDROME; HSS	0.04749835	0.5878933801956661
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.047475624	0.5876120974783016
MICROTRIPLICATION 11Q24.1	0.04735926	0.5861718448107228
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04735926	0.5861718448107228
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.047165953999999996	0.5837792708002129
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.04700985	0.5818471508797933
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.046000054	0.569348771804561
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.04592227	0.5683860289159103
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045867254	0.5677050885841968
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0458128	0.5670311042010514
WHIM SYNDROME	0.0456402	0.5648948110998853
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.5625963775605658
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.5625963775605658
LITHIUM TRANSPORT	0.0454545	0.5625963775605658
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.045287384	0.5605279606550359
CD8 DEFICIENCY, FAMILIAL	0.04507352	0.5578809375508192
WHITE FORELOCK WITH MALFORMATIONS	0.04472363000000001	0.5535503025962017
HAMAMY SYNDROME; HMMS	0.044678749999999996	0.5529948168813678
8P INVERTED DUPLICATION/DELETION SYNDROME	0.044546199999999994	0.5513542279441743
LYME DISEASE	0.04454545	0.5513449450946619
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.04448623	0.550611971297147
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.04418211	0.5468478377054515
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.044146050000000006	0.5464015183008859
SLC39A8-CDG	0.04367104000000001	0.5405222565049131
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.04362747	0.5399829848338945
COFFIN-LOWRY SYNDROME	0.04357054	0.5392783546702249
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.538136687951502
JUVENILE XANTHOGRANULOMA	0.043478300000000004	0.538136687951502
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	0.538136687951502
EOSINOPHILIA, FAMILIAL	0.043478300000000004	0.538136687951502
COMMON VARIABLE IMMUNODEFICIENCY	0.043478300000000004	0.538136687951502
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.043478300000000004	0.538136687951502
COMPLEMENT COMPONENT C1R DEFICIENCY	0.043478300000000004	0.538136687951502
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.538136687951502
242680 CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA;;IMMOTILE CILIA SYNDROME DUE TO EXCESSIVELY LONG CILIA	0.043478300000000004	0.538136687951502
HYPOPLASMINOGENEMIA	0.043478300000000004	0.538136687951502
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	0.538136687951502
PSEUDOTRISOMY 13 SYNDROME	0.043478300000000004	0.538136687951502
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.538136687951502
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.538136687951502
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.538136687951502
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.538136687951502
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	0.538136687951502
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.043447884	0.5377602250838017
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.04331429	0.5361067144200868
HARTNUP DISEASE	0.043299144	0.5359192503684631
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	0.5337231262079053
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04298672	0.5320523370669642
16P13.11 MICRODUPLICATION SYNDROME	0.042791624	0.5296376079889509
KEPPEN-LUBINSKY SYNDROME	0.042768509999999996	0.5293515229441053
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.042621094	0.5275269355524396
OGDEN SYNDROME	0.042527114	0.5263637326228475
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.04250626	0.5261056198978665
FETAL HYDANTOIN SYNDROME	0.042267084	0.5231453068111662
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.5228274125353239
CORNELIA DE LANGE SYNDROME	0.042053549999999995	0.520502368160735
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.04182724	0.51770129926314
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.04171128	0.5162660469571655
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	0.5157142743821365
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821365
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.041666699999999994	0.5157142743821365
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.041666699999999994	0.5157142743821365
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.041666699999999994	0.5157142743821365
DISTAL 17P13.1 MICRODELETION SYNDROME	0.041666699999999994	0.5157142743821365
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0416666	0.5157130366688683
MYELOLYMPHATIC INSUFFICIENCY	0.0414764	0.5133589060324731
CERNUNNOS-XLF DEFICIENCY	0.0414764	0.5133589060324731
IMMUNE DEFICIENCY DISEASE	0.0414764	0.5133589060324731
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.041419823999999994	0.5126586573737734
MILD CANAVAN DISEASE	0.04140923999999999	0.5125276578014515
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.0412597	0.5106767813799663
SHUKLA-VERNON SYNDROME; SHUVER	0.041107004	0.5087868427277319
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264551
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.04063418	0.5029346373438052
WILSON DISEASE	0.0406015	0.5025301526477095
MERCURY POISONING	0.04	0.49508530733860523
TYPHOID	0.04	0.49508530733860523
BUERGER DISEASE	0.04	0.49508530733860523
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.49508530733860523
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.03997337	0.4947557042952446
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.49469790308561273
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.039756354	0.49206966846880973
YOU-HOOVER-FONG SYNDROME; YHFS	0.039756354	0.49206966846880973
TRANSKETOLASE DEFICIENCY	0.039720033999999994	0.49162013100974616
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.03964811399999999	0.4907299676271513
HURLER SYNDROME	0.039642994	0.4906665967078121
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.4906171624398743
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.039366054	0.48723887358245327
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.039271904	0.4860735665403051
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.039210800000000004	0.4853172742248146
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.039210800000000004	0.4853172742248146
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.039210800000000004	0.4853172742248146
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.48465707796747853
FETAL ALCOHOL SYNDROME	0.039134213999999994	0.4843693591411186
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.03911308	0.4841077808189864
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.039075413999999996	0.4836415837393309
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.48233079587962124
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.48233079587962124
4Q21 MICRODELETION SYNDROME	0.03893063	0.4818495729608882
HYPERPROLINEMIA, TYPE I	0.038901064	0.4814836306559688
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.038842864	0.4807632815337911
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.038842864	0.4807632815337911
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.038406873999999994	0.47536697545512707
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.038376214	0.47498749256705214
XQ28 (MECP2) DUPLICATION	0.038337674	0.4745104778734314
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.038220104	0.4730552983838364
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	0.4712556137831299
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.037762834	0.46739560692166837
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037684343999999995	0.46642412577734305
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.03761906	0.46561609704723583
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.03758791399999999	0.46523059887267654
KEUTEL SYNDROME	0.037582614	0.46516500006945416
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0370879	0.4590418592510865
CILIARY DYSKINESIA, PRIMARY, 23; CILD23	0.037037060000000004	0.4584126058254591
CILIARY DYSKINESIA, PRIMARY, 41; CILD41	0.037037060000000004	0.4584126058254591
CILIARY DYSKINESIA, PRIMARY, 19; CILD19	0.037037060000000004	0.4584126058254591
CILIARY DYSKINESIA, PRIMARY, 26; CILD26	0.037037060000000004	0.4584126058254591
IMMUNODEFICIENCY 20; IMD20	0.037037060000000004	0.4584126058254591
CILIARY DYSKINESIA, PRIMARY, 28; CILD28	0.037037060000000004	0.4584126058254591
CILIARY DYSKINESIA, PRIMARY, 27; CILD27	0.037037060000000004	0.4584126058254591
CILIARY DYSKINESIA, PRIMARY, 22; CILD22	0.037037060000000004	0.4584126058254591
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.036939523999999994	0.45720538981204456
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.036926643999999995	0.45704597234308153
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.036926643999999995	0.45704597234308153
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.036915784	0.4569115566821391
PITUITARY APOPLEXY	0.03680355	0.4555224215725431
BAKER-GORDON SYNDROME; BAGOS	0.036708684	0.45434825250339356
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.036559193999999996	0.45249799493854226
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.03655809	0.45248433058405985
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.036547913999999994	0.45235838088187275
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.036487714	0.4516132774943282
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.036430540000000004	0.4509056273102839
2Q37 MICRODELETION SYNDROME	0.036427664	0.45087003067668613
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.036340774000000006	0.44979458161781993
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03627531	0.4489843250038295
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.036259854	0.4487930240410739
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036259854	0.4487930240410739
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.036157744	0.44752919502276517
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.036116034	0.4470129448185379
COFS SYNDROME	0.03597881	0.44531450516318205
CLASSIC HOMOCYSTINURIA	0.035857700000000006	0.4438155106238877
OCHOA SYNDROME	0.0357928	0.44301223471273077
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.035714300000000004	0.44204062979707875
ZELLWEGER SYNDROME	0.035714300000000004	0.44204062979707875
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.035714300000000004	0.44204062979707875
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.035714300000000004	0.44204062979707875
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	0.44204062979707875
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.035714300000000004	0.44204062979707875
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0357143	0.4420406297970787
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.03567798	0.4415910923380153
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.035664553999999994	0.441424916954607
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.035513753999999995	0.43955844534594046
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.4393830118672852
CUSHING SYNDROME	0.035376540000000005	0.43786012946191155
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.035335934	0.4373575436121668
CHOREOACANTHOCYTOSIS	0.03531859	0.43714287462290474
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.03531276	0.43707071593936014
ISOTRETINOIN-LIKE SYNDROME	0.03527015	0.4365433263157177
SMITH-MAGENIS SYNDROME	0.03502418	0.4334989229895658
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03494899	0.4325682863830961
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.034800074	0.4307251332924052
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.034781493999999996	0.4304951661671463
CHROMOSOME 10Q26 DELETION SYNDROME	0.034750784	0.4301150644224372
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03473354	0.4299016331464435
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.034732544	0.42988930552229065
MYOCLONIC-ASTASTIC EPILEPSY	0.034723604	0.4297786539561006
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.03470841399999999	0.4295906453106386
SHORT SYNDROME	0.03432861	0.424889760808928
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.034162859999999996	0.4228382510666435
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.034110344	0.42218825356663875
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.03398513	0.4206384632748114
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.4206264574561084
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.033807873999999995	0.418444542243871
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.033662404	0.4166440407524074
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.033573953999999996	0.41554928336655483
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.03350343	0.4146763984611862
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03350343	0.4146763984611862
OCULODENTODIGITAL DYSPLASIA	0.03350343	0.4146763984611862
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.033440583999999995	0.4138985451805611
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.033374334	0.41307856014028155
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.41287701091166407
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.0332735	0.41183052434327705
JOUBERT SYNDROME 1	0.033062694	0.4092213505108065
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03302721	0.40878216033466647
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.4086414323360554
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.032994343999999995	0.40837537349189157
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.032803653999999995	0.40601517806048165
DISTAL MONOSOMY 10Q	0.032783363999999995	0.4057640460383341
FRAGILE X SYNDROME	0.03276267	0.40550791365458255
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534613
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.032547964	0.4028504690046465
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.03251714	0.40246895626681134
NEPHRONOPHTHISIS 11; NPHP11	0.032508383999999994	0.4023605820930348
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.03245731	0.4017284324183597
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.03243125399999999	0.4014059338491592
AMYLOIDOSIS	0.03242385	0.4013142935587709
SECKEL SYNDROME 2; SCKL2	0.0322581	0.3992627838164865
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.3992627838164865
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	0.3992627838164865
HYPER-BETA-ALANINEMIA	0.0322581	0.3992627838164865
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.3992627838164865
MEIER-GORLIN SYNDROME 5; MGORS5	0.0322581	0.3992627838164865
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0322581	0.3992627838164865
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.3992627838164865
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.3992627838164865
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.0322581	0.3992627838164865
SECKEL SYNDROME	0.0322581	0.3992627838164865
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.3992627838164865
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	0.3992627838164865
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0322581	0.3992627838164865
DYSTONIA, JUVENILE-ONSET	0.0322581	0.3992627838164865
COG1-CDG	0.0322581	0.3992627838164865
DEND SYNDROME	0.0322581	0.3992627838164865
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	0.3992627838164865
DENT DISEASE	0.0322581	0.3992627838164865
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.032233834	0.3989624403147896
HURLER-SCHEIE SYNDROME	0.03216852	0.3981540402707017
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.032131454	0.39769526947065637
WHIPPLE DISEASE	0.03209902	0.3972938295492009
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.032047243999999996	0.3966529911273818
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03204225	0.3965911797267606
AICARDI-GOUTIERES SYNDROME 7	0.032030064	0.3964403519878799
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.03195696	0.3955355340801879
OBESITY DUE TO SIM1 DEFICIENCY	0.031952244	0.3954771635224526
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.031920474000000004	0.395083942017099
20Q11.2 MICRODUPLICATION SYNDROME	0.031778164	0.39332255226491497
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.031664000000000005	0.39190952928923994
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.031601434	0.3911351416057662
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.03158345	0.39091255125158675
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.03158345	0.39091255125158675
CLASSIC PHENYLKETONURIA	0.031581224000000005	0.3908849997542335
WHIM SYNDROME	0.0315557	0.39056908581962063
SECKEL SYNDROME 9; SCKL9	0.031432074	0.38903895041449454
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.03137492	0.38833154777310386
HELSMOORTEL-VAN DER AA SYNDROME	0.03134270399999999	0.3879328060665732
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.03133789	0.3878732225498351
2Q23.1 MICRODUPLICATION SYNDROME	0.031320504	0.38765803372100033
TRISOMY 13	0.03121691	0.3863758370377895
MEHMO SYNDROME	0.03121691	0.3863758370377895
15Q11Q13 MICRODUPLICATION SYNDROME	0.031086043999999997	0.38475609119203513
ALSTROM SYNDROME; ALMS	0.031080304	0.38468504645043206
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.031066464000000002	0.3845137469340929
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.38438274736177114
MENTAL RETARDATION, X-LINKED 21	0.031014879999999998	0.383875284921749
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.03100006	0.38369185581538007
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.03082924	0.3815775940103906
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.3807235718552315
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.3807235718552315
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.030704254	0.380030625704815
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.030657129999999998	0.37944736570423937
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.030657129999999998	0.37944736570423937
COSTELLO SYNDROME; CSTLO	0.030362284	0.3757980176410504
CONGENITAL DISORDER OF GLYCOSYLATION	0.030362284	0.3757980176410504
TETRASOMY X	0.030362284	0.3757980176410504
PENTASOMY X	0.030362284	0.3757980176410504
HARTNUP DISORDER	0.030137654000000003	0.37301774232636364
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.030060534000000003	0.37206321785381485
MENTAL RETARDATION, X-LINKED 98; MRX98	0.030060534000000003	0.37206321785381485
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0300522	0.37196006683003086
ISOLATED CEREBELLAR AGENESIS	0.03004853	0.3719146427530825
NEUROFERRITINOPATHY	0.03004853	0.3719146427530825
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.030011443999999998	0.3714556244103835
6Q16 MICRODELETION SYNDROME	0.029968694	0.3709265019881654
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.029957354	0.3707861453035349
NAVAJO NEUROHEPATOPATHY	0.029957354	0.3707861453035349
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.029894513999999997	0.3700083662857059
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.029842820000000003	0.3693685427887669
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.029833174	0.3692491529669022
DOWN SYNDROME	0.02981673	0.36904562339705527
C SYNDROME	0.02981673	0.36904562339705527
QAZI-MARKOUIZOS SYNDROME	0.02964985	0.3669801274948386
LEIGH SYNDROME; LS	0.029644084	0.36690876094778574
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.029644084	0.36690876094778574
MIRAGE SYNDROME; MIRAGE	0.029628753999999997	0.3667190195037482
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.029581304	0.3661317245579178
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.02943871	0.3643668197000518
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.0294118	0.3640337510595397
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0294118	0.3640337510595397
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0294118	0.3640337510595397
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.0294118	0.3640337510595397
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0294118	0.3640337510595397
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0294118	0.3640337510595397
MYELOPEROXIDASE DEFICIENCY	0.0294118	0.3640337510595397
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0294118	0.3640337510595397
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0294118	0.3640337510595397
MONOMELIC AMYOTROPHY	0.0294118	0.3640337510595397
RAGWEED SENSITIVITY	0.0294118	0.3640337510595397
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.0294118	0.3640337510595397
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0294118	0.3640337510595397
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0294118	0.3640337510595397
BLOOD GROUP, DUFFY SYSTEM; FY	0.0294118	0.3640337510595397
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0294118	0.3640337510595397
ECHO VIRUS 11 SENSITIVITY	0.0294118	0.3640337510595397
MYASTHENIA GRAVIS; MG	0.0294118	0.3640337510595397
IMMUNE SUPPRESSION	0.0294118	0.3640337510595397
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.0293714	0.3635337148991277
ASPARTYLGLUCOSAMINURIA; AGU	0.02931138	0.3627908393954662
17Q21.31 MICRODUPLICATION SYNDROME	0.029181284	0.36118062394187805
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.029116954	0.36038440299635077
PROPIONIC ACIDEMIA	0.029116954	0.36038440299635077
ALG1-CDG	0.029116954	0.36038440299635077
GALLOWAY-MOWAT SYNDROME	0.029116954	0.36038440299635077
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.029116954	0.36038440299635077
COFFIN-SIRIS SYNDROME 7; CSS7	0.029083903999999997	0.3599753387611622
PROGRESSIVE SUPRANUCLEAR PALSY	0.029076499999999998	0.3598836984707739
CORNELIA DE LANGE SYNDROME 1	0.029018569999999997	0.35916669117442074
WIEACKER-WOLFF SYNDROME	0.028931114	0.3580842366584556
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.028911904000000002	0.3578464719396063
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02873829	0.3556976284258992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.028737334	0.3556857958870538
ADIPOSIS DOLOROSA	0.028665130000000004	0.3547921173987769
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.3536320087523556
DYSOSTEOSCLEROSIS	0.0285714	0.3536320087523556
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.0285714	0.3536320087523556
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.0285714	0.3536320087523556
ALPHA-THALASSEMIA	0.0285714	0.3536320087523556
CHERUBISM	0.0285714	0.3536320087523556
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.3536320087523556
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0285714	0.3536320087523556
ACRODYSOSTOSIS	0.0285714	0.3536320087523556
ALG12-CDG	0.0285714	0.3536320087523556
SCHEIE SYNDROME	0.0285714	0.3536320087523556
ACHONDROPLASIA	0.0285714	0.3536320087523556
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.3536320087523556
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASES DUE TO PARTIAL IRF8 DEFICIENCY	0.0285714	0.3536320087523556
CONGENITAL LOBAR EMPHYSEMA	0.0285714	0.3536320087523556
MARSHALL-SMITH SYNDROME; MRSHSS	0.0285714	0.3536320087523556
GHOSAL HEMATODIAPHYSEAL DYSPLASIA	0.0285714	0.3536320087523556
COG7-CDG	0.0285714	0.3536320087523556
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.0285714	0.3536320087523556
CHEILITIS GLANDULARIS	0.0285714	0.3536320087523556
TOXIC EPIDERMAL NECROLYSIS	0.028550769999999996	0.3533766685050957
WYBURN-MASON SYNDROME	0.028533564	0.3531637075601441
DUPLICATION OF THE PITUITARY GLAND	0.028323354000000002	0.3505619104987529
HEREDITARY FOLATE MALABSORPTION	0.028299204	0.3502630027444472
SALT-AND-PEPPER SYNDROME	0.028297364000000002	0.35024022882030964
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.02824098	0.3495423565710851
HYPERLYSINEMIA, TYPE I	0.02822056	0.34928961552168875
7Q11.23 DUPLICATION SYNDROME	0.02822056	0.34928961552168875
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.34817072272710353
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.02798801	0.34641131331614894
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.02798801	0.34641131331614894
COFFIN-SIRIS SYNDROME 8; CSS8	0.027974979999999997	0.3462500392772833
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.027926644000000004	0.34565177819189546
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.027851554	0.34472237929869404
RICHARDS-RUNDLE SYNDROME; RRNS	0.027806824	0.34416875015376264
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME B-POSITIVE, TYPE III; CDG3	0.027777800000000002	0.34380951625475775
CILIARY DYSKINESIA, PRIMARY, 24; CILD24	0.027777800000000002	0.34380951625475775
CILIARY DYSKINESIA, PRIMARY, 25; CILD25	0.027777800000000002	0.34380951625475775
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.027777800000000002	0.34380951625475775
%120050 COXSACKIEVIRUS B3 SUSCEPTIBILITY; CXB3S;;CB3S	0.027777800000000002	0.34380951625475775
IMMUNODEFICIENCY 24	0.027777800000000002	0.34380951625475775
CILIARY DYSKINESIA, PRIMARY, 36, X-LINKED; CILD36	0.027777800000000002	0.34380951625475775
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.34380951625475775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.027751810000000002	0.3434878345763145
RABSON-MENDENHALL SYNDROME	0.027665164	0.34241540553782296
MENTAL RETARDATION, X-LINKED 104; MRX104	0.027570624000000002	0.3412452714139282
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.02740662	0.33921537214530917
SCIMITAR SYNDROME	0.02740662	0.33921537214530917
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.33755844539297364
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.3363082312206168
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.02711961	0.3356630112938278
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.3356630112938278
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.02711961	0.3356630112938278
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.026914450000000003	0.33312371875248814
MAN1B1-CDG	0.026818604	0.3319374200933087
SARCOSINEMIA	0.026581164	0.3289985937089468
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.026564034000000004	0.32878657342607903
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.02655498	0.3286745108667629
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518481
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.3285014785518481
ALG13-CDG	0.02649091	0.3278815079757333
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.026345814000000002	0.32608563553189324
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0263158	0.3257141482715317
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.3257141482715317
HUNTINGTON DISEASE-LIKE 2	0.0263158	0.3257141482715317
ALZHEIMER DISEASE 3; AD	0.0263158	0.3257141482715317
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.3257141482715317
ALZHEIMER DISEASE 10	0.0263158	0.3257141482715317
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.3257141482715317
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.026311749999999995	0.32566402088416363
BARATELA-SCOTT SYNDROME	0.026295664	0.3254649223278175
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.3240781388734313
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.0260899	0.3229181539983369
JUVENILE MYOCLONIC EPILEPSY	0.02601594	0.3220027412650679
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.025992634	0.321714279810747
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.025960614000000003	0.3213179640222225
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.321090175272316
DISTAL TRISOMY 5Q	0.02571426	0.3182688078771201
DISTAL TRISOMY 6P	0.025600384	0.3168593495156578
RETT SYNDROME	0.02557119	0.31649801150409673
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.025545554	0.3161807113306235
OROFACIODIGITAL SYNDROME TYPE 4	0.025419274	0.31461772701535545
PEHO SYNDROME	0.025419274	0.31461772701535545
DUBOWITZ SYNDROME	0.025326019999999998	0.31346350988409155
AGEL AMYLOIDOSIS	0.02527774	0.3128659419181339
BILATERAL POLYMICROGYRIA	0.025210594000000003	0.31203486696696997
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.02518961	0.31177514521474015
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.025189414	0.31177271929673417
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.025140554	0.31116797259382
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.025112464	0.3108202989367415
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.02510348	0.31070910277671326
CEREBROFACIOTHORACIC DYSPLASIA	0.02505483	0.3101069552716627
FREEMAN-SHELDON SYNDROME	0.02505483	0.3101069552716627
6P22 MICRODELETION SYNDROME	0.02505483	0.3101069552716627
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.025021579999999998	0.3096954156099374
SCHIZOPHRENIA 4	0.025	0.3094283170866283
SCHIZOPHRENIA 19; SCZD19	0.025	0.3094283170866283
SCHIZOPHRENIA 15; SCZD15	0.025	0.3094283170866283
MONILETHRIX	0.025	0.3094283170866283
HYPERPROLINEMIA TYPE 1	0.025	0.3094283170866283
MYOPATHY AND DIABETES MELLITUS	0.025	0.3094283170866283
MADRAS MOTOR NEURON DISEASE	0.025	0.3094283170866283
ACATALASEMIA	0.025	0.3094283170866283
CYSTINOSIS	0.024953649999999997	0.30885463698674964
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.30885463698674964
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.30885463698674964
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.024939354	0.30867769349790686
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02487372	0.3078653327713603
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.02485322	0.30761160155134926
19P13.3 MICRODUPLICATION SYNDROME	0.024837964	0.3074227760151303
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.024800864000000002	0.3069635843925738
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024800864000000002	0.3069635843925738
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.02476118	0.30647241025916316
TRISOMY 18P	0.02469528	0.3056567572153228
WHITE-SUTTON SYNDROME; WHSUS	0.024647314	0.30506307566902774
FRAGILE X MENTAL RETARDATION SYNDROME	0.02458615	0.3043060407255762
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.024553454	0.30390135799535767
16P11.2P12.2 MICRODELETION SYNDROME	0.024528943999999997	0.3035979944732859
CLEIDOCRANIAL DYSPLASIA	0.024430419999999998	0.3023785498527802
VASCULAR EHLERS-DANLOS SYNDROME	0.024390903999999998	0.3018894550776604
SULFOCYSTEINURIA	0.024355054	0.3014457348709582
DISTAL MONOSOMY 9P	0.024355054	0.3014457348709582
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.024355054	0.3014457348709582
GERODERMA OSTEODYSPLASTICA	0.024355054	0.3014457348709582
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.024355054	0.3014457348709582
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.024355054	0.3014457348709582
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.024355054	0.3014457348709582
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.30021119014857867
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.024193434	0.2994453426866565
SCLERODERMA	0.024156530000000002	0.29898857698210596
GAUCHER DISEASE, PERINATAL LETHAL	0.023972629999999998	0.2967124222816167
SICKLE CELL ANEMIA	0.02395281	0.2964671075118305
ROIFMAN SYNDROME; RFMN	0.023889314	0.2956812090949611
9Q33.3Q34.11 MICRODELETION SYNDROME	0.02382682	0.2949077125650406
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.29469334062696306
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.0238095	0.29469334062696306
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0238095	0.29469334062696306
BRITTLE CORNEA SYNDROME	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.29469334062696306
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.0238095	0.29469334062696306
HURLER-SCHEIE SYNDROME	0.0238095	0.29469334062696306
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.29469334062696306
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0238095	0.29469334062696306
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0238095	0.29469334062696306
MUCOPOLYSACCHARIDOSIS TYPE 4	0.0238095	0.29469334062696306
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.0238095	0.29469334062696306
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0238095	0.29469334062696306
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0238095	0.29469334062696306
SIALIDOSIS TYPE 1	0.0238095	0.29469334062696306
NON-DISTAL TRISOMY 13Q	0.0238095	0.29469334062696306
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.29469334062696306
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.023726913999999998	0.29367116274716637
JOUBERT SYNDROME 30; JBTS30	0.023726913999999998	0.29367116274716637
INTERLEUKIN 1, DEFECTIVE T-CELL RESPONSE TO	0.023343759999999998	0.288928814850966
ROIFMAN SYNDROME	0.023343759999999998	0.288928814850966
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.023293854	0.28831112166726497
KLEEFSTRA SYNDROME 2; KLEFS2	0.023246224	0.28772159883755155
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023181359999999998	0.2869187685031712
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.022917634	0.2836545968090917
2P15P16.1 MICRODELETION SYNDROME	0.022811544	0.2823415068027029
TAY-SACHS DISEASE; TSD	0.0227273	0.28129880763691706
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.28129880763691706
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.28129880763691706
CAUDAL REGRESSION SEQUENCE	0.0227273	0.28129880763691706
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.28129880763691706
MEHMO SYNDROME; MEHMO	0.022720683999999998	0.28121692052708325
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.022624184	0.28002252722312887
LOWRY-MACLEAN SYNDROME	0.02261456	0.2799034096981832
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.0225934	0.2796415095706011
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.022586794	0.2795597462320941
MOEBIUS SYNDROME; MBS	0.02257444	0.27940683913492265
CUTIS LAXA	0.022539324	0.27897220374361004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.022473180000000002	0.27815353067939497
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.02243237	0.27764841989458267
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.02240255	0.27727933379796177
CK SYNDROME	0.022392774	0.27715833494884823
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.022392774	0.27715833494884823
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.2734028158415005
CROUZON SYNDROME	0.02207863	0.2732701329791337
SAETHRE-CHOTZEN SYNDROME	0.02207863	0.2732701329791337
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.2721526016691437
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.2721526016691437
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.2721526016691437
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.021822154	0.27009569549700935
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021822154	0.27009569549700935
CEDNIK SYNDROME	0.021822154	0.27009569549700935
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.021822154	0.27009569549700935
DYSTONIA 28, CHILDHOOD-ONSET	0.021822154	0.27009569549700935
PYRUVATE DEHYDROGENASE DEFICIENCY	0.021822154	0.27009569549700935
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021822154	0.27009569549700935
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.27009569549700935
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.021757704	0.26929798929556
PORPHYRIA	0.02173918	0.26906871528973153
ALPHA-MANNOSIDOSIS	0.021647523999999998	0.26793427681649584
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.021585954	0.2671722167571749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.021585954	0.2671722167571749
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.021585954	0.2671722167571749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.021585954	0.2671722167571749
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.021585954	0.2671722167571749
INFANT BOTULISM	0.021532080000000002	0.2665054111109859
ATAXIA-TELANGIECTASIA	0.021509149999999998	0.266221603458554
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.021418750000000004	0.26510271066396884
TYSHCHENKO SYNDROME	0.021378854	0.2646089125784293
OROFACIODIGITAL SYNDROME TYPE 14	0.021378854	0.2646089125784293
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.021341464	0.2641461315873945
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530142
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.2633433012530142
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0212766	0.2633433012530142
X-LINKED RETINOSCHISIS	0.0212766	0.2633433012530142
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.2633433012530142
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530142
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530142
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.2633433012530142
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0212766	0.2633433012530142
RAVINE SYNDROME	0.0212766	0.2633433012530142
3MC SYNDROME 1	0.0212766	0.2633433012530142
PRIMARY BASILAR INVAGINATION	0.0212766	0.2633433012530142
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.2633433012530142
JUVENILE ABSENCE EPILEPSY	0.0212766	0.2633433012530142
KURU, SUSCEPTIBILITY TO	0.0212766	0.2633433012530142
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530142
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.0212766	0.2633433012530142
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.02127535	0.26332782983715985
CUTANEOUS MASTOCYTOSIS	0.02127535	0.26332782983715985
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.021234194	0.2628184365644392
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021215234000000003	0.2625837661287607
TEMPLE SYNDROME	0.021135559999999998	0.26159763045933826
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.021118994	0.261392590879304
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.021062763999999998	0.26069662470851274
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.020976494000000002	0.25962884947191023
NEPHROGENIC DIABETES INSIPIDUS	0.020953753999999998	0.2593473934746882
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.020953753999999998	0.2593473934746882
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.020953753999999998	0.2593473934746882
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020953753999999998	0.2593473934746882
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.02086915	0.2583002385411364
MORQUIO SYNDROME A	0.02086915	0.2583002385411364
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.02086915	0.2583002385411364
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.02086915	0.2583002385411364
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.2578565183344341
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.2578565183344341
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.2578565183344341
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.2578565183344341
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0208333	0.2578565183344341
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.2578565183344341
APNEA, CENTRAL SLEEP	0.0208333	0.2578565183344341
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.2578565183344341
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.2578565183344341
UNIQUE GREEN PHENOMENON	0.0208333	0.2578565183344341
DERMOIDS OF CORNEA	0.0208333	0.2578565183344341
611426 TENTED EYEBROWS	0.0208333	0.2578565183344341
INFANTILE MYOFIBROMATOSIS	0.0208333	0.2578565183344341
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.0208333	0.2578565183344341
PREPAPILLARY VASCULAR LOOPS	0.0208333	0.2578565183344341
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.2578565183344341
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344341
GLAUCOMA - SLEEP APNEA	0.0208333	0.2578565183344341
IMINOGLYCINURIA	0.0208333	0.2578565183344341
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.2578565183344341
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.2578565183344341
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.2578565183344341
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.2578565183344341
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.2578565183344341
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344341
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.0208333	0.2578565183344341
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.2578565183344341
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.2578565183344341
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.2578565183344341
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0208333	0.2578565183344341
GAUCHER DISEASE, TYPE I	0.0208333	0.2578565183344341
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0208333	0.2578565183344341
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0208333	0.2578565183344341
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.2578565183344341
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.2578565183344341
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.2578565183344341
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.2578565183344341
BLEPHAROCHALASIS AND DOUBLE LIP	0.0208333	0.2578565183344341
PUPIL, EGG-SHAPED	0.0208333	0.2578565183344341
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0208333	0.2578565183344341
HYPOCHONDROPLASIA	0.0208333	0.2578565183344341
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0208333	0.2578565183344341
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.2578565183344341
CRANDALL SYNDROME	0.0208333	0.2578565183344341
STICKLER SYNDROME, TYPE III	0.0208333	0.2578565183344341
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.2578565183344341
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.2578565183344341
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.2578565183344341
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.2578565183344341
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.2578565183344341
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.02079591	0.2573937373433994
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.020676729999999997	0.25591863067018394
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.020669680000000003	0.25583137188476557
MYHRE SYNDROME	0.020617114	0.2551807555281265
GAUCHER DISEASE, TYPE II	0.020574764	0.2546565839589818
FAMILIAL HYPERALDOSTERONISM TYPE I	0.020408199999999998	0.25259499923069306
PANHYPOPHYSITIS	0.020408199999999998	0.25259499923069306
TERATOMA, PINEAL	0.020408199999999998	0.25259499923069306
FAMILIAL COLD URTICARIA	0.020408199999999998	0.25259499923069306
PARATHYROID CARCINOMA	0.020408199999999998	0.25259499923069306
PRIMARY PARATHYROID HYPERPLASIA	0.020408199999999998	0.25259499923069306
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.020408199999999998	0.25259499923069306
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.25259499923069306
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.25259499923069306
NEPHRONOPHTHISIS 4	0.020408199999999998	0.25259499923069306
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.25259499923069306
NEPHRONOPHTHISIS 1	0.020408199999999998	0.25259499923069306
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.25259499923069306
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.020408199999999998	0.25259499923069306
FAMILIAL HYPERALDOSTERONISM TYPE III	0.020408199999999998	0.25259499923069306
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.25259499923069306
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.25259499923069306
HELIX SYNDROME; HELIX	0.020408199999999998	0.25259499923069306
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.25259499923069306
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.020407093999999997	0.2525813101219452
ANTISYNTHETASE SYNDROME	0.02026382	0.2508079888138544
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.020061544	0.2483043919231738
REACTIVE ARTHRITIS	0.01993005	0.24667687323809426
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.01993005	0.24667687323809426
HYPOTONIA-CYSTINURIA SYNDROME	0.019776354	0.24477455745317636
CHROMOSOME 18Q DELETION SYNDROME	0.0197593	0.24456347783239257
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.01967875	0.2435664997947394
ANDROGEN INSENSITIVITY SYNDROME	0.01967875	0.2435664997947394
EMANUEL SYNDROME	0.019564074	0.24214713972713042
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01944866	0.24071864533560094
XQ25 MICRODUPLICATION SYNDROME	0.019429454000000002	0.24048093012528235
CHROMOSOME 2Q37 DELETION SYNDROME	0.019369394	0.23973755953631345
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019334784	0.2393091869741387
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.019334784	0.2393091869741387
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.019334784	0.2393091869741387
ISOLATED COMPLEX I DEFICIENCY	0.019334784	0.2393091869741387
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.019334784	0.2393091869741387
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.019334784	0.2393091869741387
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.019329434	0.23924296931428216
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.019245174	0.23820007211437338
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.23803874856697713
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.23802216320918126
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.23802216320918126
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0192308	0.23802216320918126
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.23802216320918126
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0192308	0.23802216320918126
248100 MACROSOMIA ADIPOSA CONGENITA	0.0192308	0.23802216320918126
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.23802216320918126
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.23802216320918126
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.23802216320918126
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.23802216320918126
NETHERTON SYNDROME; NETH	0.019161763999999998	0.23716769547724553
RIFT VALLEY FEVER	0.01903825	0.23563894631098004
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.01900676	0.23524919040277775
GOOD SYNDROME	0.01898172	0.23493926700038376
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.01898172	0.23493926700038376
IMMUNODEFICIENCY 50; IMD50	0.01898172	0.23493926700038376
PRUNE BELLY SYNDROME	0.01898172	0.23493926700038376
SEVERE COMBINED IMMUNODEFICIENCY	0.01898172	0.23493926700038376
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.01897984	0.23491599799093885
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.018942954	0.23445945507477658
OCCIPITAL HORN SYNDROME	0.018942204	0.23445017222526393
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.23438873213862324
RUBINSTEIN-TAYBI SYNDROME	0.018892884000000002	0.23383973204131547
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3	0.018616209999999998	0.23041530123325038
CADASIL	0.01852894	0.22933514886396442
TRIMETHYLAMINURIA	0.01852894	0.22933514886396442
JOUBERT SYNDROME 26	0.018402654	0.22777209028590034
BLADDER EXSTROPHY	0.01839665	0.22769777798126883
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.01839665	0.22769777798126883
HOLMES-GANG SYNDROME	0.018327754	0.2268450430479088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.018327754	0.2268450430479088
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.018327754	0.2268450430479088
XP21 MICRODELETION SYNDROME	0.018279394	0.22624648491133642
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.018126554	0.22435476395199558
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.018126554	0.22435476395199558
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.018126554	0.22435476395199558
HEART AND BRAIN MALFORMATION SYNDROME	0.018089454	0.2238955723294391
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.018089454	0.2238955723294391
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.018089454	0.2238955723294391
WILSON-TURNER SYNDROME	0.018089454	0.2238955723294391
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.018089454	0.2238955723294391
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.018089454	0.2238955723294391
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.018089454	0.2238955723294391
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.018089454	0.2238955723294391
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.018089454	0.2238955723294391
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.01798588	0.2226136231888818
AASE-SMITH SYNDROME	0.01791203	0.22169957194020795
GORLIN SYNDROME	0.01791203	0.22169957194020795
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.017912	0.22169920062622742
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.0178571	0.22101969604190522
LARYNGEAL WEB, FAMILIAL	0.0178571	0.22101969604190522
SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION	0.0178571	0.22101969604190522
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.0178571	0.22101969604190522
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.0178571	0.22101969604190522
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0178571	0.22101969604190522
FAMILIAL NASAL ACILIA	0.0178571	0.22101969604190522
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.017841273999999997	0.22082381554005664
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.017834914	0.22074509697618985
UNILATERAL POLYMICROGYRIA	0.01778675	0.22014896475762344
19P13.12 MICRODELETION SYNDROME	0.017780144	0.22006720141911645
DISTAL MONOSOMY 6P	0.017780144	0.22006720141911645
CHROMOSOME 19P13.13 DELETION SYNDROME	0.017780144	0.22006720141911645
LISSENCEPHALY 5; LIS5	0.017716709999999997	0.2192820703844735
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.017716709999999997	0.2192820703844735
HARLEQUIN ICHTHYOSIS	0.01768162	0.21884775679861074
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017647554	0.21842611739661583
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.017636304	0.2182868746539268
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.01761532	0.218027152901697
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.01761532	0.218027152901697
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.01761532	0.218027152901697
POSTORGASMIC ILLNESS SYNDROME	0.01760606	0.21791254065304813
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.017581	0.21760236970800048
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017566263999999998	0.2174199802807769
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.017566263999999998	0.2174199802807769
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544395
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544395
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0175439	0.21714317808544395
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544395
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544395
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.0175439	0.21714317808544395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544395
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.21675676400306618
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.017479994000000002	0.21635220504417443
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.017463274	0.2161452593857069
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.017460784	0.21611444032532506
MYOCLONIC EPILEPSY OF INFANCY	0.017460784	0.21611444032532506
1Q41Q42 MICRODELETION SYNDROME	0.01742467	0.21566745255559439
PRIMARY CILIARY DYSKINESIA	0.017406679999999997	0.2154447879386188
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.017333094	0.21453400425297336
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.017295719999999997	0.2140714212960615
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.017286104	0.21395240278817734
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.017256203999999997	0.21358232652094172
MYOPATHY, CONGENITAL	0.0172414	0.2133990954486957
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.2133990954486957
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.2133990954486957
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.2133990954486957
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.2133990954486957
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.2133990954486957
THUMBS, CONGENITAL CLASPED	0.0172414	0.2133990954486957
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.2133990954486957
269800 SENILE PLAQUE FORMATION	0.0172414	0.2133990954486957
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.2133990954486957
CARDIAC ARRHYTHMIA	0.0172414	0.2133990954486957
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.2133990954486957
CERVICAL RIB	0.0172414	0.2133990954486957
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.2133990954486957
TRANSSEXUALITY	0.0172414	0.2133990954486957
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.2133990954486957
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.2133990954486957
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.2133990954486957
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.2133990954486957
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.2133990954486957
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.2133990954486957
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.2133990954486957
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.2133990954486957
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.2133990954486957
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.2133990954486957
PALMOMENTAL REFLEX	0.0172414	0.2133990954486957
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.2133990954486957
DIASTEMATOMYELIA	0.0172414	0.2133990954486957
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.2133990954486957
JUMPING FRENCHMAN OF MAINE	0.0172414	0.2133990954486957
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.2133990954486957
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.2133990954486957
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.2133990954486957
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.2133990954486957
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.2133990954486957
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.2133990954486957
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.2133990954486957
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.2133990954486957
ERYTHERMALGIA, PRIMARY	0.0172414	0.2133990954486957
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.2133990954486957
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.2133990954486957
MOSAIC TRISOMY 15	0.0172414	0.2133990954486957
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.2133990954486957
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.2133990954486957
MOTION SICKNESS	0.0172414	0.2133990954486957
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.2133990954486957
HOYERAAL-HREIDARSSON SYNDROME	0.017212254	0.21303835153950343
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.017212254	0.21303835153950343
FANCONI ANEMIA	0.017175484	0.21258324437073245
CONGENITAL HYPOTHYROIDISM	0.017162484000000002	0.21242234164584742
TENORIO SYNDROME; TNORS	0.01714017	0.21214615830714856
EHLERS-DANLOS SYNDROME, TYPE VI	0.01709655	0.2116062677794958
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.017020709999999998	0.2106675860367818
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026906
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.016762159999999998	0.20746747838147186
ACHROMATOPSIA	0.01674055	0.20720000854418222
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.016736014	0.20714386587033004
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.016736014	0.20714386587033004
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.20679341973553036
LANDAU-KLEFFNER SYNDROME	0.016686724	0.206533797000362
CHOROIDAL OSTEOMA, BILATERAL	0.0166667	0.2062859572955083
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS	0.0166667	0.2062859572955083
BUTYRYLCHOLINESTERASE DEFICIENCY	0.0166667	0.2062859572955083
PAGET DISEASE, EXTRAMAMMARY	0.0166667	0.2062859572955083
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.0166667	0.2062859572955083
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.0166667	0.2062859572955083
117600 CEREBRAL SARCOMA	0.0166667	0.2062859572955083
PITYRIASIS RUBRA PILARIS	0.0166667	0.2062859572955083
ONCOCYTOMA	0.0166667	0.2062859572955083
ICHTHYOSIS, X-LINKED	0.0166667	0.2062859572955083
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.0166667	0.2062859572955083
HURIEZ SYNDROME; HRZ	0.0166667	0.2062859572955083
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.0166667	0.2062859572955083
N SYNDROME	0.0166667	0.2062859572955083
NASOPHARYNGEAL CARCINOMA	0.0166667	0.2062859572955083
BROOKE-SPIEGLER SYNDROME; BSS	0.0166667	0.2062859572955083
EPIDERMOLYSIS BULLOSA SIMPLEX	0.0166667	0.2062859572955083
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.0166667	0.2062859572955083
MALIGNANT PERITONEAL MESOTHELIOMA	0.0166667	0.2062859572955083
SECONDARY INTESTINAL LYMPHANGIECTASIA	0.0166667	0.2062859572955083
THYMOMA, FAMILIAL	0.0166667	0.2062859572955083
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.0166667	0.2062859572955083
PRIMARY PERITONEAL CARCINOMA	0.0166667	0.2062859572955083
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.0166667	0.2062859572955083
CHYLOUS ASCITES	0.0166667	0.2062859572955083
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.0166667	0.2062859572955083
ACQUIRED PURPURA FULMINANS	0.0166667	0.2062859572955083
PHEOCHROMOCYTOMA	0.0166667	0.2062859572955083
ADAMANTINOMA OF LONG BONES	0.0166667	0.2062859572955083
PERITONEAL CYSTIC MESOTHELIOMA	0.0166667	0.2062859572955083
HAND-FOOT-GENITAL SYNDROME	0.01662993	0.2058308501267373
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.01662993	0.2058308501267373
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185227
ANGELMAN SYNDROME	0.016525810000000002	0.20454214307173493
MUENKE SYNDROME	0.016514624	0.20440369246553766
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062438
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.016266514	0.20133280207544313
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.016237154	0.20096940945985658
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.016237154	0.20096940945985658
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.01619046	0.2003914716263349
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01619046	0.2003914716263349
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.01619046	0.2003914716263349
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.1996307730516091
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.01608196	0.19904855273017888
NETHERTON SYNDROME	0.016047474	0.1986217149324569
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.016047474	0.1986217149324569
IMMUNODEFICIENCY 23; IMD23	0.016047474	0.1986217149324569
17Q12 MICRODUPLICATION SYNDROME	0.015989259999999998	0.19790119253042165
MEIER-GORLIN SYNDROME 3; MGORS3	0.015989259999999998	0.19790119253042165
45,X/46,XY MIXED GONADAL DYSGENESIS	0.01597067	0.19767110163383608
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.015930154	0.19716962972603277
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.015930154	0.19716962972603277
EVEN-PLUS SYNDROME	0.015930154	0.19716962972603277
JOUBERT SYNDROME 35; JBTS35	0.015930154	0.19716962972603277
CURRARINO SYNDROME	0.015930154	0.19716962972603277
611961 STEVENSON-CAREY SYNDROME	0.015930154	0.19716962972603277
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.01588199	0.19657349750746636
HEREDITARY METHEMOGLOBINEMIA	0.01588199	0.19657349750746636
RING CHROMOSOME 7 SYNDROME	0.01588199	0.19657349750746636
DISTAL MONOSOMY 15Q	0.015871534	0.19644408220812806
ASPARTYLGLUCOSAMINURIA	0.01576031	0.19506744800254233
CHROMOSOME 16P13.3 DELETION SYNDROME	0.015748674	0.19492342768663756
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.01573813	0.19479292319962307
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.015731544	0.1947114074037698
MARFAN SYNDROME	0.01572291	0.19460454324018076
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.015679574	0.19406816781821012
3P25.3 MICRODELETION SYNDROME	0.01567239	0.19397925049701212
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.015656820000000002	0.19378653854113054
BARDET-BIEDL SYNDROME 1; BBS1	0.015600443999999998	0.19308876530896749
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.015596684	0.19304222729007767
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.015596684	0.19304222729007767
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.015544544	0.1923968835919618
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.01553103	0.19222961902087746
AORTIC ARCH DEFECTS	0.015501919999999999	0.19186932068846177
PRIMARY PULMONARY HYPOPLASIA	0.015501919999999999	0.19186932068846177
WEAVER SYNDROME	0.015479624	0.19159336013815126
ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY	0.0153846	0.19041723548203765
HARDIKAR SYNDROME	0.0153846	0.19041723548203765
UROFACIAL SYNDROME 2	0.0153846	0.19041723548203765
POLYCYSTIC KIDNEY DISEASE 2	0.0153846	0.19041723548203765
SCALP-EAR-NIPPLE SYNDROME	0.0153846	0.19041723548203765
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.0153846	0.19041723548203765
HINMAN SYNDROME	0.0153846	0.19041723548203765
CONGENITAL PRIMARY MEGAURETER	0.0153846	0.19041723548203765
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0153846	0.19041723548203765
UROFACIAL SYNDROME	0.0153846	0.19041723548203765
109820 BLADDER DIVERTICULUM	0.0153846	0.19041723548203765
PRIMARY HYPEROXALURIA TYPE 2	0.0153846	0.19041723548203765
PRIMARY HYPEROXALURIA TYPE 1	0.0153846	0.19041723548203765
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0153846	0.19041723548203765
SMALL CELL CARCINOMA OF THE BLADDER	0.0153846	0.19041723548203765
POSTERIOR URETHRAL VALVE	0.0153846	0.19041723548203765
VESICOURETERAL REFLUX 8; VUR8	0.0153846	0.19041723548203765
CONGENITAL MEGACALYCOSIS	0.0153846	0.19041723548203765
TRISOMY X	0.015380584	0.19036752891718084
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.01532983	0.18973933992496428
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.015299293999999998	0.18936139180134196
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.015213704000000002	0.18830203301496423
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.015213704	0.1883020330149642
LOEYS-DIETZ SYNDROME 3; LDS3	0.015207150000000001	0.18822091328735677
LOEYS-DIETZ SYNDROME 5	0.015207150000000001	0.18822091328735677
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.01520312	0.1881710334426424
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.01518599	0.18795901315977465
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01493168	0.18481138454704263
CLASSICAL EHLERS-DANLOS SYNDROME	0.014916849999999999	0.18462783166934685
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.014831254	0.18356839862017296
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.18356839862017296
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01470287	0.181979372817739
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.014664374	0.18150290271795633
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.014645414	0.1812682322822778
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.014645414	0.1812682322822778
SALLA DISEASE	0.014645414	0.1812682322822778
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.014645414	0.1812682322822778
CEREBROFACIOARTICULAR SYNDROME	0.014630054	0.18107811952425978
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.014630054	0.18107811952425978
PETTIGREW SYNDROME	0.014630054	0.18107811952425978
XQ25 DUPLICATION SYNDROME	0.014622804000000001	0.18098838531230468
PIERPONT SYNDROME	0.014599554	0.1807006169774141
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.014503344000000001	0.17950981304193792
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.014503344000000001	0.17950981304193792
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.014498514000000002	0.1794500314910768
MAPLE SYRUP URINE DISEASE; MSUD	0.0144928	0.17937930855492346
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492346
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492346
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0144928	0.17937930855492346
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.014451974	0.1788739997359883
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.014451974	0.1788739997359883
NIEMANN-PICK DISEASE, TYPE A	0.014451974	0.1788739997359883
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.014351354	0.17762861264537805
MENTAL RETARDATION, X-LINKED 91; MRX91	0.014351354	0.17762861264537805
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.014351354	0.17762861264537805
MACROCEPHALY/AUTISM SYNDROME	0.014299214000000001	0.17698326894726218
TIMOTHY SYNDROME; TS	0.014299214000000001	0.17698326894726218
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.014297614	0.17696346553496864
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.1768522693749404
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.1768160043761778
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0142857	0.1768160043761778
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0142857	0.1768160043761778
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.1768160043761778
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.1768160043761778
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.014244153999999998	0.17630178402171057
AMISH LETHAL MICROCEPHALY	0.01411882	0.17475050847396117
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01411882	0.17475050847396117
2Q24 MICRODELETION SYNDROME	0.01411882	0.17475050847396117
MELNICK-NEEDLES SYNDROME	0.01410171	0.17453873573374706
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.01409986	0.17451583803828266
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0140845	0.17432572528026463
KERATODERMA HEREDITARIUM MUTILANS	0.0140845	0.17432572528026463
PULMONARY BLASTOMA	0.0140845	0.17432572528026463
MICROPHTHALMIA, LENZ TYPE	0.0140845	0.17432572528026463
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.0140845	0.17432572528026463
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.17432572528026463
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0140845	0.17432572528026463
CRANIOECTODERMAL DYSPLASIA 4	0.0140845	0.17432572528026463
ROWLEY-ROSENBERG SYNDROME	0.0140845	0.17432572528026463
TRACHEOPATHIA OSTEOPLASTICA	0.0140845	0.17432572528026463
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.0140845	0.17432572528026463
MASP2 DEFICIENCY	0.0140845	0.17432572528026463
AICARDI SYNDROME; AIC	0.0140845	0.17432572528026463
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.17432572528026463
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.17432572528026463
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.014059314000000002	0.17401399481649893
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.014004943999999998	0.17334105011249887
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.014004943999999998	0.17334105011249887
FOLATE MALABSORPTION, HEREDITARY	0.013968374	0.17288841837026458
SILVER-RUSSELL SYNDROME	0.013957790000000001	0.1727574187979428
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.013916000000000001	0.17224017842310077
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.013866904	0.17163251071687335
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.0138058	0.1708762184013829
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.013753660000000001	0.17023087470326706
CYCLIC VOMITING SYNDROME	0.01375206	0.1702110712909735
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.013698599999999998	0.16954938977771541
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 3	0.013698599999999998	0.16954938977771541
IMMUNODEFICIENCY, COMMON VARIABLE, 13; CVID13	0.013698599999999998	0.16954938977771541
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.013698599999999998	0.16954938977771541
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.013698599999999998	0.16954938977771541
NEUTROPHIL ACTIN DYSFUNCTION	0.013698599999999998	0.16954938977771541
GRISCELLI SYNDROME, TYPE 2; GS2	0.013698599999999998	0.16954938977771541
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.013698599999999998	0.16954938977771541
COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D	0.013698599999999998	0.16954938977771541
COMPLEMENT FACTOR H DEFICIENCY	0.013698599999999998	0.16954938977771541
GLYCOGEN STORAGE DISEASE IB	0.013698599999999998	0.16954938977771541
INFANTILE SYSTEMIC HYALINOSIS	0.013698599999999998	0.16954938977771541
SPECIFIC GRANULE DEFICIENCY	0.013698599999999998	0.16954938977771541
X-LINKED SEVERE CONGENITAL NEUTROPENIA	0.013698599999999998	0.16954938977771541
IMMUNODEFICIENCY 33	0.013698599999999998	0.16954938977771541
SICKLE CELL ANEMIA	0.013698599999999998	0.16954938977771541
IMMUNODEFICIENCY 47	0.013698599999999998	0.16954938977771541
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01359558	0.16827429756866485
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.01344043	0.16635398543282526
STURGE-WEBER SYNDROME	0.013421220000000001	0.1661162207139759
MICROFORM HOLOPROSENCEPHALY	0.013150129999999998	0.16276090381481528
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.013052284	0.16154985089026902
10Q22.3Q23.3 MICRODELETION SYNDROME	0.013052284	0.16154985089026902
IMMUNODEFICIENCY 53; IMD53	0.01285638	0.15912512108904744
COFFIN-SIRIS SYNDROME 6; CSS6	0.012840904	0.15893357258363813
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.012759613999999999	0.15792743546779925
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.012759613999999999	0.15792743546779925
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.012759613999999999	0.15792743546779925
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.012740654	0.15769276503212076
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012740654	0.15769276503212076
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.012740654	0.15769276503212076
CRANIOFRONTONASAL SYNDROME; CFNS	0.012740654	0.15769276503212076
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.012740654	0.15769276503212076
ELEJALDE DISEASE	0.012740654	0.15769276503212076
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.012740654	0.15769276503212076
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.012740654	0.15769276503212076
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.012617254000000001	0.1561654268589812
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012593754000000002	0.15587456424091975
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.012593754000000002	0.15587456424091975
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012593754000000002	0.15587456424091975
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012593754000000002	0.15587456424091975
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012516634000000002	0.15492003976837093
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.012516634000000002	0.15492003976837093
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.012516634000000002	0.15492003976837093
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.15479745664627387
TUBEROUS SCLEROSIS-1	0.01250673	0.15479745664627387
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.15479745664627387
15Q14 MICRODELETION SYNDROME	0.012504614	0.15477126663351568
MENTAL RETARDATION, X-LINKED 90	0.012467574	0.1543128176389201
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.012450353999999999	0.15409968341411082
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.012450353999999999	0.15409968341411082
OCULO-PALATO-CEREBRAL SYNDROME	0.012450353999999999	0.15409968341411082
LOCKED-IN SYNDROME	0.012369050000000001	0.1530933730184144
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.012369050000000001	0.1530933730184144
FAMILIAL DYSAUTONOMIA	0.012369050000000001	0.1530933730184144
PELIZAEUS-MERZBACHER DISEASE	0.012369050000000001	0.1530933730184144
MENTAL RETARDATION, X-LINKED 105; MRX105	0.01226843	0.15184798592780413
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0121951	0.15094037078812564
X-LINKED INTELLECTUAL DISABILITY, MILES-CARPENTER TYPE	0.0121951	0.15094037078812564
CATARACT 48; CTRCT48	0.0121951	0.15094037078812564
RHYNS SYNDROME; RHYNS	0.0121951	0.15094037078812564
LELIS SYNDROME	0.0121951	0.15094037078812564
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0121951	0.15094037078812564
COMBINED HAMARTOMA OF THE RETINA AND RETINAL PIGMENT EPITHELIUM	0.0121951	0.15094037078812564
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0121951	0.15094037078812564
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE;;CONGENITAL FIBROSIS SYNDROME WITH SYNERGISTIC DIVERGENCE;;EXTERNAL OPHTHALMOPLEGIA WITH SYNERGISTIC DIVERGENCEEXTERNAL OPHTHALMOPLEGIA, SYNERGISTIC DIVERGENCE, JAW WINKING, ANDOCULOCUTANEOUS HYPOPIGMENTATION, INCLUDED	0.0121951	0.15094037078812564
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.0121951	0.15094037078812564
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.0121951	0.15094037078812564
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0121951	0.15094037078812564
FACIOCARDIOMELIC SYNDROME	0.0121951	0.15094037078812564
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.0121951	0.15094037078812564
OROFACIODIGITAL SYNDROME TYPE 3	0.0121951	0.15094037078812564
JUBERG-MARSIDI SYNDROME	0.0121951	0.15094037078812564
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.012173774	0.15067641605651805
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.012149239999999999	0.1503727554832619
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.012149239999999999	0.1503727554832619
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.012100183999999998	0.14976558286234182
C SYNDROME	0.012100183999999998	0.14976558286234182
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.012100183999999998	0.14976558286234182
ADAMS-OLIVER SYNDROME 2; AOS2	0.012100183999999998	0.14976558286234182
GLYCEROL KINASE DEFICIENCY; GKD	0.012100183999999998	0.14976558286234182
MARINESCO-SJOGREN SYNDROME; MSS	0.012100183999999998	0.14976558286234182
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.012100183999999998	0.14976558286234182
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692463
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692463
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692463
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692463
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692463
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692463
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.012048200000000002	0.14912216999692463
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692463
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692463
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.012048200000000002	0.14912216999692463
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.012048200000000002	0.14912216999692463
FRIED SYNDROME	0.011996304	0.14847984631918348
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.011996304	0.14847984631918348
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.011971080000000002	0.1481676455243758
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.011931484000000001	0.1476775605786413
ASTHMA, SHORT STATURE, AND ELEVATED IGA	0.011904799999999998	0.14734728917011566
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.011904799999999998	0.14734728917011566
MASTOCYTOSIS	0.011904799999999998	0.14734728917011566
POTASSIUM-AGGRAVATED MYOTONIA	0.011904799999999998	0.14734728917011566
PERIPARTUM CARDIOMYOPATHY	0.011904799999999998	0.14734728917011566
YAO SYNDROME	0.011904799999999998	0.14734728917011566
BRONCHIAL NEUROENDOCRINE TUMOR	0.011904799999999998	0.14734728917011566
EOSINOPHILIC GASTROENTERITIS	0.011904799999999998	0.14734728917011566
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.011904799999999998	0.14734728917011566
BERNARD-SOULIER SYNDROME	0.011904799999999998	0.14734728917011566
CARCINOID SYNDROME	0.011904799999999998	0.14734728917011566
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.011904799999999998	0.14734728917011566
IMMUNODEFICIENCY 11B WITH ATOPIC DERMATITIS; IMD11B	0.011904799999999998	0.14734728917011566
STÜVE-WIEDEMANN SYNDROME	0.011904799999999998	0.14734728917011566
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.011904799999999998	0.14734728917011566
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.011904799999999998	0.14734728917011566
CHILBLAIN LUPUS	0.011904799999999998	0.14734728917011566
TRANSALDOLASE DEFICIENCY	0.011904799999999998	0.14734728917011566
ASTHMA, SUSCEPTIBILITY TO	0.011904799999999998	0.14734728917011566
KERATOSIS PILARIS ATROPHICANS	0.011904799999999998	0.14734728917011566
SYSTEMIC MASTOCYTOSIS	0.011904799999999998	0.14734728917011566
ICHTHYOSIS VULGARIS	0.011904799999999998	0.14734728917011566
IGE RESPONSIVENESS, ATOPIC	0.011904799999999998	0.14734728917011566
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.011904799999999998	0.14734728917011566
DERMATITIS, ATOPIC	0.011904799999999998	0.14734728917011566
MYOTONIA PERMANENS	0.011904799999999998	0.14734728917011566
2Q33.1 DELETION SYNDROME	0.011783980000000001	0.14585188399929944
MENKES DISEASE	0.011783980000000001	0.14585188399929944
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.14582230265218596
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.01166479	0.1443766535547572
INTELLECTUAL DISABILITY, WOLFF TYPE	0.01166479	0.1443766535547572
HYPERTELORISM, TEEBI TYPE; TBHS	0.01163752	0.14403912914647915
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.011486630000000001	0.1421715435958711
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01145324	0.14175827113557019
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.14172745207518836
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.011450749999999999	0.14172745207518836
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.011449464	0.1417115350825574
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.011411294	0.14123909992802955
VICI SYNDROME	0.011389054000000001	0.1409638324971493
CHRONIC GRAFT VERSUS HOST DISEASE	0.01125686	0.1393276498191913
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.011247890000000002	0.13921662693902062
MONOSOMY 18P	0.011222244000000001	0.13889920299422048
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.011222244000000001	0.13889920299422048
TEMPLE SYNDROME	0.01116402	0.1381785568208584
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.01116402	0.1381785568208584
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.01116402	0.1381785568208584
CLEFT LIP/PALATE	0.01116402	0.1381785568208584
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683447
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01115462	0.13806221177363381
KABUKI SYNDROME 1	0.011050144	0.1367690984593961
PELGER-HUET ANOMALY; PHA	0.011050144	0.1367690984593961
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.010965014	0.13571543315405274
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.010942024	0.13543088287365987
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.010942024	0.13543088287365987
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.010942024	0.13543088287365987
CHROMOSOME 5Q12 DELETION SYNDROME	0.010924894000000001	0.13521886259079213
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.010924894000000001	0.13521886259079213
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.010924894000000001	0.13521886259079213
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.010924894000000001	0.13521886259079213
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.010924894000000001	0.13521886259079213
PMM2-CDG	0.010924894000000001	0.13521886259079213
HAREL-YOON SYNDROME; HAYOS	0.010924894000000001	0.13521886259079213
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.010924894000000001	0.13521886259079213
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.01090391	0.13495914083856225
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.01090391	0.13495914083856225
HALL-RIGGS SYNDROME	0.01090391	0.13495914083856225
TEMPLE-BARAITSER SYNDROME	0.01090391	0.13495914083856225
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.01090391	0.13495914083856225
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01090391	0.13495914083856225
ADENYLOSUCCINATE LYASE DEFICIENCY	0.01090391	0.13495914083856225
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.01090391	0.13495914083856225
WARBURG MICRO SYNDROME 2; WARBM2	0.01090391	0.13495914083856225
ALLAN-HERNDON-DUDLEY SYNDROME	0.01090391	0.13495914083856225
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.01090391	0.13495914083856225
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.010854853999999999	0.1343519682176422
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.010854853999999999	0.1343519682176422
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.010854853999999999	0.1343519682176422
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.010854853999999999	0.1343519682176422
WARSAW BREAKAGE SYNDROME; WABS	0.010854853999999999	0.1343519682176422
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.010854853999999999	0.1343519682176422
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010854853999999999	0.1343519682176422
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010854853999999999	0.1343519682176422
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010854853999999999	0.1343519682176422
HYDROCEPHALUS, NORMAL-PRESSURE	0.010854853999999999	0.1343519682176422
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010854853999999999	0.1343519682176422
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010854853999999999	0.1343519682176422
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010854853999999999	0.1343519682176422
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010854853999999999	0.1343519682176422
ADAMS-OLIVER SYNDROME 3; AOS3	0.010854853999999999	0.1343519682176422
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010854853999999999	0.1343519682176422
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.010854853999999999	0.1343519682176422
MEVALONIC ACIDURIA; MEVA	0.010854853999999999	0.1343519682176422
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010854853999999999	0.1343519682176422
CREE MENTAL RETARDATION SYNDROME	0.010854853999999999	0.1343519682176422
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010854853999999999	0.1343519682176422
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010854853999999999	0.1343519682176422
ROSSELLI-GULIENETTI SYNDROME	0.010854853999999999	0.1343519682176422
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010854853999999999	0.1343519682176422
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010854853999999999	0.1343519682176422
GENITOPATELLAR SYNDROME; GTPTS	0.010854853999999999	0.1343519682176422
SEPTOOPTIC DYSPLASIA	0.010854853999999999	0.1343519682176422
PROPIONIC ACIDEMIA	0.010854853999999999	0.1343519682176422
REVESZ SYNDROME	0.010854853999999999	0.1343519682176422
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010854853999999999	0.1343519682176422
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.010854853999999999	0.1343519682176422
PYRUVATE CARBOXYLASE DEFICIENCY	0.010854853999999999	0.1343519682176422
ARIMA SYNDROME	0.010854853999999999	0.1343519682176422
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010854853999999999	0.1343519682176422
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010854853999999999	0.1343519682176422
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010854853999999999	0.1343519682176422
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010854853999999999	0.1343519682176422
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010854853999999999	0.1343519682176422
GABA-TRANSAMINASE DEFICIENCY	0.010854853999999999	0.1343519682176422
CHROMOSOME 4Q21 DELETION SYNDROME	0.010854853999999999	0.1343519682176422
HARTSFIELD SYNDROME; HRTFDS	0.010854853999999999	0.1343519682176422
KRABBE DISEASE	0.010854084	0.13434243782547595
INFANTILE DYSTONIA-PARKINSONISM	0.010753464	0.1330970507348657
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.010753464	0.1330970507348657
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010753464	0.1330970507348657
COFFIN-SIRIS SYNDROME 5	0.010753464	0.1330970507348657
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.010753464	0.1330970507348657
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.010753464	0.1330970507348657
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.010753464	0.1330970507348657
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.010753464	0.1330970507348657
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.010753464	0.1330970507348657
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.010753464	0.1330970507348657
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.010737894	0.13290433877898414
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01067669	0.13214680875022533
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.01053875	0.13043950706786817
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.01050459	0.13001670421540099
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.01050459	0.13001670421540099
SPINOCEREBELLAR ATAXIA TYPE 27	0.01042911	0.12908247824045305
MONOSOMY 5P	0.01041946	0.1289630389100576
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.010407054	0.12880948820198654
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.010407053999999999	0.1288094882019865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.010407053999999999	0.1288094882019865
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.01037934	0.128466468346797
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.01037934	0.128466468346797
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.01037934	0.128466468346797
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.12759957397364707
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.12759957397364707
PIERSON SYNDROME	0.010309299999999999	0.12759957397364707
HYPOPHOSPHATASIA, INFANTILE	0.01030853	0.1275900435814808
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.010269014	0.127100948806361
SYNDROMIC DIARRHEA	0.010269014	0.127100948806361
OGDEN SYNDROME; OGDNS	0.010269014	0.127100948806361
AARSKOG-SCOTT SYNDROME	0.010267413999999999	0.12708114539406745
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010265464	0.1270570099853347
MUCOPOLYSACCHARIDOSIS TYPE 3	0.01025843	0.12696994923403923
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.010211004	0.12638295133939317
16Q24.3 MICRODELETION SYNDROME	0.01019234	0.12615194453498899
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01001726	0.12398495614476793
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.01001726	0.12398495614476793
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.01001726	0.12398495614476793
NANCE-HORAN SYNDROME	0.01001726	0.12398495614476793
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984131
COG5-CDG	0.009861499999999999	0.12205709395799137
5Q14.3 MICRODELETION SYNDROME	0.009861499999999999	0.12205709395799137
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.009857724	0.12201035790497863
MUCOLIPIDOSIS IV; ML4	0.009832834000000002	0.12170229107248721
LARSEN-LIKE SYNDROME	0.009804814	0.12135548381469649
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00972346	0.12034855456236587
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.009696694	0.12001726822896024
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.009607154	0.11890901976848275
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.009492564	0.1174907241342845
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.009492564	0.1174907241342845
MENTAL RETARDATION, X-LINKED 9	0.009492564	0.1174907241342845
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.009492564	0.1174907241342845
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.009492564	0.1174907241342845
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.009492564	0.1174907241342845
PITT-HOPKINS SYNDROME	0.00948117	0.11734969908448911
FABRY DISEASE	0.00937055	0.11598054066704419
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704419
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00937055	0.11598054066704419
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704419
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704419
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00937055	0.11598054066704419
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704419
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704419
SAGLIKER SYNDROME	0.00937055	0.11598054066704419
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704419
BETA-THALASSEMIA MAJOR	0.00937055	0.11598054066704419
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704419
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00937055	0.11598054066704419
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704419
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.11532373574406343
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.009317484000000001	0.11532373574406343
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.009317484000000001	0.11532373574406343
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.009317484000000001	0.11532373574406343
20Q11.2 MICRODELETION SYNDROME	0.009317484000000001	0.11532373574406343
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.009317484000000001	0.11532373574406343
ARGININEMIA	0.009317484000000001	0.11532373574406343
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.11532373574406343
INFANTILE REFSUM DISEASE	0.009317484000000001	0.11532373574406343
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.009317484000000001	0.11532373574406343
MUCOLIPIDOSIS TYPE IV	0.009287280000000002	0.11494989682849206
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00925926	0.11460308957070135
AGAMMAGLOBULINEMIA 8, AUTOSOMAL DOMINANT	0.00925926	0.11460308957070135
NEUROFIBROMA	0.00925926	0.11460308957070135
OTITIS MEDIA, SUSCEPTIBILITY TO; OMS	0.00925926	0.11460308957070135
MUCOPOLYSACCHARIDOSIS TYPE IX	0.00925926	0.11460308957070135
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00925926	0.11460308957070135
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00925926	0.11460308957070135
CILIARY DYSKINESIA, PRIMARY, 21; CILD21	0.00925926	0.11460308957070135
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00925926	0.11460308957070135
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575339
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009161724	0.11339587355728689
COFFIN-SIRIS SYNDROME 2; CSS2	0.009161724	0.11339587355728689
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.009161724	0.11339587355728689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.009161724	0.11339587355728689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009161724	0.11339587355728689
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009161724	0.11339587355728689
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.009161724	0.11339587355728689
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.009160124	0.11337607014499336
MACHADO-JOSEPH DISEASE TYPE 3	0.00915114	0.11326487398496511
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00915114	0.11326487398496511
LARYNGOTRACHEAL ANGIOMA	0.00915114	0.11326487398496511
MACHADO-JOSEPH DISEASE TYPE 1	0.00915114	0.11326487398496511
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00915114	0.11326487398496511
MACHADO-JOSEPH DISEASE TYPE 2	0.00915114	0.11326487398496511
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009059484	0.11213043551172941
CHAR SYNDROME	0.009037264	0.11185541562350283
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009037264	0.11185541562350283
CHROMOSOME 15Q25 DELETION SYNDROME	0.009022084	0.11166753074936782
JOUBERT SYNDROME 2	0.009020134	0.11164339534063508
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.009020134	0.11164339534063508
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.009020134	0.11164339534063508
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009020134	0.11164339534063508
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.009020134	0.11164339534063508
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.009020134	0.11164339534063508
OROFACIODIGITAL SYNDROME VI	0.009020134	0.11164339534063508
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.009020134	0.11164339534063508
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009020134	0.11164339534063508
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.009020134	0.11164339534063508
RING CHROMOSOME 12 SYNDROME	0.009020134	0.11164339534063508
OROFACIODIGITAL SYNDROME TYPE 6	0.009020134	0.11164339534063508
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.009020134	0.11164339534063508
ADAMS-OLIVER SYNDROME 1; AOS1	0.009020134	0.11164339534063508
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.009020134	0.11164339534063508
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.009020134	0.11164339534063508
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.009020134	0.11164339534063508
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00896098	0.11091123843387737
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00894701	0.11073832989028937
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00894701	0.11073832989028937
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00894701	0.11073832989028937
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.00894701	0.11073832989028937
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.008884504	0.1099646848347767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.008884504	0.1099646848347767
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.008884504	0.1099646848347767
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.008833134	0.10932887152882709
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.008833134	0.10932887152882709
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.008802830000000001	0.10895379489998737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.008781394000000001	0.10868847868378462
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.008781394000000001	0.10868847868378462
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.008781394000000001	0.10868847868378462
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.008781394000000001	0.10868847868378462
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.1085713415000683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.1085713415000683
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.1085713415000683
BREATH-HOLDING SPELLS	0.00877193	0.1085713415000683
PINEOBLASTOMA	0.00877193	0.1085713415000683
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.1085713415000683
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.1085713415000683
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.00877193	0.1085713415000683
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.1085713415000683
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.1085713415000683
MILROY DISEASE	0.00877193	0.1085713415000683
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.00877193	0.1085713415000683
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, DUTCH TYPE	0.00877193	0.1085713415000683
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.00877193	0.1085713415000683
HUNTINGTON DISEASE	0.00877193	0.1085713415000683
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.1085713415000683
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.1085713415000683
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.1085713415000683
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.1085713415000683
CAFFEY DISEASE	0.00877193	0.1085713415000683
CRYPTOCOCCOSIS	0.00877193	0.1085713415000683
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.1085713415000683
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.1085713415000683
KEIPERT SYNDROME	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.1085713415000683
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.1085713415000683
SNEDDON SYNDROME	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.1085713415000683
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.1085713415000683
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.1085713415000683
NEUROCUTANEOUS MELANOCYTOSIS	0.00877193	0.1085713415000683
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.1085713415000683
CORTICOBASAL SYNDROME	0.00877193	0.1085713415000683
HISTIDINEMIA	0.00877193	0.1085713415000683
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.1085713415000683
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.1085713415000683
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.1085713415000683
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.00877193	0.1085713415000683
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.1085713415000683
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.1085713415000683
LESCH-NYHAN SYNDROME	0.00877193	0.1085713415000683
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.008652739999999999	0.10709611105552608
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.008652739999999999	0.10709611105552608
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.008652739999999999	0.10709611105552608
CRANIOFACIAL DYSSYNOSTOSIS	0.008652739999999999	0.10709611105552608
DISTAL MONOSOMY 10P	0.008652739999999999	0.10709611105552608
NEONATAL ADRENOLEUKODYSTROPHY	0.008652739999999999	0.10709611105552608
LAMB-SHAFFER SYNDROME	0.008621754	0.10671259322219623
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00861617	0.10664347931329177
9Q21.13 MICRODELETION SYNDROME	0.00861617	0.10664347931329177
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.00861617	0.10664347931329177
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00861617	0.10664347931329177
20Q13.33 MICRODELETION SYNDROME	0.00861617	0.10664347931329177
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.008502294	0.1052340209518295
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.008502294	0.1052340209518295
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.008502294	0.1052340209518295
JOUBERT SYNDROME 14	0.008502294	0.1052340209518295
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.008502294	0.1052340209518295
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.008502294	0.1052340209518295
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.008502294	0.1052340209518295
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.008502294	0.1052340209518295
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.008502294	0.1052340209518295
DOORS SYNDROME	0.008502294	0.1052340209518295
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00849171	0.10510302137950768
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00847458	0.10489100109663993
PACHYGYRIA, FRONTOTEMPORAL	0.00847458	0.10489100109663993
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00847458	0.10489100109663993
HYPEREKPLEXIA 2; HKPX2	0.00847458	0.10489100109663993
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00847458	0.10489100109663993
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	0.10489100109663993
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00847458	0.10489100109663993
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	0.10489100109663993
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	0.10489100109663993
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	0.10489100109663993
RICHIERI COSTA-DA SILVA SYNDROME	0.00847458	0.10489100109663993
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	0.10489100109663993
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	0.10489100109663993
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00847458	0.10489100109663993
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	0.10489100109663993
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.00847458	0.10489100109663993
TUFTED ANGIOMA	0.00847458	0.10489100109663993
SCLEROSTEOSIS 1; SOST1	0.00847458	0.10489100109663993
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.00847458	0.10489100109663993
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00847458	0.10489100109663993
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	0.10489100109663993
WIEDEMANN-STEINER SYNDROME; WDSTS	0.008434984	0.10440091615090544
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.008434984	0.10440091615090544
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.008434984	0.10440091615090544
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.00833895	0.10321229059078155
MOEBIUS SYNDROME	0.00828758	0.10257647728483194
CHIME SYNDROME	0.00828758	0.10257647728483194
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.008235840000000001	0.10193608443978949
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.008235840000000001	0.10193608443978949
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00814257	0.10078166927440267
STEVENS-JOHNSON SYNDROME	0.00814257	0.10078166927440267
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.008103054	0.10029257449928287
SOTOS SYNDROME 2	0.0080762	0.0999601989782011
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00795674	0.09848162670783435
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00795674	0.09848162670783435
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00795674	0.09848162670783435
PROTEUS SYNDROME	0.00795674	0.09848162670783435
KABUKI SYNDROME	0.00795674	0.09848162670783435
WEBB-DATTANI SYNDROME; WEDAS	0.007952964	0.09843489065482157
300270 ADRENOMYODYSTROPHY	0.007952964	0.09843489065482157
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.007952964	0.09843489065482157
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.007952964	0.09843489065482157
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.007952964	0.09843489065482157
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.09843489065482157
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.007914794	0.09796245550029371
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.007914794	0.09796245550029371
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.007914794	0.09796245550029371
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.007914794	0.09796245550029371
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007914794	0.09796245550029371
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00788943	0.0976485219069103
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.0078545	0.09721618866227688
GM1 GANGLIOSIDOSIS	0.0078545	0.09721618866227688
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007791934	0.0964418009788032
PRIMARY CONGENITAL HYPOTHYROIDISM	0.007791934	0.0964418009788032
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.007791934	0.0964418009788032
NIEMANN-PICK DISEASE TYPE C	0.007791934	0.0964418009788032
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.007791934	0.0964418009788032
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007791934	0.0964418009788032
PERIPHERAL HYPOTHYROIDISM	0.007791934	0.0964418009788032
BAND HETEROTOPIA; BH	0.007791934	0.0964418009788032
SEVERE CANAVAN DISEASE	0.007791934	0.0964418009788032
AUSTRALIA ANTIGEN	0.007587804	0.09391525688412745
17Q12 MICRODELETION SYNDROME	0.007587804	0.09391525688412745
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.007587804	0.09391525688412745
MENTAL RETARDATION, X-LINKED 88	0.007587804	0.09391525688412745
COWDEN SYNDROME	0.007587804	0.09391525688412745
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00740741	0.09168249641082644
GLUTAMINE DEFICIENCY, CONGENITAL	0.00740741	0.09168249641082644
FRYNS SYNDROME	0.00740741	0.09168249641082644
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00740741	0.09168249641082644
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00740741	0.09168249641082644
BOWEN-CONRADI SYNDROME	0.00740741	0.09168249641082644
14Q11.2 MICRODELETION SYNDROME	0.00740741	0.09168249641082644
CONO-SPONDYLAR DYSPLASIA	0.00740741	0.09168249641082644
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.00740741	0.09168249641082644
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.09168249641082644
ADRENOMYODYSTROPHY	0.00740741	0.09168249641082644
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00740741	0.09168249641082644
CROME SYNDROME	0.00740741	0.09168249641082644
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.00740741	0.09168249641082644
YUNIS-VARON SYNDROME	0.00740741	0.09168249641082644
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.09168249641082644
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.00740741	0.09168249641082644
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.00740741	0.09168249641082644
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00740741	0.09168249641082644
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.09168249641082644
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00740741	0.09168249641082644
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.00740741	0.09168249641082644
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00740741	0.09168249641082644
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00740741	0.09168249641082644
SECKEL SYNDROME 7; SCKL7	0.00740741	0.09168249641082644
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.00740741	0.09168249641082644
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.00740741	0.09168249641082644
DPM1-CDG	0.00740741	0.09168249641082644
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00740741	0.09168249641082644
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00736924	0.09121006125629857
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00736924	0.09121006125629857
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00736924	0.09121006125629857
MICROTIA	0.00736924	0.09121006125629857
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00736924	0.09121006125629857
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.007292764	0.0902635076571979
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.007256964	0.08982040630712985
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.007256964	0.08982040630712985
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.007256964	0.08982040630712985
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.007256964	0.08982040630712985
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.007256964	0.08982040630712985
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007256964	0.08982040630712985
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.007256964	0.08982040630712985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.007256964	0.08982040630712985
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.007256964	0.08982040630712985
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.007256964	0.08982040630712985
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.007256964	0.08982040630712985
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.007256964	0.08982040630712985
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.007256964	0.08982040630712985
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.007256964	0.08982040630712985
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007256964	0.08982040630712985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007256964	0.08982040630712985
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.007256964	0.08982040630712985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.007256964	0.08982040630712985
MENTAL RETARDATION, X-LINKED 107; MRX107	0.007256964	0.08982040630712985
CITRULLINEMIA, CLASSIC	0.007256964	0.08982040630712985
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.007256964	0.08982040630712985
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.007256964	0.08982040630712985
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.007256964	0.08982040630712985
AICARDI-GOUTIERES SYNDROME 5	0.007256964	0.08982040630712985
AICARDI-GOUTIÈRES SYNDROME	0.007256964	0.08982040630712985
NARP SYNDROME	0.007256964	0.08982040630712985
JOUBERT SYNDROME 10	0.007256964	0.08982040630712985
SHWACHMAN-DIAMOND SYNDROME	0.007256964	0.08982040630712985
ARGININOSUCCINIC ACIDURIA	0.007256964	0.08982040630712985
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.007256964	0.08982040630712985
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.007256964	0.08982040630712985
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.007256964	0.08982040630712985
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.007256964	0.08982040630712985
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.007255364	0.08980060289483631
8P23.1 MICRODELETION SYNDROME	0.007255364	0.08980060289483631
19P13.13 MICRODELETION SYNDROME	0.007255364	0.08980060289483631
INCONTINENTIA PIGMENTI	0.007255364	0.08980060289483631
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.08968940673480806
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00724638	0.08968940673480806
BRONCHOPULMONARY DYSPLASIA	0.00724638	0.08968940673480806
HEREDITARY HYPEREKPLEXIA	0.00724638	0.08968940673480806
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00724638	0.08968940673480806
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00724638	0.08968940673480806
NEURALGIC AMYOTROPHY	0.00724638	0.08968940673480806
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.08968940673480806
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.08968940673480806
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.007189654	0.08898730150620582
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.007189654	0.08898730150620582
11P15.4 MICRODUPLICATION SYNDROME	0.007189654	0.08898730150620582
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.007189654	0.08898730150620582
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.007189654	0.08898730150620582
3C SYNDROME	0.007154724	0.08855496826157239
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.007054104	0.08730958117096212
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.007054104	0.08730958117096212
RING CHROMOSOME 13 SYNDROME	0.00704225	0.08716286264013232
NANCE-HORAN SYNDROME	0.00704225	0.08716286264013232
GOLDENHAR SYNDROME	0.00704225	0.08716286264013232
HYPERLEXIA	0.00704225	0.08716286264013232
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013232
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00683087	0.08454658433350147
MEIER-GORLIN SYNDROME 6; MGORS6	0.00674721	0.08351111341320276
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00671141	0.08306801206313472
IMMUNODEFICIENCY 32A	0.00671141	0.08306801206313472
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.00671141	0.08306801206313472
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00671141	0.08306801206313472
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.00671141	0.08306801206313472
IDIOPATHIC APLASTIC ANEMIA	0.00671141	0.08306801206313472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313472
UROCANIC ACIDURIA	0.00671141	0.08306801206313472
LETTERER-SIWE DISEASE	0.00671141	0.08306801206313472
LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3, WITH OR WITHOUT GLOMERULONEPHRITIS; APLDC3	0.00671141	0.08306801206313472
NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE	0.00671141	0.08306801206313472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.00671141	0.08306801206313472
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00671141	0.08306801206313472
IMMUNODEFICIENCY 9; IMD9	0.00671141	0.08306801206313472
TUFTSIN DEFICIENCY	0.00671141	0.08306801206313472
MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE	0.00671141	0.08306801206313472
IMMUNODEFICIENCY 55; IMD55	0.00671141	0.08306801206313472
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00671141	0.08306801206313472
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00671141	0.08306801206313472
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00671141	0.08306801206313472
LAZY LEUKOCYTE SYNDROME	0.00671141	0.08306801206313472
BULLOUS PEMPHIGOID	0.00671141	0.08306801206313472
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.00671141	0.08306801206313472
IMMUNODEFICIENCY 52; IMD52	0.00671141	0.08306801206313472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313472
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313472
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00671141	0.08306801206313472
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313472
224250 DYSMYELINATION WITH JAUNDICE	0.00671141	0.08306801206313472
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00671141	0.08306801206313472
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313472
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.00671141	0.08306801206313472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.00671141	0.08306801206313472
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313472
HYPOPHOSPHATASIA	0.00671141	0.08306801206313472
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00671141	0.08306801206313472
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313472
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00671141	0.08306801206313472
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00671141	0.08306801206313472
CYSTIC DISEASE OF LUNG	0.00671141	0.08306801206313472
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313472
WALDENSTRÖM MACROGLOBULINEMIA	0.00671141	0.08306801206313472
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00671141	0.08306801206313472
IMMUNE DEFICIENCY, FAMILIAL VARIABLE	0.00671141	0.08306801206313472
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.00671141	0.08306801206313472
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.00671141	0.08306801206313472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313472
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00671141	0.08306801206313472
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00671141	0.08306801206313472
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313472
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313472
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313472
IMMUNODEFICIENCY 37; IMD37	0.00671141	0.08306801206313472
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313472
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00671141	0.08306801206313472
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00671141	0.08306801206313472
T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY	0.00671141	0.08306801206313472
BEHCET SYNDROME	0.00671141	0.08306801206313472
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00671141	0.08306801206313472
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00671141	0.08306801206313472
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00671141	0.08306801206313472
CONGENITAL ATRANSFERRINEMIA	0.00671141	0.08306801206313472
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00671141	0.08306801206313472
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313472
BETA-THALASSEMIA	0.00671141	0.08306801206313472
HISTIOCYTOSIS, FAMILIAL LIPOCHROME	0.00671141	0.08306801206313472
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313472
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313472
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313472
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.00671141	0.08306801206313472
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII; HSAN8	0.00671141	0.08306801206313472
PSEUDODIASTROPHIC DYSPLASIA	0.00671141	0.08306801206313472
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00670981	0.08304820865084117
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.006707694	0.08302201863808296
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.006707694	0.08302201863808296
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.006707694	0.08302201863808296
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00660917	0.08180257401757725
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00660917	0.08180257401757725
ACROOSTEOLYSIS DOMINANT TYPE	0.00660917	0.08180257401757725
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00660917	0.08180257401757725
LEPRECHAUNISM	0.00660917	0.08180257401757725
ACERULOPLASMINEMIA	0.0063492	0.07858489083385681
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0063492	0.07858489083385681
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.006336334000000001	0.07842564664475137
MALAN OVERGROWTH SYNDROME	0.00617144	0.07638473172804405
RENPENNING SYNDROME 1; RENS1	0.00617144	0.07638473172804405
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.006047434	0.07484989301249827
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006010034	0.07438698825013668
MARDEN-WALKER SYNDROME	0.006010034	0.07438698825013668
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.006010034	0.07438698825013668
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.006010034	0.07438698825013668
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.006010034	0.07438698825013668
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.006010034	0.07438698825013668
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00598467	0.07407305465675326
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00598467	0.07407305465675326
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.005946814000000001	0.07360450592188802
RETINAL CONE DYSTROPHY 3B	0.005790780000000001	0.07167325240075623
HIDROTIC ECTODERMAL DYSPLASIA	0.005790780000000001	0.07167325240075623
OCULOCUTANEOUS ALBINISM	0.005790780000000001	0.07167325240075623
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.005790780000000001	0.07167325240075623
OCULOCUTANEOUS ALBINISM TYPE 2	0.005790780000000001	0.07167325240075623
X-LINKED RECESSIVE OCULAR ALBINISM	0.005790780000000001	0.07167325240075623
LEBER CONGENITAL AMAUROSIS 16	0.005790780000000001	0.07167325240075623
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.005790780000000001	0.07167325240075623
GAPO SYNDROME; GAPOS	0.005790780000000001	0.07167325240075623
XERODERMA PIGMENTOSUM	0.005790780000000001	0.07167325240075623
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.005790780000000001	0.07167325240075623
OCULOCUTANEOUS ALBINISM TYPE 1B	0.005790780000000001	0.07167325240075623
HERMANSKY-PUDLAK SYNDROME	0.005790780000000001	0.07167325240075623
OCULOCUTANEOUS ALBINISM TYPE 4	0.005790780000000001	0.07167325240075623
OCULAR ALBINISM	0.005790780000000001	0.07167325240075623
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00568977	0.0704230382283994
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00568977	0.0704230382283994
GAUCHER DISEASE	0.00568977	0.0704230382283994
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00550188	0.06809749876850313
CHITAYAT SYNDROME	0.00550188	0.06809749876850313
19Q13.11 MICRODELETION SYNDROME	0.00550188	0.06809749876850313
ALAZAMI SYNDROME; ALAZS	0.005471664	0.06772351132733956
DYSTONIA-APHONIA SYNDROME	0.005471664	0.06772351132733956
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.005471664	0.06772351132733956
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614154
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.06763459400614154
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.06763459400614154
LEGIUS SYNDROME	0.00546448	0.06763459400614154
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614154
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614154
SPINOCEREBELLAR ATAXIA TYPE 36	0.00546448	0.06763459400614154
CHROMOSOME 9P DELETION SYNDROME	0.005462364	0.06760840399338332
SIALIDOSIS TYPE 2	0.005462364	0.06760840399338332
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.005462364	0.06760840399338332
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.005462364	0.06760840399338332
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.005462364	0.06760840399338332
COFFIN-SIRIS SYNDROME	0.005388004	0.06668804040704086
WOLF-HIRSCHHORN SYNDROME	0.005388004	0.06668804040704086
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.005388004	0.06668804040704086
MENTAL RETARDATION, X-LINKED 101; MRX101	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.005287384000000001	0.06544265331643062
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.005287384000000001	0.06544265331643062
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.005287384000000001	0.06544265331643062
HADZISELIMOVIC SYNDROME	0.005287384000000001	0.06544265331643062
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.005287384000000001	0.06544265331643062
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.005287384000000001	0.06544265331643062
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.005287384000000001	0.06544265331643062
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.005287384000000001	0.06544265331643062
OPTIC ATROPHY 11; OPA11	0.005287384000000001	0.06544265331643062
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005287384000000001	0.06544265331643062
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005287384000000001	0.06544265331643062
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.005287384000000001	0.06544265331643062
PONTINE TEGMENTAL CAP DYSPLASIA	0.005287384000000001	0.06544265331643062
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005287384000000001	0.06544265331643062
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.005287384000000001	0.06544265331643062
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.005287384000000001	0.06544265331643062
MENTAL RETARDATION, X-LINKED 99	0.005284894	0.06541183425604878
JAWAD SYNDROME	0.005284894	0.06541183425604878
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.005284894	0.06541183425604878
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.005284894	0.06541183425604878
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.005284894	0.06541183425604878
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.005284894	0.06541183425604878
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.005284894	0.06541183425604878
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.005284894	0.06541183425604878
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.005284894	0.06541183425604878
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0050910040000000005	0.06301203200005173
L1 SYNDROME	0.004989994	0.06176181782769491
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.004989994	0.06176181782769491
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.06097111708334441
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.06097111708334441
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.06097111708334441
GENIOSPASM 1; GSM1	0.00492611	0.06097111708334441
PANIC DISORDER 1	0.00492611	0.06097111708334441
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.06097111708334441
ACQUIRED METHEMOGLOBINEMIA	0.00492611	0.06097111708334441
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00491681	0.060856009749388186
GAUCHER DISEASE TYPE 2	0.00484245	0.059935646163045725
GAUCHER DISEASE TYPE 3	0.00484245	0.059935646163045725
JACOBSEN SYNDROME	0.00484245	0.059935646163045725
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00484245	0.059935646163045725
STICKLER SYNDROME	0.00484245	0.059935646163045725
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004802934	0.05944655138792592
BOHRING-OPITZ SYNDROME	0.004802934	0.05944655138792592
ARTERIAL TORTUOSITY SYNDROME	0.004802934	0.05944655138792592
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.004802934	0.05944655138792592
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.004802934	0.05944655138792592
2Q31.1 MICRODELETION SYNDROME	0.004802934	0.05944655138792592
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004802934	0.05944655138792592
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.004802934	0.05944655138792592
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.004802934	0.05944655138792592
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.004802934	0.05944655138792592
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.004802934	0.05944655138792592
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.004741830000000001	0.05869025907243547
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004741830000000001	0.05869025907243547
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.058659440012053636
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.058659440012053636
MENTAL RETARDATION, X-LINKED 102	0.00473934	0.058659440012053636
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.058659440012053636
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.058659440012053636
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.058659440012053636
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.058659440012053636
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.058659440012053636
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.058659440012053636
YELLOW FEVER	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.05625963775605659
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.05625963775605659
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.05625963775605659
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.05625963775605659
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.05625963775605659
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.05625963775605659
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.05625963775605659
SCRUB TYPHUS	0.00454545	0.05625963775605659
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 4	0.00454545	0.05625963775605659
CONE DYSTROPHY 3	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.05625963775605659
BLAU SYNDROME	0.00454545	0.05625963775605659
OLIGOCONE TRICHROMACY	0.00454545	0.05625963775605659
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00454545	0.05625963775605659
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 10	0.00454545	0.05625963775605659
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.05625963775605659
ALBINISM, OCULAR, TYPE I	0.00454545	0.05625963775605659
CORNEAL FLECK DYSTROPHY	0.00454545	0.05625963775605659
SJÖGREN-LARSSON SYNDROME	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.05625963775605659
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA	0.00454545	0.05625963775605659
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.05625963775605659
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.05625963775605659
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.05625963775605659
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.00454545	0.05625963775605659
ERMINE PHENOTYPE	0.00454545	0.05625963775605659
CONE DYSTROPHY 4	0.00454545	0.05625963775605659
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.05625963775605659
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 17	0.00454545	0.05625963775605659
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.05625963775605659
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.05625963775605659
LEUKONYCHIA TOTALIS	0.00454545	0.05625963775605659
MACULAR CORNEAL DYSTROPHY	0.00454545	0.05625963775605659
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.05625963775605659
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00454545	0.05625963775605659
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00454545	0.05625963775605659
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.05625963775605659
AMOEBIC KERATITIS	0.00454545	0.05625963775605659
COGAN SYNDROME	0.00454545	0.05625963775605659
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.05625963775605659
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.05625963775605659
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.05625963775605659
ALACRIMA	0.00454545	0.05625963775605659
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.05625963775605659
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 79	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.05625963775605659
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.05625963775605659
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.05625963775605659
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00454545	0.05625963775605659
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.05625963775605659
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.05625963775605659
ALPORT SYNDROME	0.00454545	0.05625963775605659
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.05625963775605659
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 16	0.00454545	0.05625963775605659
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.05625963775605659
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.05625963775605659
ACHROMATOPSIA 7; ACHM7	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.05625963775605659
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.05625963775605659
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.05625963775605659
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00454545	0.05625963775605659
IRVAN SYNDROME	0.00454545	0.05625963775605659
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.05625963775605659
JALILI SYNDROME	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.05625963775605659
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.05625963775605659
NEOVASCULAR GLAUCOMA	0.00454545	0.05625963775605659
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.05625963775605659
TYROSINEMIA TYPE 2	0.00454545	0.05625963775605659
BRADYOPSIA	0.00454545	0.05625963775605659
CORNEODERMATOOSSEOUS SYNDROME	0.00454545	0.05625963775605659
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.05625963775605659
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.05625963775605659
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.05625963775605659
IDIOPATHIC PANUVEITIS	0.00454545	0.05625963775605659
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00454545	0.05625963775605659
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.05625963775605659
CONE ROD DYSTROPHY	0.00454545	0.05625963775605659
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.05625963775605659
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.05625963775605659
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.05625963775605659
BLUE CONE MONOCHROMATISM	0.00454545	0.05625963775605659
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.05625963775605659
EEC SYNDROME	0.00454545	0.05625963775605659
CORNEODERMATOOSSEOUS SYNDROME	0.00454545	0.05625963775605659
FLOTCH SYNDROME	0.00454545	0.05625963775605659
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.05625963775605659
ALACRIMA, CONGENITAL	0.00454545	0.05625963775605659
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.00444444	0.05500942358369977
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369977
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00444444	0.05500942358369977
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00444444	0.05500942358369977
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.05500942358369977
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.05500942358369977
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.05500942358369977
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.05500942358369977
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.05500942358369977
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00444444	0.05500942358369977
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.05500942358369977
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.05500942358369977
GLUCAGONOMA	0.00444444	0.05500942358369977
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.05500942358369977
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.05500942358369977
CENTRAL NEUROCYTOMA	0.00444444	0.05500942358369977
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.00444444	0.05500942358369977
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.00444444	0.05500942358369977
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.05500942358369977
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.05500942358369977
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.00425738	0.05269415714393078
TRISOMY 20P	0.00425738	0.05269415714393078
FOCAL DERMAL HYPOPLASIA; FDH	0.00425738	0.05269415714393078
SHPRINTZEN-GOLDBERG SYNDROME	0.00425738	0.05269415714393078
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00425738	0.05269415714393078
ACROCALLOSAL SYNDROME; ACLS	0.00425738	0.05269415714393078
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00425738	0.05269415714393078
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00425738	0.05269415714393078
SCARF SYNDROME	0.00425738	0.05269415714393078
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00425738	0.05269415714393078
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00425738	0.05269415714393078
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00425738	0.05269415714393078
PALLISTER-KILLIAN SYNDROME	0.00425738	0.05269415714393078
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00425738	0.05269415714393078
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00425738	0.05269415714393078
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00425738	0.05269415714393078
SCARF SYNDROME	0.00425738	0.05269415714393078
FEMORAL-FACIAL SYNDROME	0.00425738	0.05269415714393078
MARDEN-WALKER SYNDROME	0.00425738	0.05269415714393078
FOCAL DERMAL HYPOPLASIA	0.00425738	0.05269415714393078
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.004142674	0.05127442576234123
ICF SYNDROME	0.004142674	0.05127442576234123
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.004142674	0.05127442576234123
TAY-SACHS DISEASE	0.004142674	0.05127442576234123
HEREDITARY OROTIC ACIDURIA	0.004142674	0.05127442576234123
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004142674	0.05127442576234123
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.004142674	0.05127442576234123
TETRASOMY 5P	0.004142674	0.05127442576234123
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004142674	0.05127442576234123
FREE SIALIC ACID STORAGE DISEASE	0.004142674	0.05127442576234123
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004142674	0.05127442576234123
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.004142674	0.05127442576234123
DYSKERATOSIS CONGENITA	0.004142674	0.05127442576234123
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.004142674	0.05127442576234123
EARLY MYOCLONIC ENCEPHALOPATHY	0.004142674	0.05127442576234123
FARBER DISEASE	0.004142674	0.05127442576234123
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.004042054000000001	0.05002903867173098
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.004042054000000001	0.05002903867173098
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.004042054000000001	0.05002903867173098
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.004042054000000001	0.05002903867173098
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.004042054000000001	0.05002903867173098
CHROMOSOME 1P35 DELETION SYNDROME	0.004042054000000001	0.05002903867173098
OROFACIODIGITAL SYNDROME XIV; OFD14	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.004042054000000001	0.05002903867173098
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004042054000000001	0.05002903867173098
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004042054000000001	0.05002903867173098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004042054000000001	0.05002903867173098
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004042054000000001	0.05002903867173098
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.004042054000000001	0.05002903867173098
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004042054000000001	0.05002903867173098
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004042054000000001	0.05002903867173098
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.004042054000000001	0.05002903867173098
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.004042054000000001	0.05002903867173098
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.004042054000000001	0.05002903867173098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004042054000000001	0.05002903867173098
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.004042054000000001	0.05002903867173098
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.004042054000000001	0.05002903867173098
MENTAL RETARDATION, X-LINKED 103	0.004042054000000001	0.05002903867173098
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.004042054000000001	0.05002903867173098
AL-RAQAD SYNDROME; ARS	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.004042054000000001	0.05002903867173098
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004042054000000001	0.05002903867173098
PEHO-LIKE SYNDROME; PEHOL	0.004042054000000001	0.05002903867173098
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.004042054000000001	0.05002903867173098
FOIX-CHAVANY-MARIE SYNDROME	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004042054000000001	0.05002903867173098
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.004042054000000001	0.05002903867173098
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.004042054000000001	0.05002903867173098
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.004042054000000001	0.05002903867173098
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004042054000000001	0.05002903867173098
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.004042054000000001	0.05002903867173098
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.004042054000000001	0.05002903867173098
LISSENCEPHALY 8; LIS8	0.004042054000000001	0.05002903867173098
IMMUNODEFICIENCY 49; IMD49	0.004042054000000001	0.05002903867173098
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.004042054000000001	0.05002903867173098
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.004042054000000001	0.05002903867173098
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.004042054000000001	0.05002903867173098
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.004042054000000001	0.05002903867173098
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.004042054000000001	0.05002903867173098
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004042054000000001	0.05002903867173098
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.004042054000000001	0.05002903867173098
JOUBERT SYNDROME 24	0.004042054000000001	0.05002903867173098
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004042054000000001	0.05002903867173098
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.004042054000000001	0.05002903867173098
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.004042054000000001	0.05002903867173098
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.004042054000000001	0.05002903867173098
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.004042054000000001	0.05002903867173098
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.004042054000000001	0.05002903867173098
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0036956439999999997	0.04574147613885181
6Q TERMINAL DELETION SYNDROME	0.0036956439999999997	0.04574147613885181
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0036956439999999997	0.04574147613885181
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0036956439999999997	0.04574147613885181
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0036956439999999997	0.04574147613885181
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.0036956439999999997	0.04574147613885181
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0036956439999999997	0.04574147613885181
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.0036956439999999997	0.04574147613885181
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0036956439999999997	0.04574147613885181
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0036956439999999997	0.04574147613885181
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0036956439999999997	0.04574147613885181
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0036956439999999997	0.04574147613885181
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0036956439999999997	0.04574147613885181
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0036956439999999997	0.04574147613885181
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0036956439999999997	0.04574147613885181
1Q44 MICRODELETION SYNDROME	0.0036956439999999997	0.04574147613885181
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0036956439999999997	0.04574147613885181
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0036956439999999997	0.04574147613885181
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0036956439999999997	0.04574147613885181
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0036956439999999997	0.04574147613885181
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0036956439999999997	0.04574147613885181
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.04452203151834609
VAN DEN BOSCH SYNDROME	0.00359712	0.04452203151834609
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00359712	0.04452203151834609
PRIMARY ERYTHROMELALGIA	0.00359712	0.04452203151834609
DERMATOMYOSITIS	0.00359712	0.04452203151834609
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00359712	0.04452203151834609
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00359712	0.04452203151834609
ODONTOCHONDRODYSPLASIA; ODCD	0.00359712	0.04452203151834609
PAROXYSMAL COLD HEMOGLOBINURIA	0.00359712	0.04452203151834609
IMMUNODEFICIENCY 32B; IMD32B	0.00359712	0.04452203151834609
RETICULAR DYSGENESIS	0.00359712	0.04452203151834609
SANDHOFF DISEASE	0.00359712	0.04452203151834609
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.00359712	0.04452203151834609
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IGE; EPKHE	0.00359712	0.04452203151834609
ATAXIA-PANCYTOPENIA SYNDROME	0.00359712	0.04452203151834609
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00359712	0.04452203151834609
BETA-MANNOSIDOSIS	0.00359712	0.04452203151834609
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00359712	0.04452203151834609
IMMUNODEFICIENCY 43	0.00359712	0.04452203151834609
LARYNX ATRESIA	0.00359712	0.04452203151834609
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.00359712	0.04452203151834609
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00359712	0.04452203151834609
OPSISMODYSPLASIA	0.00359712	0.04452203151834609
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00359712	0.04452203151834609
CYSTIC FIBROSIS	0.00359712	0.04452203151834609
ALOPECIA ANTIBODY DEFICIENCY	0.00359712	0.04452203151834609
PULMONARY ARTERIAL HYPERTENSION	0.00359712	0.04452203151834609
LIPOID PROTEINOSIS	0.00359712	0.04452203151834609
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00359712	0.04452203151834609
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.00359712	0.04452203151834609
GRANULOMATOSIS WITH POLYANGIITIS	0.00359712	0.04452203151834609
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.00359712	0.04452203151834609
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.00359712	0.04452203151834609
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00359712	0.04452203151834609
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00359712	0.04452203151834609
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.00359712	0.04452203151834609
THORACIC DYSOSTOSIS, ISOLATED	0.00359712	0.04452203151834609
LAMELLAR ICHTHYOSIS	0.00359712	0.04452203151834609
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.00359712	0.04452203151834609
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00359712	0.04452203151834609
LYMPHANGIOLEIOMYOMATOSIS	0.00359712	0.04452203151834609
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.00359712	0.04452203151834609
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.00359712	0.04452203151834609
ZLOTOGORA-OGUR SYNDROME	0.00359712	0.04452203151834609
IMMUNODEFICIENCY 22; IMD22	0.00359712	0.04452203151834609
HENNEKAM SYNDROME	0.00359712	0.04452203151834609
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00359712	0.04452203151834609
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.00359712	0.04452203151834609
GAMMA-HEAVY CHAIN DISEASE	0.00359712	0.04452203151834609
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.00359712	0.04452203151834609
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.00359712	0.04452203151834609
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00359712	0.04452203151834609
MARTSOLF SYNDROME	0.00359712	0.04452203151834609
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00359712	0.04452203151834609
DIASTROPHIC DWARFISM	0.00359712	0.04452203151834609
RETINITIS PIGMENTOSA 6	0.00359712	0.04452203151834609
IMMUNODEFICIENCY 57; IMD57	0.00359712	0.04452203151834609
CHRONIC GRANULOMATOUS DISEASE	0.00359712	0.04452203151834609
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00359712	0.04452203151834609
MALT LYMPHOMA	0.00359712	0.04452203151834609
NIEMANN-PICK DISEASE, TYPE B	0.00359712	0.04452203151834609
BLOOM SYNDROME	0.00359712	0.04452203151834609
PARTIAL ATRIOVENTRICULAR CANAL	0.00359712	0.04452203151834609
X-LINKED IMMUNONEUROLOGIC DISORDER	0.00359712	0.04452203151834609
GLYCOGEN STORAGE DISEASE II	0.00359712	0.04452203151834609
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00359712	0.04452203151834609
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.00359712	0.04452203151834609
MELNICK-NEEDLES SYNDROME	0.00359712	0.04452203151834609
JUNG SYNDROME	0.00359712	0.04452203151834609
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.00359712	0.04452203151834609
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00359712	0.04452203151834609
SANJAD-SAKATI SYNDROME	0.00359712	0.04452203151834609
CYCLIC NEUTROPENIA	0.00359712	0.04452203151834609
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.00359712	0.04452203151834609
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00359712	0.04452203151834609
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00359712	0.04452203151834609
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.00359712	0.04452203151834609
YELLOW NAIL SYNDROME	0.00359712	0.04452203151834609
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00359712	0.04452203151834609
SPINAL MUSCULAR ATROPHY, TYPE II	0.00359712	0.04452203151834609
WISKOTT-ALDRICH SYNDROME	0.00359712	0.04452203151834609
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.00359712	0.04452203151834609
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.00359712	0.04452203151834609
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00359712	0.04452203151834609
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00359712	0.04452203151834609
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00359712	0.04452203151834609
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.00359712	0.04452203151834609
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00359712	0.04452203151834609
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00359712	0.04452203151834609
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.00359712	0.04452203151834609
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.00359712	0.04452203151834609
OPSISMODYSPLASIA; OPSMD	0.00359712	0.04452203151834609
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00359712	0.04452203151834609
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00359712	0.04452203151834609
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.00359712	0.04452203151834609
SPASTIC PARAPLEGIA TYPE 2	0.00359712	0.04452203151834609
HYPEREKPLEXIA 4; HKPX4	0.003557604	0.04403293674322628
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.003557604	0.04403293674322628
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.003557604	0.04403293674322628
KAGAMI-OGATA SYNDROME	0.003557604	0.04403293674322628
17P13.3 MICRODUPLICATION SYNDROME	0.003557604	0.04403293674322628
PETERS PLUS SYNDROME	0.003557604	0.04403293674322628
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.003557604	0.04403293674322628
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.003557604	0.04403293674322628
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003557604	0.04403293674322628
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003557604	0.04403293674322628
CATEL-MANZKE SYNDROME; CATMANS	0.003557604	0.04403293674322628
RUVALCABA SYNDROME	0.003557604	0.04403293674322628
DIAPHANOSPONDYLODYSOSTOSIS	0.003557604	0.04403293674322628
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.003557604	0.04403293674322628
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.003557604	0.04403293674322628
KAGAMI-OGATA SYNDROME	0.003557604	0.04403293674322628
PERLMAN SYNDROME	0.003557604	0.04403293674322628
LATERAL MENINGOCELE SYNDROME	0.003557604	0.04403293674322628
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003557604	0.04403293674322628
AYMÉ-GRIPP SYNDROME	0.003557604	0.04403293674322628
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003557604	0.04403293674322628
PSEUDOAMINOPTERIN SYNDROME	0.003557604	0.04403293674322628
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.003557604	0.04403293674322628
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003557604	0.04403293674322628
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.003557604	0.04403293674322628
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.003557604	0.04403293674322628
OROFACIODIGITAL SYNDROME XVI; OFD16	0.003557604	0.04403293674322628
WEAVER SYNDROME	0.003557604	0.04403293674322628
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0034965000000000005	0.04327664442773584
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0034965000000000005	0.04327664442773584
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.0034965000000000005	0.04327664442773584
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0034965000000000005	0.04327664442773584
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0034965000000000005	0.04327664442773584
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0034965000000000005	0.04327664442773584
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.0034965000000000005	0.04327664442773584
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.0034965000000000005	0.04327664442773584
14Q12 MICRODELETION SYNDROME	0.0034965000000000005	0.04327664442773584
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.0034965000000000005	0.04327664442773584
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0034965000000000005	0.04327664442773584
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0034965000000000005	0.04327664442773584
OLIVER SYNDROME	0.0034965000000000005	0.04327664442773584
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.0034965000000000005	0.04327664442773584
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.0034965000000000005	0.04327664442773584
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0034965000000000005	0.04327664442773584
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.0034965000000000005	0.04327664442773584
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.0034965000000000005	0.04327664442773584
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.0034965000000000005	0.04327664442773584
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0034965000000000005	0.04327664442773584
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.0034965000000000005	0.04327664442773584
OPTICOCOCHLEODENTATE DEGENERATION	0.0034965000000000005	0.04327664442773584
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00315009	0.03898908189485667
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00315009	0.03898908189485667
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00315009	0.03898908189485667
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00315009	0.03898908189485667
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.00315009	0.03898908189485667
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00301205	0.03728054249923115
HUNTER-MACDONALD SYNDROME	0.00301205	0.03728054249923115
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00301205	0.03728054249923115
SIMOSA CRANIOFACIAL SYNDROME	0.00301205	0.03728054249923115
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00301205	0.03728054249923115
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00301205	0.03728054249923115
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00301205	0.03728054249923115
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, TYPE I	0.00301205	0.03728054249923115
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00301205	0.03728054249923115
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00301205	0.03728054249923115
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00301205	0.03728054249923115
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00301205	0.03728054249923115
HYPEREKPLEXIA 1; HKPX1	0.00301205	0.03728054249923115
VACTERL WITH HYDROCEPHALUS	0.00301205	0.03728054249923115
OSTEOGENESIS IMPERFECTA	0.00301205	0.03728054249923115
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00301205	0.03728054249923115
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00301205	0.03728054249923115
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00301205	0.03728054249923115
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00301205	0.03728054249923115
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.00301205	0.03728054249923115
WIDOW'S PEAK SYNDROME	0.00301205	0.03728054249923115
OMPHALOCELE, AUTOSOMAL	0.00301205	0.03728054249923115
LAMBERT SYNDROME	0.00301205	0.03728054249923115
HERNIA, DOUBLE INGUINAL	0.00301205	0.03728054249923115
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00301205	0.03728054249923115
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00301205	0.03728054249923115
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00301205	0.03728054249923115
MUCOLIPIDOSIS TYPE III	0.00301205	0.03728054249923115
268650 RUDIGER SYNDROME	0.00301205	0.03728054249923115
EXSTROPHY OF BLADDER	0.00301205	0.03728054249923115
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923115
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.00301205	0.03728054249923115
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00301205	0.03728054249923115
ACROCALLOSAL SYNDROME	0.00301205	0.03728054249923115
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00301205	0.03728054249923115
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00301205	0.03728054249923115
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00301205	0.03728054249923115
ADAMS-OLIVER SYNDROME 5; AOS5	0.00301205	0.03728054249923115
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00301205	0.03728054249923115
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.00301205	0.03728054249923115
X-LINKED EHLERS-DANLOS SYNDROME	0.00301205	0.03728054249923115
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00301205	0.03728054249923115
SHORT SYNDROME	0.00301205	0.03728054249923115
BRITTLE CORNEA SYNDROME 2; BCS2	0.00301205	0.03728054249923115
LATERAL MENINGOCELE SYNDROME	0.00301205	0.03728054249923115
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00301205	0.03728054249923115
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00301205	0.03728054249923115
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00301205	0.03728054249923115
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.00301205	0.03728054249923115
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00301205	0.03728054249923115
RHINY	0.00301205	0.03728054249923115
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00301205	0.03728054249923115
DISTAL MONOSOMY 3P	0.00301205	0.03728054249923115
FRANK-TER HAAR SYNDROME	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00301205	0.03728054249923115
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00301205	0.03728054249923115
BRUCK SYNDROME 2	0.00301205	0.03728054249923115
OSTEOGLOSPHONIC DYSPLASIA	0.00301205	0.03728054249923115
RUVALCABA SYNDROME	0.00301205	0.03728054249923115
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00301205	0.03728054249923115
ARTERIAL TORTUOSITY SYNDROME	0.00301205	0.03728054249923115
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00301205	0.03728054249923115
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00301205	0.03728054249923115
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00301205	0.03728054249923115
POLYDACTYLY-MYOPIA SYNDROME	0.00301205	0.03728054249923115
NEURAMINIDASE DEFICIENCY	0.00301205	0.03728054249923115
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.00301205	0.03728054249923115
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.00301205	0.03728054249923115
AUTOSOMAL DOMINANT CUTIS LAXA	0.00301205	0.03728054249923115
DIPHALLIA	0.00301205	0.03728054249923115
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.00301205	0.03728054249923115
OSTEOGENESIS IMPERFECTA, TYPE X	0.00301205	0.03728054249923115
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00301205	0.03728054249923115
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00301205	0.03728054249923115
MICROSPHEROPHAKIA WITH HERNIA	0.00301205	0.03728054249923115
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.00301205	0.03728054249923115
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00301205	0.03728054249923115
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00301205	0.03728054249923115
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00301205	0.03728054249923115
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.00301205	0.03728054249923115
ULNAR-MAMMARY SYNDROME; UMS	0.00301205	0.03728054249923115
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.00301205	0.03728054249923115
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.03728054249923115
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00301205	0.03728054249923115
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00301205	0.03728054249923115
FACIOCARDIORENAL SYNDROME	0.00301205	0.03728054249923115
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00301205	0.03728054249923115
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00301205	0.03728054249923115
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00301205	0.03728054249923115
ISOLATED HEMIHYPERPLASIA	0.00301205	0.03728054249923115
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00301205	0.03728054249923115
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00301205	0.03728054249923115
LAMBERT SYNDROME	0.00301205	0.03728054249923115
COFFIN-LOWRY SYNDROME; CLS	0.00301205	0.03728054249923115
ACHONDROGENESIS	0.00301205	0.03728054249923115
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00301205	0.03728054249923115
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00301205	0.03728054249923115
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00301205	0.03728054249923115
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00301205	0.03728054249923115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002450314	0.03032786149415218
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002450314	0.03032786149415218
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.002450314	0.03032786149415218
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.002450314	0.03032786149415218
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002450314	0.03032786149415218
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.002450314	0.03032786149415218
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.002450314	0.03032786149415218
SAUL-WILSON SYNDROME; SWILS	0.002450314	0.03032786149415218
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002450314	0.03032786149415218
EPILEPSY, PYRIDOXINE-DEPENDENT	0.002450314	0.03032786149415218
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.002450314	0.03032786149415218
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.002450314	0.03032786149415218
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.002450314	0.03032786149415218
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.002450314	0.03032786149415218
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.002450314	0.03032786149415218
AL KAISSI SYNDROME; ALKAS	0.002450314	0.03032786149415218
EPIDERMAL NEVUS SYNDROME	0.002450314	0.03032786149415218
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.002450314	0.03032786149415218
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.002450314	0.03032786149415218
SHASHI-PENA SYNDROME; SHAPNS	0.002450314	0.03032786149415218
NOONAN SYNDROME 6; NS6	0.002450314	0.03032786149415218
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.002450314	0.03032786149415218
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.002450314	0.03032786149415218
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.002450314	0.03032786149415218
ABLEPHARON MACROSTOMIA SYNDROME	0.002450314	0.03032786149415218
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.002450314	0.03032786149415218
COHEN-GIBSON SYNDROME; COGIS	0.002450314	0.03032786149415218
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.002450314	0.03032786149415218
DUCHENNE MUSCULAR DYSTROPHY	0.002450314	0.03032786149415218
LIG4 SYNDROME	0.002450314	0.03032786149415218
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.002450314	0.03032786149415218
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.002450314	0.03032786149415218
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.002450314	0.03032786149415218
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.002450314	0.03032786149415218
SAY-BARBER-MILLER SYNDROME	0.002450314	0.03032786149415218
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.002450314	0.03032786149415218
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.002450314	0.03032786149415218
FORSYTHE-WAKELING SYNDROME; FWS	0.002450314	0.03032786149415218
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.002450314	0.03032786149415218
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.002450314	0.03032786149415218
8P23.1 DUPLICATION SYNDROME	0.002450314	0.03032786149415218
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.002450314	0.03032786149415218
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002450314	0.03032786149415218
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.002450314	0.03032786149415218
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.002450314	0.03032786149415218
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.002450314	0.03032786149415218
GALACTOSE EPIMERASE DEFICIENCY	0.002450314	0.03032786149415218
17Q11.2 MICRODUPLICATION SYNDROME	0.002450314	0.03032786149415218
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.002450314	0.03032786149415218
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.002450314	0.03032786149415218
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.002450314	0.03032786149415218
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.002450314	0.03032786149415218
OKAMOTO SYNDROME	0.002450314	0.03032786149415218
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.002450314	0.03032786149415218
DESBUQUOIS DYSPLASIA 2; DBQD2	0.002450314	0.03032786149415218
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.002450314	0.03032786149415218
12Q14 MICRODELETION SYNDROME	0.002450314	0.03032786149415218
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.002450314	0.03032786149415218
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.002450314	0.03032786149415218
GENITOPATELLAR SYNDROME	0.002450314	0.03032786149415218
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.002450314	0.03032786149415218
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.002450314	0.03032786149415218
PELIZAEUS-MERZBACHER DISEASE	0.002450314	0.03032786149415218
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.002450314	0.03032786149415218
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.002450314	0.03032786149415218
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.002450314	0.03032786149415218
7P22.1 MICRODUPLICATION SYNDROME	0.002450314	0.03032786149415218
OROFACIODIGITAL SYNDROME XVII	0.00190476	0.023575467250157044
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00190476	0.023575467250157044
CRANIOSYNOSTOSIS 7	0.00190476	0.023575467250157044
MENTAL RETARDATION, X-LINKED 93	0.00190476	0.023575467250157044
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00190476	0.023575467250157044
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.00190476	0.023575467250157044
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00190476	0.023575467250157044
SPINOCEREBELLAR ATAXIA TYPE 3	0.00190476	0.023575467250157044
MENTAL RETARDATION, X-LINKED 95	0.00190476	0.023575467250157044
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00190476	0.023575467250157044
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00190476	0.023575467250157044
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00190476	0.023575467250157044
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00190476	0.023575467250157044
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00190476	0.023575467250157044
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00190476	0.023575467250157044
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.00190476	0.023575467250157044
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00190476	0.023575467250157044
FG SYNDROME 2; FGS2	0.00190476	0.023575467250157044
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00190476	0.023575467250157044
BRACHYDACTYLY, TYPE A1, D	0.00190476	0.023575467250157044
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.00190476	0.023575467250157044
VERVERI-BRADY SYNDROME; VERBRAS	0.00190476	0.023575467250157044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.00190476	0.023575467250157044
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00190476	0.023575467250157044
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00190476	0.023575467250157044
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.00190476	0.023575467250157044
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.00190476	0.023575467250157044
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.00190476	0.023575467250157044
EPISODIC ATAXIA TYPE 1	0.00190476	0.023575467250157044
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00190476	0.023575467250157044
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00190476	0.023575467250157044
BARDET-BIEDL SYNDROME 21; BBS21	0.00190476	0.023575467250157044
GERODERMA OSTEODYSPLASTICUM; GO	0.00190476	0.023575467250157044
RETINITIS PIGMENTOSA 71; RP71	0.00190476	0.023575467250157044
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00190476	0.023575467250157044
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00190476	0.023575467250157044
224550 DYSTONIA WITH RINGBINDEN	0.00190476	0.023575467250157044
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00190476	0.023575467250157044
MENTAL RETARDATION, X-LINKED 19	0.00190476	0.023575467250157044
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.00190476	0.023575467250157044
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.00190476	0.023575467250157044
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.00190476	0.023575467250157044
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.00190476	0.023575467250157044
20P13 MICRODELETION SYNDROME	0.00190476	0.023575467250157044
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00190476	0.023575467250157044
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.00190476	0.023575467250157044
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00190476	0.023575467250157044
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.00190476	0.023575467250157044
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00190476	0.023575467250157044
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.00190476	0.023575467250157044
NAGER SYNDROME	0.00190476	0.023575467250157044
MASA SYNDROME	0.00190476	0.023575467250157044
HYPOGLOSSIA WITH SITUS INVERSUS	0.00190476	0.023575467250157044
CRIGLER-NAJJAR SYNDROME TYPE 1	0.00190476	0.023575467250157044
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.00190476	0.023575467250157044
ABLEPHARON-MACROSTOMIA SYNDROME	0.00190476	0.023575467250157044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00190476	0.023575467250157044
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00190476	0.023575467250157044
DYSTONIA 16; DYT16	0.00190476	0.023575467250157044
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.00190476	0.023575467250157044
SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1	0.00190476	0.023575467250157044
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.00190476	0.023575467250157044
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00190476	0.023575467250157044
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.00190476	0.023575467250157044
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00190476	0.023575467250157044
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00190476	0.023575467250157044
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00190476	0.023575467250157044
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00190476	0.023575467250157044
PARTINGTON SYNDROME	0.00190476	0.023575467250157044
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00190476	0.023575467250157044
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.00190476	0.023575467250157044
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00190476	0.023575467250157044
MAXILLOFACIAL DYSOSTOSIS	0.00190476	0.023575467250157044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00190476	0.023575467250157044
FAMILIAL MULTIPLE LIPOMATOSIS	0.00190476	0.023575467250157044
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00190476	0.023575467250157044
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00190476	0.023575467250157044
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00190476	0.023575467250157044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.00190476	0.023575467250157044
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00190476	0.023575467250157044
CHROMOSOME 13Q14 DELETION SYNDROME	0.00190476	0.023575467250157044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.00190476	0.023575467250157044
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00190476	0.023575467250157044
SPEECH-LANGUAGE DISORDER 1	0.00190476	0.023575467250157044
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001790884	0.022166008888694768
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001790884	0.022166008888694768
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001790884	0.022166008888694768
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001790884	0.022166008888694768
CRANIOSYNOSTOSIS 6; CRS6	0.001790884	0.022166008888694768
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.001790884	0.022166008888694768
MONOSOMY 9P	0.001790884	0.022166008888694768
TRISOMY 17P	0.001790884	0.022166008888694768
RAHMAN SYNDROME	0.001790884	0.022166008888694768
SENIOR-LOKEN SYNDROME 9	0.001790884	0.022166008888694768
OROFACIODIGITAL SYNDROME VIII; OFD8	0.001790884	0.022166008888694768
XQ21 MICRODELETION SYNDROME	0.001790884	0.022166008888694768
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.022166008888694768
CARDIOFACIOCUTANEOUS SYNDROME	0.001790884	0.022166008888694768
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.001790884	0.022166008888694768
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001790884	0.022166008888694768
JOUBERT SYNDROME 31; JBTS31	0.001790884	0.022166008888694768
TOLUENE EMBRYOPATHY	0.001790884	0.022166008888694768
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.022166008888694768
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001790884	0.022166008888694768
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001790884	0.022166008888694768
JOUBERT SYNDROME 21	0.001790884	0.022166008888694768
FETAL TRIMETHADIONE SYNDROME	0.001790884	0.022166008888694768
POTOCKI-SHAFFER SYNDROME	0.001790884	0.022166008888694768
PHACE SYNDROME	0.001790884	0.022166008888694768
SCHINDLER DISEASE, TYPE I	0.001790884	0.022166008888694768
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.022166008888694768
SCHIZENCEPHALY	0.001790884	0.022166008888694768
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001790884	0.022166008888694768
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.022166008888694768
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001790884	0.022166008888694768
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001790884	0.022166008888694768
TREACHER-COLLINS SYNDROME	0.001790884	0.022166008888694768
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001790884	0.022166008888694768
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.001790884	0.022166008888694768
KBG SYNDROME	0.001790884	0.022166008888694768
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001790884	0.022166008888694768
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.001790884	0.022166008888694768
DUANE RETRACTION SYNDROME	0.001790884	0.022166008888694768
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001790884	0.022166008888694768
RECOMBINANT CHROMOSOME 8 SYNDROME	0.001790884	0.022166008888694768
OROFACIODIGITAL SYNDROME IX; OFD9	0.001790884	0.022166008888694768
ZTTK SYNDROME; ZTTKS	0.001790884	0.022166008888694768
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.001790884	0.022166008888694768
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001790884	0.022166008888694768
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.022166008888694768
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.022166008888694768
MEIER-GORLIN SYNDROME 7	0.001790884	0.022166008888694768
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001790884	0.022166008888694768
MATERNAL PHENYLKETONURIA	0.001790884	0.022166008888694768
JOUBERT SYNDROME WITH RENAL DEFECT	0.001790884	0.022166008888694768
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	0.022166008888694768
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	0.022166008888694768
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001790884	0.022166008888694768
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.022166008888694768
CODAS SYNDROME	0.001790884	0.022166008888694768
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001790884	0.022166008888694768
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.001790884	0.022166008888694768
MARINESCO-SJÖGREN SYNDROME	0.001790884	0.022166008888694768
GERMAN SYNDROME	0.001790884	0.022166008888694768
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001790884	0.022166008888694768
OPTIC PATHWAY GLIOMA	0.001790884	0.022166008888694768
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001790884	0.022166008888694768
ROTHMUND-THOMSON SYNDROME	0.001790884	0.022166008888694768
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001790884	0.022166008888694768
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001790884	0.022166008888694768
JOUBERT SYNDROME	0.001790884	0.022166008888694768
MONOSOMY 18Q	0.001790884	0.022166008888694768
3MC SYNDROME 2	0.001790884	0.022166008888694768
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.022166008888694768
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.001790884	0.022166008888694768
COHEN SYNDROME	0.001790884	0.022166008888694768
X SMALL RINGS	0.001790884	0.022166008888694768
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001790884	0.022166008888694768
OCULOECTODERMAL SYNDROME; OES	0.001790884	0.022166008888694768
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.001790884	0.022166008888694768
FRONTOOCULAR SYNDROME	0.001790884	0.022166008888694768
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001790884	0.022166008888694768
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.001790884	0.022166008888694768
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.001790884	0.022166008888694768
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.001790884	0.022166008888694768
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001790884	0.022166008888694768
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001790884	0.022166008888694768
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.022166008888694768
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.022166008888694768
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.001790884	0.022166008888694768
SSR4-CDG	0.001790884	0.022166008888694768
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.001790884	0.022166008888694768
ISOLATED PLAGIOCEPHALY	0.001790884	0.022166008888694768
BOHRING-OPITZ SYNDROME	0.001790884	0.022166008888694768
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001790884	0.022166008888694768
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.022166008888694768
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001790884	0.022166008888694768
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001790884	0.022166008888694768
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.022166008888694768
MONOSOMY 9Q22.3	0.001790884	0.022166008888694768
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001790884	0.022166008888694768
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.022166008888694768
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.015413614644699633
MULTIMINICORE MYOPATHY	0.00124533	0.015413614644699633
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00124533	0.015413614644699633
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00124533	0.015413614644699633
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00124533	0.015413614644699633
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.015413614644699633
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00124533	0.015413614644699633
BASAL CELL NEVUS SYNDROME	0.00124533	0.015413614644699633
ROBINOW-SORAUF SYNDROME	0.00124533	0.015413614644699633
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00124533	0.015413614644699633
NOONAN SYNDROME	0.00124533	0.015413614644699633
IVIC SYNDROME	0.00124533	0.015413614644699633
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00124533	0.015413614644699633
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.015413614644699633
MOSAIC TRISOMY 8	0.00124533	0.015413614644699633
NANOPHTHALMOS	0.00124533	0.015413614644699633
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.015413614644699633
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.015413614644699633
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.00124533	0.015413614644699633
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.00124533	0.015413614644699633
WOOLLY HAIR	0.00124533	0.015413614644699633
MORNING GLORY DISC ANOMALY	0.00124533	0.015413614644699633
MEIER-GORLIN SYNDROME 1; MGORS1	0.00124533	0.015413614644699633
BRANCHIOOCULOFACIAL SYNDROME	0.00124533	0.015413614644699633
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00124533	0.015413614644699633
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.015413614644699633
COOPER-JABS SYNDROME	0.00124533	0.015413614644699633
MENTAL RETARDATION, X-LINKED 1	0.00124533	0.015413614644699633
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.015413614644699633
HYPERTELORISM, TEEBI TYPE	0.00124533	0.015413614644699633
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00124533	0.015413614644699633
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.015413614644699633
15Q OVERGROWTH SYNDROME	0.00124533	0.015413614644699633
JACKSON-WEISS SYNDROME	0.00124533	0.015413614644699633
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.015413614644699633
KNOBLOCH SYNDROME	0.00124533	0.015413614644699633
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.015413614644699633
MCDONOUGH SYNDROME	0.00124533	0.015413614644699633
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.015413614644699633
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.015413614644699633
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.015413614644699633
NON-DISTAL MONOSOMY 10Q	0.00124533	0.015413614644699633
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.015413614644699633
IVIC SYNDROME	0.00124533	0.015413614644699633
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.015413614644699633
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00124533	0.015413614644699633
ODONTOCHONDRODYSPLASIA	0.00124533	0.015413614644699633
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00124533	0.015413614644699633
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699633
LAURENCE-MOON SYNDROME	0.00124533	0.015413614644699633
COCKAYNE SYNDROME A; CSA	0.00124533	0.015413614644699633
TRISOMY 4P	0.00124533	0.015413614644699633
LEIGH SYNDROME	0.00124533	0.015413614644699633
CARTILAGE-HAIR HYPOPLASIA	0.00124533	0.015413614644699633
MARSHALL SYNDROME	0.00124533	0.015413614644699633
ABDUCENS PALSY	0.00124533	0.015413614644699633
APERT SYNDROME	0.00124533	0.015413614644699633
MCDONOUGH SYNDROME	0.00124533	0.015413614644699633
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00124533	0.015413614644699633
HALLERMANN-STREIFF SYNDROME	0.00124533	0.015413614644699633
X-LINKED RETINAL DYSPLASIA	0.00124533	0.015413614644699633
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00124533	0.015413614644699633
TETRASOMY 12P	0.00124533	0.015413614644699633
15Q26 OVERGROWTH SYNDROME	0.00124533	0.015413614644699633
CROUZON DISEASE	0.00124533	0.015413614644699633
GASTROCUTANEOUS SYNDROME	0.00124533	0.015413614644699633
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00124533	0.015413614644699633
LAMBOTTE SYNDROME	0.00124533	0.015413614644699633
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.015413614644699633
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00124533	0.015413614644699633
EEM SYNDROME	0.00124533	0.015413614644699633
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699633
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.015413614644699633
SMITH-KINGSMORE SYNDROME; SKS	0.00124533	0.015413614644699633
COCKAYNE SYNDROME	0.00124533	0.015413614644699633
WAARDENBURG SYNDROME TYPE 1	0.00124533	0.015413614644699633
FETAL IODINE SYNDROME	0.00124533	0.015413614644699633
JOHANSON-BLIZZARD SYNDROME; JBS	0.00124533	0.015413614644699633
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00124533	0.015413614644699633
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.015413614644699633
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00124533	0.015413614644699633
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.015413614644699633
MUSCLE-EYE-BRAIN DISEASE	0.00124533	0.015413614644699633
PROXIMAL SYMPHALANGISM	0.00124533	0.015413614644699633
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.015413614644699633
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.015413614644699633
RETINOBLASTOMA	0.00124533	0.015413614644699633
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.015413614644699633
SUMMITT SYNDROME	0.00124533	0.015413614644699633
NOONAN SYNDROME 7; NS7	0.00124533	0.015413614644699633
DYSEQUILIBRIUM SYNDROME	0.00124533	0.015413614644699633
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.015413614644699633
GLUTATHIONURIA	0.00124533	0.015413614644699633
TOWNES-BROCKS SYNDROME	0.00124533	0.015413614644699633
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00124533	0.015413614644699633
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.015413614644699633
RENPENNING SYNDROME	0.00124533	0.015413614644699633
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.015413614644699633
CONGENITAL HYDROCEPHALUS	0.00124533	0.015413614644699633
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00124533	0.015413614644699633
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.00124533	0.015413614644699633
DIAMOND-BLACKFAN ANEMIA 1	0.00124533	0.015413614644699633
SECKEL SYNDROME 5; SCKL5	0.00124533	0.015413614644699633
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00124533	0.015413614644699633
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699633
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00124533	0.015413614644699633
ALAGILLE SYNDROME	0.00124533	0.015413614644699633
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.015413614644699633
DESMOSTEROLOSIS	0.00124533	0.015413614644699633
MOWAT-WILSON SYNDROME	0.00124533	0.015413614644699633
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00124533	0.015413614644699633
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.015413614644699633
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00124533	0.015413614644699633
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00124533	0.015413614644699633
PETERS ANOMALY	0.00124533	0.015413614644699633
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.015413614644699633
RENAL COLOBOMA SYNDROME	0.00124533	0.015413614644699633
HEMIFACIAL MICROSOMIA	0.00124533	0.015413614644699633
MASA SYNDROME	0.00124533	0.015413614644699633
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.015413614644699633
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.015413614644699633
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.015413614644699633
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.00124533	0.015413614644699633
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	0.015413614644699633
8Q21.11 MICRODELETION SYNDROME	0.00124533	0.015413614644699633
PELVISCAPULAR DYSPLASIA	0.00124533	0.015413614644699633
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.015413614644699633
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00124533	0.015413614644699633
ADAMS-OLIVER SYNDROME	0.00124533	0.015413614644699633
BRANCHIO-OCULO-FACIAL SYNDROME	0.00124533	0.015413614644699633
FANCONI ANEMIA	0.00124533	0.015413614644699633
ANTLEY-BIXLER SYNDROME	0.00124533	0.015413614644699633
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00124533	0.015413614644699633
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.015413614644699633
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00124533	0.015413614644699633
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00124533	0.015413614644699633
SECKEL SYNDROME 1; SCKL1	0.00124533	0.015413614644699633
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.00124533	0.015413614644699633
COATS DISEASE	0.00124533	0.015413614644699633
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00124533	0.015413614644699633
BRANCHIOSKELETOGENITAL SYNDROME	0.00124533	0.015413614644699633
ALAGILLE SYNDROME 1; ALGS1	0.00124533	0.015413614644699633
URBAN-ROGERS-MEYER SYNDROME	0.00124533	0.015413614644699633
BENCZE SYNDROME	0.00124533	0.015413614644699633
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.015413614644699633
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.015413614644699633
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00124533	0.015413614644699633
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.015413614644699633
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.015413614644699633
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.015413614644699633
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00124533	0.015413614644699633
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.015413614644699633
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00124533	0.015413614644699633
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.00124533	0.015413614644699633
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.00124533	0.015413614644699633
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00124533	0.015413614644699633
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00124533	0.015413614644699633
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.015413614644699633
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.015413614644699633
PETERS ANOMALY	0.00124533	0.015413614644699633
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.015413614644699633
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00124533	0.015413614644699633
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.015413614644699633
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.015413614644699633
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.015413614644699633
STIFF SKIN SYNDROME	0.00124533	0.015413614644699633
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.015413614644699633
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00124533	0.015413614644699633
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00124533	0.015413614644699633
CHANARIN-DORFMAN SYNDROME	0.00124533	0.015413614644699633
GAUCHER DISEASE, TYPE IIIC	0.00124533	0.015413614644699633
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.015413614644699633
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00124533	0.015413614644699633
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.015413614644699633
CROSSED POLYSYNDACTYLY	0.00124533	0.015413614644699633
SENGERS SYNDROME	0.00124533	0.015413614644699633
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00124533	0.015413614644699633
COSTELLO SYNDROME	0.00124533	0.015413614644699633
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00124533	0.015413614644699633
CONGENITAL RUBELLA SYNDROME	0.00124533	0.015413614644699633
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00124533	0.015413614644699633
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.015413614644699633
LERI PLEONOSTEOSIS	0.00124533	0.015413614644699633
PRIMARY CUTIS VERTICIS GYRATA	0.00124533	0.015413614644699633
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00124533	0.015413614644699633
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00124533	0.015413614644699633
INCONTINENTIA PIGMENTI; IP	0.00124533	0.015413614644699633
FRONTORHINY	0.00124533	0.015413614644699633
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.00124533	0.015413614644699633
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00124533	0.015413614644699633
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.015413614644699633
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00124533	0.015413614644699633
OTOMANDIBULAR SYNDROME	0.00124533	0.015413614644699633
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.00124533	0.015413614644699633
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00124533	0.015413614644699633
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.015413614644699633
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.015413614644699633
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00124533	0.015413614644699633
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00124533	0.015413614644699633
LINEAR VERRUCOUS NEVUS SYNDROME	0.00124533	0.015413614644699633
ELLIS VAN CREVELD SYNDROME	0.00124533	0.015413614644699633
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00124533	0.015413614644699633
OPTIC ATROPHY 1; OPA1	0.00124533	0.015413614644699633
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.00124533	0.015413614644699633
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.015413614644699633
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.015413614644699633
GRISCELLI SYNDROME TYPE 1	0.000545554	0.006752394243995135
ALG6-CDG	0.000545554	0.006752394243995135
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000545554	0.006752394243995135
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.006752394243995135
RIGID SPINE SYNDROME	0.000545554	0.006752394243995135
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.006752394243995135
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000545554	0.006752394243995135
WALKER-WARBURG SYNDROME	0.000545554	0.006752394243995135
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.006752394243995135
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.006752394243995135
LIG4 SYNDROME	0.000545554	0.006752394243995135
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.006752394243995135
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995135
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995135
ALG3-CDG	0.000545554	0.006752394243995135
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.006752394243995135
ZEBRA BODY MYOPATHY	0.000545554	0.006752394243995135
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.000545554	0.006752394243995135
MONOSOMY 13Q34	0.000545554	0.006752394243995135
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.006752394243995135
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.006752394243995135
TEMTAMY SYNDROME; TEMTYS	0.000545554	0.006752394243995135
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.006752394243995135
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.006752394243995135
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995135
RECOMBINANT 8 SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 2; HPE2	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.006752394243995135
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.006752394243995135
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995135
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.006752394243995135
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.006752394243995135
WOLMAN DISEASE	0.000545554	0.006752394243995135
THYROID HYPOPLASIA	0.000545554	0.006752394243995135
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000545554	0.006752394243995135
PALLISTER-HALL SYNDROME	0.000545554	0.006752394243995135
COACH SYNDROME	0.000545554	0.006752394243995135
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.000545554	0.006752394243995135
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.006752394243995135
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.000545554	0.006752394243995135
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.006752394243995135
LEBER CONGENITAL AMAUROSIS	0.000545554	0.006752394243995135
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000545554	0.006752394243995135
HYDROXYKYNURENINURIA	0.000545554	0.006752394243995135
KBG SYNDROME	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.006752394243995135
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000545554	0.006752394243995135
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.006752394243995135
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.000545554	0.006752394243995135
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.000545554	0.006752394243995135
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000545554	0.006752394243995135
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.006752394243995135
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.006752394243995135
PFEIFFER SYNDROME TYPE 2	0.000545554	0.006752394243995135
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.006752394243995135
DISTAL MONOSOMY 19P13.3	0.000545554	0.006752394243995135
MOSAIC TRISOMY 9	0.000545554	0.006752394243995135
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000545554	0.006752394243995135
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.006752394243995135
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.006752394243995135
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.006752394243995135
DPAGT1-CDG	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA TYPE 13	0.000545554	0.006752394243995135
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.000545554	0.006752394243995135
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.000545554	0.006752394243995135
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000545554	0.006752394243995135
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 1; HPE1	0.000545554	0.006752394243995135
CONGENITAL TOXOPLASMOSIS	0.000545554	0.006752394243995135
BRESEK SYNDROME	0.000545554	0.006752394243995135
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.006752394243995135
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000545554	0.006752394243995135
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.000545554	0.006752394243995135
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.006752394243995135
GRISCELLI SYNDROME, TYPE 1	0.000545554	0.006752394243995135
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.006752394243995135
PITUITARY STALK INTERRUPTION SYNDROME	0.000545554	0.006752394243995135
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
MULTIPLE SULFATASE DEFICIENCY	0.000545554	0.006752394243995135
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000545554	0.006752394243995135
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.006752394243995135
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.006752394243995135
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.006752394243995135
INFANTILE LIVER FAILURE SYNDROME 1	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000545554	0.006752394243995135
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000545554	0.006752394243995135
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.000545554	0.006752394243995135
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.006752394243995135
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000545554	0.006752394243995135
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.000545554	0.006752394243995135
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.006752394243995135
CANAVAN DISEASE	0.000545554	0.006752394243995135
STEEL SYNDROME; STLS	0.000545554	0.006752394243995135
CINCA SYNDROME	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
MULTIPLE CARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995135
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.006752394243995135
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.006752394243995135
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.006752394243995135
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000545554	0.006752394243995135
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.006752394243995135
BARAITSER-WINTER SYNDROME 1; BRWS1	0.000545554	0.006752394243995135
CULLER-JONES SYNDROME; CJS	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000545554	0.006752394243995135
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.006752394243995135
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000545554	0.006752394243995135
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000545554	0.006752394243995135
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000545554	0.006752394243995135
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.006752394243995135
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000545554	0.006752394243995135
NOONAN SYNDROME 11; NS11	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.000545554	0.006752394243995135
SECKEL SYNDROME 8; SCKL8	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.006752394243995135
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000545554	0.006752394243995135
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000545554	0.006752394243995135
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995135
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.006752394243995135
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000545554	0.006752394243995135
EAST SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 11	0.000545554	0.006752394243995135
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.006752394243995135
COLE-CARPENTER SYNDROME	0.000545554	0.006752394243995135
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.006752394243995135
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995135
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.006752394243995135
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.006752394243995135
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000545554	0.006752394243995135
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.006752394243995135
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.006752394243995135
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000545554	0.006752394243995135
LISSENCEPHALY 4	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.006752394243995135
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.000545554	0.006752394243995135
DONNAI-BARROW SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY	0.000545554	0.006752394243995135
ZECHI-CEIDE SYNDROME	0.000545554	0.006752394243995135
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995135
HYDRANENCEPHALY	0.000545554	0.006752394243995135
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.006752394243995135
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.006752394243995135
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000545554	0.006752394243995135
JOUBERT SYNDROME 15	0.000545554	0.006752394243995135
ACROMELIC FRONTONASAL DYSPLASIA	0.000545554	0.006752394243995135
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000545554	0.006752394243995135
2P21 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.006752394243995135
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 5B	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.006752394243995135
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.006752394243995135
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.006752394243995135
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.000545554	0.006752394243995135
TRISOMY 12P	0.000545554	0.006752394243995135
MOSAIC TRISOMY 14	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000545554	0.006752394243995135
DISTAL TRISOMY 18Q	0.000545554	0.006752394243995135
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000545554	0.006752394243995135
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.006752394243995135
COFFIN-SIRIS SYNDROME 4; CSS4	0.000545554	0.006752394243995135
COFFIN-SIRIS SYNDROME 3; CSS3	0.000545554	0.006752394243995135
TRISOMY 8Q	0.000545554	0.006752394243995135
TEMTAMY SYNDROME	0.000545554	0.006752394243995135
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000545554	0.006752394243995135
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.006752394243995135
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000545554	0.006752394243995135
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 2	0.000545554	0.006752394243995135
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000545554	0.006752394243995135
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000545554	0.006752394243995135
JOUBERT SYNDROME 27	0.000545554	0.006752394243995135
JOUBERT SYNDROME 28	0.000545554	0.006752394243995135
ALAZAMI-YUAN SYNDROME	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000545554	0.006752394243995135
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000545554	0.006752394243995135
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.000545554	0.006752394243995135
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.006752394243995135
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.006752394243995135
CHOPS SYNDROME; CHOPS	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.000545554	0.006752394243995135
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.006752394243995135
MECKEL SYNDROME 13; MKS13	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.006752394243995135
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000545554	0.006752394243995135
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000545554	0.006752394243995135
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.000545554	0.006752394243995135
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000545554	0.006752394243995135
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.000545554	0.006752394243995135
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.006752394243995135
JOUBERT SYNDROME 25	0.000545554	0.006752394243995135
RING CHROMOSOME 14 SYNDROME	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.006752394243995135
AU-KLINE SYNDROME; AUKS	0.000545554	0.006752394243995135
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.006752394243995135
LYMPHEDEMA, HEREDITARY, III	0.000545554	0.006752394243995135
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.006752394243995135
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.006752394243995135
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.006752394243995135
NOONAN SYNDROME 9; NS9	0.000545554	0.006752394243995135
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000545554	0.006752394243995135
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.006752394243995135
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.006752394243995135
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.006752394243995135
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000545554	0.006752394243995135
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.006752394243995135
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.006752394243995135
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000545554	0.006752394243995135
JABERI-ELAHI SYNDROME; JABELS	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.006752394243995135
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.006752394243995135
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.000545554	0.006752394243995135
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.006752394243995135
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.006752394243995135
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000545554	0.006752394243995135
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.000545554	0.006752394243995135
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.006752394243995135
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.006752394243995135
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000545554	0.006752394243995135
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.006752394243995135
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.006752394243995135
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000545554	0.006752394243995135
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.006752394243995135
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.006752394243995135
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.006752394243995135
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000545554	0.006752394243995135
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.000545554	0.006752394243995135
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.006752394243995135
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.006752394243995135
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.006752394243995135
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.006752394243995135
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000545554	0.006752394243995135
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.006752394243995135
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.006752394243995135
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000545554	0.006752394243995135
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000545554	0.006752394243995135
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000545554	0.006752394243995135
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.006752394243995135
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000545554	0.006752394243995135
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000545554	0.006752394243995135
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.006752394243995135
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.000545554	0.006752394243995135
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000545554	0.006752394243995135
TARP SYNDROME; TARPS	0.000545554	0.006752394243995135
WAISMAN SYNDROME; WSMN	0.000545554	0.006752394243995135
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.000545554	0.006752394243995135
DISTAL MONOSOMY 1Q	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.000545554	0.006752394243995135
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.006752394243995135
STT3A-CDG	0.000545554	0.006752394243995135
STT3B-CDG	0.000545554	0.006752394243995135
GRISCELLI SYNDROME	0.000545554	0.006752394243995135
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.000545554	0.006752394243995135
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.006752394243995135
ISOLATED GLYCEROL KINASE DEFICIENCY	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.006752394243995135
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.006752394243995135
MEND SYNDROME; MEND	0.000545554	0.006752394243995135
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.000545554	0.006752394243995135
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.006752394243995135
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.006752394243995135
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000545554	0.006752394243995135
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000545554	0.006752394243995135
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.006752394243995135
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.006752394243995135
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000545554	0.006752394243995135
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.006752394243995135
SRD5A3-CDG	0.000545554	0.006752394243995135
CURRY-JONES SYNDROME	0.000545554	0.006752394243995135
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.000545554	0.006752394243995135
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.000545554	0.006752394243995135
ISOVALERIC ACIDEMIA	0.000545554	0.006752394243995135
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.006752394243995135
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.000545554	0.006752394243995135
DISTAL TRISOMY 17Q	0.000545554	0.006752394243995135
TRISOMY 18	0.000545554	0.006752394243995135
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000545554	0.006752394243995135
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000545554	0.006752394243995135
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.006752394243995135
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.006752394243995135
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.006752394243995135
CODAS SYNDROME	0.000545554	0.006752394243995135
YUNIS-VARON SYNDROME	0.000545554	0.006752394243995135
LOWRY-MACLEAN SYNDROME	0.000545554	0.006752394243995135
FUCOSIDOSIS	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.006752394243995135
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000545554	0.006752394243995135
GALACTOSEMIA	0.000545554	0.006752394243995135
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 41	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000545554	0.006752394243995135
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000545554	0.006752394243995135
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000545554	0.006752394243995135
PELLAGRA-LIKE SYNDROME	0.000545554	0.006752394243995135
PEHO SYNDROME; PEHO	0.000545554	0.006752394243995135
RAINE SYNDROME	0.000545554	0.006752394243995135
OROTIC ACIDURIA	0.000545554	0.006752394243995135
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.000545554	0.006752394243995135
LISSENCEPHALY 2; LIS2	0.000545554	0.006752394243995135
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.006752394243995135
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.000545554	0.006752394243995135
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000545554	0.006752394243995135
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.006752394243995135
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.000545554	0.006752394243995135
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.006752394243995135
MAPLE SYRUP URINE DISEASE	0.000545554	0.006752394243995135
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.006752394243995135
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000545554	0.006752394243995135
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.006752394243995135
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000545554	0.006752394243995135
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000545554	0.006752394243995135
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.000545554	0.006752394243995135
MACDERMOT-WINTER SYNDROME	0.000545554	0.006752394243995135
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000545554	0.006752394243995135
ATELOSTEOGENESIS TYPE III	0.000545554	0.006752394243995135
KETOADIPICACIDURIA	0.000545554	0.006752394243995135
PETERS-PLUS SYNDROME; PTRPLS	0.000545554	0.006752394243995135
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000545554	0.006752394243995135
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.006752394243995135
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.006752394243995135
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000545554	0.006752394243995135
COG2-CDG	0.000545554	0.006752394243995135
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, X-LINKED 72	0.000545554	0.006752394243995135
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.000545554	0.006752394243995135
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000545554	0.006752394243995135
WAARDENBURG-SHAH SYNDROME	0.000545554	0.006752394243995135
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.006752394243995135
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.000545554	0.006752394243995135
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.006752394243995135
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.006752394243995135
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.006752394243995135
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.006752394243995135
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.006752394243995135
LATHOSTEROLOSIS	0.000545554	0.006752394243995135
INFANTILE SIALIC ACID STORAGE DISEASE	0.000545554	0.006752394243995135
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.000545554	0.006752394243995135
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.006752394243995135
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.006752394243995135
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.006752394243995135
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.006752394243995135
GRACILE BONE DYSPLASIA; GCLEB	0.000545554	0.006752394243995135
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000545554	0.006752394243995135
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.000545554	0.006752394243995135
CORNELIA DE LANGE SYNDROME 3	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.000545554	0.006752394243995135
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.006752394243995135
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.006752394243995135
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000545554	0.006752394243995135
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.006752394243995135
JOUBERT SYNDROME 7	0.000545554	0.006752394243995135
NOONAN SYNDROME 5; NS5	0.000545554	0.006752394243995135
N SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.006752394243995135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000545554	0.006752394243995135
20P12.3 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 7	0.000545554	0.006752394243995135
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.006752394243995135
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000545554	0.006752394243995135
JOUBERT SYNDROME 6	0.000545554	0.006752394243995135
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.006752394243995135
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.000545554	0.006752394243995135
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000545554	0.006752394243995135
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000545554	0.006752394243995135
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.006752394243995135
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.006752394243995135
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.000545554	0.006752394243995135
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.000545554	0.006752394243995135
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995135
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.006752394243995135
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000545554	0.006752394243995135
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000545554	0.006752394243995135
JOUBERT SYNDROME 8	0.000545554	0.006752394243995135
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.006752394243995135
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.006752394243995135
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.006752394243995135
MICROVILLUS INCLUSION DISEASE	0.000545554	0.006752394243995135
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.006752394243995135
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.006752394243995135
ROIFMAN-CHITAYAT SYNDROME	0.000545554	0.006752394243995135
TRISOMY 9P	0.000545554	0.006752394243995135
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.006752394243995135
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.006752394243995135
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.006752394243995135
CENTRAL BILATERAL MACROGYRIA	0.000545554	0.006752394243995135
RFT1-CDG	0.000545554	0.006752394243995135
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000545554	0.006752394243995135
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.006752394243995135
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.006752394243995135
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.006752394243995135
MICRO SYNDROME	0.000545554	0.006752394243995135
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.000545554	0.006752394243995135
3Q29 MICRODUPLICATION SYNDROME	0.000545554	0.006752394243995135
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.006752394243995135
6Q25 MICRODELETION SYNDROME	0.000545554	0.006752394243995135
8P11.2 DELETION SYNDROME	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.006752394243995135
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.006752394243995135
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000545554	0.006752394243995135
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000545554	0.006752394243995135
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.006752394243995135
CDAGS SYNDROME	0.000545554	0.006752394243995135
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.006752394243995135
MEVALONIC ACIDURIA	0.000545554	0.006752394243995135
CONGENITAL VARICELLA SYNDROME	0.000545554	0.006752394243995135
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.006752394243995135
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.006752394243995135
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.000545554	0.006752394243995135
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.006752394243995135
LISSENCEPHALY 1; LIS1	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.006752394243995135
FUMARASE DEFICIENCY; FMRD	0.000545554	0.006752394243995135
PHACE ASSOCIATION	0.000545554	0.006752394243995135
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.006752394243995135
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.000545554	0.006752394243995135
OPITZ G/BBB SYNDROME	0.000545554	0.006752394243995135
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.006752394243995135
NOONAN SYNDROME 2; NS2	0.000545554	0.006752394243995135
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.006752394243995135
OXOGLUTARIC ACIDURIA	0.000545554	0.006752394243995135
ROBERTS SYNDROME	0.000545554	0.006752394243995135
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.006752394243995135
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.006752394243995135
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.006752394243995135
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000545554	0.006752394243995135
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
SENIOR-LOKEN SYNDROME	0.000545554	0.006752394243995135
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.006752394243995135
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.006752394243995135
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.006752394243995135
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.006752394243995135
TARP SYNDROME	0.000545554	0.006752394243995135
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000545554	0.006752394243995135
OROFACIODIGITAL SYNDROME TYPE 2	0.000545554	0.006752394243995135
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.006752394243995135
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.006752394243995135
NOONAN SYNDROME 3; NS3	0.000545554	0.006752394243995135
FRIAS SYNDROME	0.000545554	0.006752394243995135
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.006752394243995135
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.006752394243995135
GOLDBERG-SHPRINTZEN SYNDROME	0.000545554	0.006752394243995135
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000545554	0.006752394243995135
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.006752394243995135
OTOFACIOCERVICAL SYNDROME	0.000545554	0.006752394243995135
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.006752394243995135
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000545554	0.006752394243995135
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.000545554	0.006752394243995135
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.006752394243995135
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.006752394243995135
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000545554	0.006752394243995135
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.006752394243995135
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.000545554	0.006752394243995135
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.006752394243995135
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.006752394243995135
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000545554	0.006752394243995135
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.006752394243995135
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.006752394243995135
